UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 29, 2012

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

(Exact name of registrant as specified in its charter)

 

Maryland

 

1-12993

 

95-4502084

(State or other jurisdiction of
incorporation)

 

(Commission File Number)

 

(I.R.S. Employer Identification No.)

 

 

 

 

385 East Colorado Boulevard, Suite 299

 

 

Pasadena, California

 

91101

(Address of principal executive offices)

 

(Zip Code)

 

 

Registrant’s telephone number, including area code: (626) 578-0777

 

 


 

N/A

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o               Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o               Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o               Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o               Pre-commencement communications pursuant to Rule 13e-4 (c) under the Exchange Act (17 CFR 240.13e-4 (c))

 



 

Item 2.02.  Results of Operations and Financial Condition.

 

On October 29, 2012, Alexandria Real Estate Equities, Inc. (the “Company”) issued a press release entitled “Alexandria Real Estate Equities, Inc. Reports Third Quarter Ended September 30, 2012 Financial and Operating Results” which sets forth the Company’s results of operations and financial condition for the third quarter ended September 30, 2012.  The press release referred to certain supplemental information that is available on the Company’s website at www.are.com.  Copies of the press release and supplemental information are attached hereto as Exhibits 99.1 and 99.2, respectively.

 

The information contained in this Item 2.02, including the exhibits referenced herein, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section.  Such information shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

 

 

Item 9.01.  Financial Statements and Exhibits.

 

(d)   Exhibits.

 

99.1               Press Release dated October 29, 2012.

 

99.2               Alexandria Real Estate Equities, Inc.’s Earnings Press Release and Supplemental Information for the Third Quarter Ended September 30, 2012.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

 

 

 

 

 

 

 

 

October 29, 2012

By:

/s/ Joel S. Marcus

 

 

 

Joel S. Marcus

 

 

 

Chairman/Chief Executive Officer

 

 

 

(Principal Executive Officer)

 

 

 

 

 

 

 

 

 

 

By:

/s/ Dean A. Shigenaga

 

 

 

Dean A. Shigenaga

 

 

 

Chief Financial Officer

 

 

 

(Principal Financial Officer)

 

 

3



 

EXHIBIT INDEX

 

Exhibit
Number

 

Exhibit Title

99.1

 

Press Release dated October 29, 2012.

99.2

 

Alexandria Real Estate Equities, Inc.’s Earnings Press Release and Supplemental Information for the Third Quarter Ended September 30, 2012.

 

4


Exhibit 99.1

 

 

Contact:

Joel S. Marcus

 

Chairman, Chief Executive Officer, & Founder

 

Alexandria Real Estate Equities, Inc.

 

(626) 578-9693

 

Alexandria Real Estate Equities, Inc.

Reports

Third Quarter Ended September 30, 2012

 Financial and Operating Results

FFO Per Share – Diluted of $1.08 and $3.18 for Three and Nine Months Ended 3Q12

EPS – Diluted of $0.17 and $0.75 for Three and Nine Months Ended 3Q12

Significant Progress Converting Non-Income-Producing Assets into Income-Producing Operating Assets

 

*******This earnings release was initially released on October 26, 2012, and re-released on October 29, 2012, without modification. *******

 

PASADENA, CA. – October 26, 2012 – Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced financial and operating results for the third quarter ended September 30, 2012.

 

Third Quarter Ended September 30, 2012, Highlights

 

Results

 

·                   Funds From Operations (“FFO”) Attributable to Alexandria Real Estate Equities, Inc.’s Common Stockholders – Diluted, for the Three Months Ended September 30, 2012, was $67.1 Million, or $1.08 Per Share;  FFO Attributable to Alexandria Real Estate Equities, Inc.’s Common Stockholders – Diluted, for the Nine Months Ended September 30, 2012, was $196.8 Million, or $3.18 Per Share

·                   Adjusted Funds From Operations (“AFFO”) Attributable to Alexandria Real Estate Equities, Inc.’s Common Stockholders – Diluted, for the Three Months Ended September 30, 2012, was $65.0 Million, or $1.04 Per Share;  AFFO Attributable to Alexandria Real Estate Equities, Inc.’s Common Stockholders – Diluted, for the Nine Months Ended September 30, 2012, was $191.4 Million, or $3.09 Per Share

·                   Net Income Attributable to Alexandria Real Estate Equities, Inc.’s Common Stockholders – Diluted, for the Three Months Ended September 30, 2012, was $10.6 Million, or $0.17 Per Share; Net Income Attributable to Alexandria Real Estate Equities, Inc.’s Common Stockholders – Diluted, for the Three Months Ended September 30, 2012, Excluding $9.8 Million, or $0.16 Per Share, Related to Impairment of Real Estate, and Excluding $1.6 Million, or $0.03 Per Share, Related to Gain on Sale of Real Estate, was $18.8 Million, or $0.30 Per Share;  Net Income Attributable to Alexandria Real Estate Equities, Inc.’s Common Stockholders – Diluted, for the Nine Months Ended September 30, 2012, was $46.6 Million, or $0.75 Per Share; Net Income Attributable to Alexandria Real Estate Equities, Inc.’s Common Stockholders – Diluted, for the Nine Months Ended September 30, 2012, Excluding $9.8 Million, or $0.16 Per Share, Related to Impairment of Real Estate, Excluding $2.2 Million, or $0.03 Per Share, Related to Loss on Early Extinguishment of Debt, and Excluding $1.6 Million, or $0.03 Per Share, Related to Gain on Sale of Real Estate, was $57.0 Million, or $0.91 Per Share

 

Core Operating Metrics

 

·                   Total Revenues for the Three Months Ended September 30, 2012, were $145.5 Million, Compared to Total Revenues for the Three Months Ended September 30, 2011, of $138.1 Million; Total Revenues for the Nine Months Ended September 30, 2012, were $431.9 Million, Compared to Total Revenues for the Nine Months Ended September 30, 2011, of $409.0 Million

·                   Net Operating Income (“NOI”) for the Three Months Ended September 30, 2012, was $100.8 Million, Compared to NOI for the Three Months Ended September 30, 2011, of $97.2 Million; NOI for the Nine Months Ended September 30, 2012, was $304.0 Million, Compared to NOI for the Nine Months Ended September 30, 2011, of $291.0 Million

·                   Operating Margins at 69% for the Three Months Ended September 30, 2012

·                   Cash and GAAP Same Property Net Operating Income Increase of 4.3% and Decrease of 0.9%, Respectively, for the Three Months Ended September 30, 2012

·                   Cash and GAAP Same Property Net Operating Income Increase of 2.6% and Decrease of 0.8%, Respectively, for the Nine Months Ended September 30, 2012

·                   48% of Annualized Base Rent from Investment-Grade Client Tenants

·                   During the Three Months Ended September 30, 2012, Executed 47 Leases for 732,000 Rentable Square Feet, Including 266,000 Rentable Square Feet of Development and Redevelopment Space; Rental Rate Decrease of 2.9% and Increase of 7.6% on a Cash and GAAP Basis, Respectively, on Renewed/Re-Leased Space

·                   During the Nine Months Ended September 30, 2012, Executed 146 Leases for 2,603,000 Rentable Square Feet, Including 829,000 Rentable Square Feet of Development and Redevelopment Space; Rental Rate Decrease of 1.9% and Increase of 5.9% on a Cash and GAAP Basis, Respectively, on Renewed/Re-Leased Space; Excluding One Lease for 48,000 Rentable Square Feet Related to One Client Tenant in the Research Triangle Park Market and One Lease for 71,000 Rentable Square Feet Related to One Client Tenant in the Suburban Washington, D.C. Market, Rental Rates for Renewed/Re-Leased Space were, on Average, 0.1% Higher and 7.3% Higher than Rental Rates for Expiring Leases on a Cash and GAAP Basis, Respectively

·                   Occupancy Percentage for North America Operating Properties of 94.2% and Occupancy Percentage for North America Operating and Redevelopment Properties of 90.0%; Occupancy Percentage for All Operating Properties of 93.0%, Including Asia Properties, and Occupancy Percentage for All Operating and Redevelopment Properties of 88.3%, Including Asia Properties

 

Value-Added Opportunities and External Growth

 

·                   From November 2011 to September 2012, Completed Redevelopment of 10300 Campus Point Drive, Located in the San Diego Market, a 96% Leased Project with 279,138 Rentable Square Feet, Including the Completion of 189,562 Rentable Square Feet in September 2012

·                   In September 2012, Completed Development of 4755 Nexus Center Drive, Located in the San Diego Market, a 100% Leased Project with 45,255 Rentable Square Feet

·                   In June 2012, Completed Redevelopment of 3530/3550 John Hopkins Court, Located in the San Diego Market, a 100% Leased Project with 98,320 Rentable Square Feet

·                   In April 2012, Completed Development Located in the Canadian Market, a 100% Leased Project with 26,426 Rentable Square Feet

·                   In April 2012, Commenced Unconsolidated Joint Venture Development of 360 Longwood Avenue, Located in the Greater Boston Market, a 37% Pre-Leased Project with 414,000 Rentable Square Feet

·                   In January 2012, Commenced Development of 259 East Grand Avenue, Located in the San Francisco Bay Market, a 100% Pre-Leased Building with 170,618 Rentable Square Feet

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

ALL RIGHTS RESERVED © 2012

1

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Third Quarter Ended September 30, 2012, Financial and Operating Results

(Unaudited)

 

Significant Balance Sheet Milestones

 

·                   Completed $75.1 Million of Asset Sales Year to Date with Additional $34.0 Million of Land Sales Forecasted in Fourth Quarter 2012 for a Total of $109.1 Million; Additional $84.5 Million Sales of Income-Producing Assets in Process

·                   Established an “At The Market” Common Stock Offering Program Under Which We May Sell Up to $250.0 Million of Our Common Stock; and Raised $98.4 Million in Net Proceeds from Sales Under This Program for the Nine Months Ended September 30, 2012, including $58.5 Million in Net Proceeds from Sales Under This Program for the Three Months Ended September 30, 2012

·                   In June 2012, Closed a Secured Construction Loan with Aggregate Commitments of $55 Million for a Development Project at 259 East Grand Avenue located in the San Francisco Bay Market

·                   In April 2012, Amended Our $1.5 Billion Unsecured Senior Line of Credit to Reduce Its Interest Rate and Extend Its Maturity Date to April 2017, Assuming We Exercise Our Sole Right to Extend the Maturity Date Twice

·                   In April 2012, Redeemed All $129.6 Million of Our Outstanding 8.375% Series C Preferred Stock

·                   In March 2012, Completed a 6.45% Series E Preferred Stock Offering with Net Proceeds of $124.9 Million

·                   In February 2012, Completed Our Debut 4.60% Unsecured Senior Notes Offering with Net Proceeds of $544.6 Million; Net Proceeds from the Offering Were Used to Repay Certain Outstanding Variable Rate Bank Debt

·                   In February 2012, Repaid All $250 Million of Our 2012 Unsecured Senior Bank Term Loan

·                   In January and April 2012, Retired All $84.8 Million of Our 3.70% Unsecured Senior Convertible Notes

 

Events Subsequent to Quarter End

 

·                   In the Fourth Quarter of 2012, We Expect to Commence Vertical Construction of the Ground-Up Development of 430 East 29th Street, the West Tower of the Alexandria Center for Life Science – New York City, a Project with 419,806 Rentable Square Feet Located in the Greater NYC Market

 

 

VALUE-ADDED OPPORTUNITIES AND EXTERNAL GROWTH

 

Development and redevelopment

 

As of September 30, 2012, 96% of our overall leases contained annual rent escalations that were either fixed or based on a consumer price index or another index.  Our initial stabilized yield on a cash basis reflects cash rents upon stabilization and does not reflect contractual rent escalations beyond the stabilization date.  We expect, on average, our contractual cash rents related to our value-added projects to increase over time.  Initial stabilized yield is calculated as the quotient of net operating income and our investment in the property at stabilization (“Initial Stabilized Yield”).

 

During the three and nine months ended September 30, 2012, we executed leases aggregating 266,000 and 829,000 rentable square feet, respectively, related to our development and redevelopment projects.

 

In the fourth quarter of 2012, we expect to commence a ground-up development of a multi-tenant laboratory building with 419,806 rentable square feet at 430 East 29th Street, the West Tower of the Alexandria Center for Life Science – New York City.  We expect to provide an estimate of our Initial Stabilized Yields next quarter upon commencement of ground-up development.

 

From November 2011 to September 2012, we completed the redevelopment of 279,138 rentable square feet, including the completion of 189,562 rentable square feet in September 2012, at 10300 Campus Point Drive, located in the San Diego market.  This property is a multi-tenant campus with 449,759 rentable square feet that is 96% leased to (1) Eli Lilly and Company, (2) The Regents of the University of California, (3) Celgene Corporation, and (4) Covance Inc.  The Initial Stabilized Yield on a cash and GAAP basis for the 279,138 rentable square feet redevelopment project was approximately 7.9% and 7.7%, respectively.

 

In September 2012, we completed the development of 4755 Nexus Center Drive, located in the San Diego market, a single-tenant building with 45,255 rentable square feet that is 100% leased to Optimer Pharmaceuticals, Inc.  The Initial Stabilized Yield on a cash and GAAP basis for this project was approximately 6.8% and 7.5%, respectively.

 

In June 2012, we completed the redevelopment of 3530/3550 John Hopkins Court, located in the San Diego market, a multi-tenant campus with 98,320 rentable square feet that is 100% leased to (1) Genomics Institute of the Novartis Research Foundation, a non-profit research institute, and (2) a leading industrial biotechnology company.  The Initial Stabilized Yield on a cash and GAAP basis for this project was approximately 8.9% and 9.1%, respectively.

 

In April 2012, we completed the development of a building located in the Canadian market with 26,426 rentable square feet that is 100% leased to GlaxoSmithKline plc.  The Initial Stabilized Yield on a cash and GAAP basis for this project was approximately 7.7% and 8.3%, respectively.

 

In April 2012, we commenced ground-up development of 360 Longwood Avenue, located in the Longwood Medical Area of the Greater Boston market, our 414,000 rentable square feet unconsolidated joint venture development project that is 37% pre-leased to the Dana-Farber Cancer Institute, Inc.  Dana-Farber Cancer Institute, Inc. also has an option to lease an additional two floors of approximately 99,000 rentable square feet, or an additional 24% of the total rentable square feet of the project.  We expect to achieve an unlevered Initial Stabilized Yield on a cash and GAAP basis in a range from 8.1% to 8.5% and 8.7% to 9.1%, respectively.  Funding for this project is provided primarily by capital from our joint venture partner and a $213.2 million non-recourse secured construction loan.  Additionally, our share of the future funding is expected to be less than the $22.3 million distribution we received in March 2012, upon admittance of the new partner and refinancing of the project.

 

In January 2012, we commenced a ground-up development of a single-tenant building with 170,618 rentable square feet at 259 East Grand Avenue, located in the San Francisco Bay market, which is 100% pre-leased to Onyx Pharmaceuticals Inc.  We expect to achieve an Initial Stabilized Yield on both a cash and GAAP basis for this property in a range from 7.8% to 8.2%.  Funding for this project will be provided primarily by the $55 million secured construction loan we closed in June 2012.

 

Acquisitions

 

In April 2012, we acquired 3013/3033 Science Park Road located in the San Diego market, which consists of two life science laboratory buildings aggregating 176,500 rentable square feet, for approximately $13.7 million.  The property was 100% leased on a short-term basis, and thereafter, we expect to redevelop approximately 98,000 rentable square feet.  The remaining square footage will be classified as future developable square feet once the existing client tenant vacates.  We expect to provide an estimate of our Initial Stabilized Yields in the future upon commencement of development/redevelopment activity.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

2

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Third Quarter Ended September 30, 2012, Financial and Operating Results

(Tabular dollar amounts in thousands, except per square foot amounts)

(Unaudited)

 

SIGNIFICANT BALANCE SHEET MILESTONES

 

Real estate asset sales

 

In September 2012, four properties aggregating 504,130 rentable square feet met the classification requirements for held for sale.  The current buyers are expected to reposition these assets and/or incur significant investments to re-tenant the properties.  During the three months ended September 30, 2012, we recorded impairment charges aggregating approximately $9.8 million to reduce the aggregate carrying value of the properties to the estimated sales price less costs to sell.

 

 

 

 

 

 

 

Rentable/

 

Sales

 

Occupancy

 

Annualized

 

 

 

 

 

 

 

 

 

Date

 

Developable

 

Price

 

at Date

 

GAAP

 

Sales

 

Gain

 

Description

 

Location

 

of Sale

 

Square Feet

 

per SF

 

of Sale

 

NOI (1)

 

Price (2)

 

on Sale

 

Land parcels and assets with a previous operating component:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1201/1209 Mercer Street (3)

 

Seattle

 

September 2012

 

76,029

 

$

73

 

0%

 

 

$

45

 

$

5,570

 

$

54

 

801 Dexter Avenue North (3)

 

Seattle

 

August 2012

 

120,000

 

$

72

 

0%

 

 

$

(96

)

8,600

 

$

55

 

Land parcel

 

Greater Boston

 

March 2012

 

(4)

 

$

275

 

N/A

 

 

N/A

 

31,360

 

$

1,864

 

Sale of land parcels and assets with a previous operating component

 

 

 

 

 

 

 

 

 

 

 

 

 

 

45,530

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income-producing properties:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

200 Lawrence Drive/210 Welsh Pool Road

 

Pennsylvania

 

July 2012

 

210,866

 

$

94

 

100%

 

 

$

2,193

 

19,750

 (5)

$

103

 

155 Fortune Boulevard (6)

 

Route 495/Worcester

 

July 2012

 

36,000

 

$

222

 

100%

 

 

$

804

 

8,000

 

$

1,350

 

5110 Campus Drive (6)

 

Pennsylvania

 

May 2012

 

21,000

 

$

86

 

71%

 

 

$

77

 

1,800

 

$

2

 

Sales of income-producing properties

 

 

 

 

 

 

 

 

 

 

 

 

 

 

29,550

 (7)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Completed sales subtotal

 

 

 

 

 

 

 

 

 

 

 

 

 

 

75,080

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales in process

 

Various

 

Pending

 

261,000

 

$

130

 

N/A

 

 

$

(470

)

34,000

 (8)

TBD

 

Subtotal

 

 

 

 

 

 

 

 

 

 

 

 

 

 

109,080

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other incremental dispositions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales in process (9)

 

Various

 

Pending

 

504,130

 

$

174

 

N/A

 

 

$

12,798

 

84,500

 

TBD

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total projected dispositions

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

193,580

 

 

 

 

(1)

Annualized using actual year to date results as of the quarter end prior to date of sale or September 30, 2012.

(2)

Represents contractual sales price for assets sold or contractual/estimated sale price for sales in process.

(3)

Properties sold to residential developers.

(4)

In March 2012, we sold one-half of our 55% interest in a land parcel supporting a 414,000 rentable square feet project for approximately $31.4 million, or approximately $275 per rentable square foot.

(5)

Sales price reflects the near-term lease expiration of a client tenant occupying 38,513 rentable square feet, or 18% of the total rentable square feet, on the date of sale. In connection with the sale, we received an interest-only secured note receivable for $6.1 million due in 2018.

(6)

Properties were sold to client tenants.

(7)

The weighted average capitalization rate (Annualized GAAP NOI divided by Sales Price) related to sales of income-producing assets in the nine months ended September 30, 2012, was 10.4%.

(8)

Includes a $13.3 million amortizing secured note receivable due in 2014.

(9)

Includes four properties, which the buyers expect to renovate. During the three months ended September 30, 2012, we recognized an aggregate charge for impairment of real estate of approximately $9.8 million to adjust the carrying values of the four properties to their fair value, less costs to sell. We may receive a note receivable in connection with sale of one property. One sale ranging from $42 million to $47 million may close during the three months ended December 31, 2012.

 

Sale of land parcel

 

In March 2012, we contributed our 55% ownership interest in a land parcel supporting a future building with 414,000 rentable square feet in the Longwood Medical Area of the Greater Boston market to a newly formed joint venture (the “Restated JV”) with National Development and Charles River Realty Investors, and admitted as a 50% member, Clarion Partners, LLC, resulting in a reduction of our ownership interest from 55% to 27.5%.  The transfer of one-half of our 55% ownership interest in this real estate venture to Clarion Partners, LLC, was accounted for as an in-substance partial sale of an interest in the underlying real estate.  In connection with the sale of one-half of our 55% ownership interest in the land parcel, we received a special distribution of approximately $22.3 million, which included the recognition of a $1.9 million gain on sale of land and approximately $5.4 million from our share of loan refinancing proceeds.  The land parcel we sold in March 2012 did not meet the criteria for discontinued operations since the parcel did not have any significant operations prior to disposition. Pursuant to the presentation and disclosure literature on gains/losses on sales or disposals by REITs required by the Securities and Exchange Commission (“SEC”), gains or losses on sales or disposals by a REIT that do not qualify as discontinued operations are classified below (loss) income from discontinued operations in the income statement.  Accordingly, we classified the $1.9 million gain on sale of land below (loss) income from discontinued operations, net, in the condensed consolidated statements of income.  Our 27.5% share of the land was sold at approximately $31 million (including closing costs), or approximately $275 per rentable square foot.  Upon formation of the Restated JV, the existing $38.4 million secured loan was refinanced with a seven-year (including two one-year extension options) non-recourse $213 million secured construction loan with initial loan proceeds of $50 million.  As of September 30, 2012, the outstanding balance on the construction loan was $56.4 million.  We do not expect our share of capital contributions through the completion of the project to exceed the approximate $22.3 million in net proceeds received in this transaction.  Construction of this $350 million project commenced in April 2012.  The initial occupancy date for this project is expected to be in the fourth quarter of 2014.  The project is 37% pre-leased to Dana-Farber Cancer Institute, Inc.  In addition, Dana-Farber Cancer Institute, Inc. has an option to lease an additional two floors approximating 99,000 rentable square feet, or 24% of the total rentable square feet of the project.  In addition to our economic share of the joint venture, we also expect to earn development and other fees of approximately $3.5 million through 2015, and recurring annual property management fees thereafter, from this project.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

3

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Third Quarter Ended September 30, 2012, Financial and Operating Results

(Unaudited)

 

“At the market” common stock offering program

 

In June 2012, we established an “at the market” common stock offering program under which we may sell, from time to time, up to an aggregate of $250.0 million of our common stock through our sales agents, BNY Mellon Capital Markets, LLC and Credit Suisse Securities (USA) LLC, during a three-year period.  During the nine months ended September 30, 2012, we sold an aggregate of 1,366,977 shares of common stock for gross proceeds of approximately $100.0 million at an average stock price of $73.15 and net proceeds of approximately $98.4 million.  This includes the sale of an aggregate of 793,291 shares of common stock for gross proceeds of approximately $59.5 million at an average stock price of $74.97 and net proceeds of approximately $58.5 million during the three months ended September 30, 2012.  As of September 30, 2012, approximately $150.0 million of our common stock remained available for issuance under the “at the market” common stock offering program.

 

Secured construction loan for development project in San Francisco Bay market

 

In June 2012, we closed a secured construction loan with aggregate commitments of $55 million.  The construction loan matures in July 2015, and we have an option to extend the stated maturity date of July 1, 2015, by one year, twice, to July 1, 2017.  The construction loan will be used to fund the majority of the cost to complete the development of a 100% pre-leased life science laboratory building with 170,618 rentable square feet at 259 East Grand Avenue in the San Francisco Bay market.  The construction loan bears interest at the London Interbank Offered Rate (“LIBOR”) or the base rate specified in the construction loan agreement, defined as the higher of either the prime rate being offered by our lender or the federal funds rate in effect on the day of borrowing (“Base Rate”), plus in either case a specified margin of 1.50% for LIBOR borrowings or 0.25% for Base Rate borrowings.  As of September 30, 2012, commitments of $53.0 million were available.

 

Debut 4.60% unsecured senior notes payable offering

 

In February 2012, we completed the issuance of our 4.60% unsecured senior notes payable due in February 2022.  Net proceeds of approximately $544.6 million were used to repay certain outstanding variable rate bank debt, including the entire $250 million of our 2012 unsecured senior bank term loan (“2012 Unsecured Senior Bank Term Loan”), and approximately $294.6 million of outstanding borrowings under our unsecured senior line of credit.  In connection with the retirement of our 2012 Unsecured Senior Bank Term Loan, we recognized a loss on early extinguishment of debt of approximately $0.6 million related to the write-off of unamortized loan fees for the three months ended March 31, 2012.

 

Retirement of 3.70% unsecured senior convertible notes

 

During January 2012, we repurchased approximately $83.8 million in principal amount of our 3.70% unsecured senior convertible notes (“3.70% Unsecured Senior Convertible Notes”) at par, pursuant to options exercised by holders thereof under the indenture governing the notes.  During April 2012, we repurchased the remaining outstanding $1.0 million in principal amount of the notes.  In aggregate, we repurchased approximately $84.8 million in principal amount of the notes and we did not recognize a gain or loss as a result during the six months ended June 30, 2012.

 

Amendment of $1.5 billion unsecured senior line of credit

 

In April 2012, we amended our $1.5 billion unsecured senior line of credit with Merrill Lynch, Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities Inc., and Citigroup Global Markets Inc. as joint lead arrangers, and certain lenders, to extend the maturity date of our unsecured senior line of credit, provide an accordion option for up to an additional $500 million, and reduce the interest rate for outstanding borrowings.  The maturity date of the unsecured senior line of credit was extended to April 2017, assuming we exercise our sole right to extend the stated maturity date twice by an additional six months after each exercise.  Borrowings under the unsecured senior line of credit bear interest at LIBOR or the base rate specified in the amended unsecured senior line of credit agreement, plus in either case a specified margin (the “Applicable Margin”).  The Applicable Margin for LIBOR borrowings under the unsecured senior line of credit was set at 1.20%, down from 2.40% in effect immediately prior to the modification.  In addition to the Applicable Margin, our unsecured senior line of credit is subject to an annual facility fee of 0.25%.  In connection with the modification of our unsecured senior line of credit in April 2012, we recognized a loss on early extinguishment of debt of approximately $1.6 million related to the write-off of a portion of unamortized loan fees for the three months ended June 30, 2012.

 

6.45% series E preferred stock offering

 

In March 2012, we completed a public offering of 5,200,000 shares of our 6.45% series E cumulative redeemable preferred stock (“Series E Preferred Stock”).  The shares were issued at a price of $25.00 per share, resulting in net proceeds of approximately $124.9 million (after deducting underwriters’ discounts and other offering costs).  The proceeds were initially used to reduce the outstanding borrowings under our unsecured senior line of credit.  We then borrowed funds under our unsecured senior line of credit to redeem our 8.375% series C cumulative redeemable preferred stock (“Series C Preferred Stock”) in April 2012.  The dividends on our Series E Preferred Stock are cumulative and accrue from the date of original issuance.  We pay dividends quarterly in arrears at an annual rate of 6.45%, or $1.6125 per share.  Our Series E Preferred Stock has no stated maturity date, is not subject to any sinking fund or mandatory redemption provisions, and is not redeemable before March 15, 2017, except to preserve our status as a REIT.  On and after March 15, 2017, we may, at our option, redeem the Series E Preferred Stock, in whole or in part, at any time for cash at a redemption price of $25.00 per share, plus any accrued and unpaid dividends on the Series E Preferred Stock up to, but excluding, the redemption date.  In addition, upon the occurrence of a change of control, we may, at our option, redeem the Series E Preferred Stock, in whole or in part within 120 days after the first date on which such change of control occurred, by paying $25.00 per share, plus any accrued and unpaid dividends up to, but excluding, the date of redemption.  Investors in our Series E Preferred Stock generally have no voting rights.

 

8.375% series C preferred stock redemption

 

In April 2012, we redeemed all 5,185,500 outstanding shares of our Series C Preferred Stock at a price equal to $25.00 per share, or approximately $129.6 million in aggregate, and paid $0.5234375 per share, representing accumulated and unpaid dividends to the redemption date on such shares.  We recognized a charge of approximately $6.0 million to net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders in March 2012, related to the write-off of original issuance costs of the Series C Preferred Stock.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

4

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Third Quarter Ended September 30, 2012, Financial and Operating Results

(Unaudited)

 

GUIDANCE

 

Earnings outlook

 

Based on our current view of existing market conditions and certain current assumptions, we expect that our earnings per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted and FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted for the year ended December 31, 2012, will be as set forth in the table below.  The table below provides a reconciliation of FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, as adjusted, a non-GAAP measure, to earnings per share, the most directly comparable GAAP measure.

 

Guidance for the Year Ended December 31, 2012

 

Reported on October 26, 2012

 

Reported on July 30, 2012

Earnings per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted

 

$1.16 - $1.26

 

$1.36 - $1.46

Depreciation and amortization

 

$3.00 - $3.06

 

$2.93 - $2.99

Gain on sales of property

 

$(0.06)

 

$(0.03)

Impairment of real estate

 

$0.16

 

FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted

 

$4.32 - $4.36

 

$4.32 - $4.36

Write-off of unamortized loan fees upon early retirement of the 2012 Unsecured Senior Bank Term Loan

 

$0.01

 

$0.01

Write-off of unamortized loan fees upon modification of unsecured senior line of credit

 

$0.03

 

$0.03

Preferred stock redemption charge

 

$0.10

 

$0.10

Realized gain on equity investment primarily related to one non-tenant life science entity

 

$(0.09)

 

$(0.09)

FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, as adjusted

 

$4.37 - $4.41

 

$4.37 - $4.41

 

 

 

 

 

Key net operating income projection assumptions:

 

 

 

 

Same property net operating income growth – cash basis

 

3% to 4%

 

3% to 5%

Same property net operating income growth – GAAP basis

 

Slightly negative/positive

 

0% to 2%

Rental rate steps on lease renewals and re-leasing of space – cash basis

 

Slightly negative/positive

 

Slightly negative/positive

Rental rate steps on lease renewals and re-leasing of space – GAAP basis

 

Up to 5%

 

Up to 5%

Straight-line rents

 

$6.5 million/qtr

 

$6.5 million/qtr

Amortization of above and below market leases

 

$0.8 million/qtr

 

$0.8 million/qtr

Realized gain on equity investment primarily related to one non-tenant life science entity

 

$5.8 million

 

$5.8 million

 

Net operating income, net income, and FFO for the three months ended December 31, 2012

 

As of September 30, 2012, we had approximately $304.6 million and $277.5 million of construction in progress related to our five North American development and eight North American redevelopment projects, respectively. The completion of these projects, along with recently delivered projects, certain future projects, and contributions from same properties, are expected to contribute significant increases in rental income, net operating income, and cash flows.  Net operating income from continuing operations is projected to increase from $100.8 million for the three months ended September 30, 2012, to a range from $107.5 million to $109.5 million for the three months ended December 31, 2012 (after considering approximately $3.0 million in required reclassifications for discontinued operations).  Operating performance assumptions related to the completion of our North America development and redevelopment projects, including the timing of initial occupancy, stabilization dates, and Initial Stabilized Yields, are included on page 7.  Certain key assumptions regarding our projections, including the impact of various development and redevelopment projects, are included in the tables above, below, and on the following page.

 

The completion of our development and redevelopment projects will result in increased interest expense and other direct project costs, because these project costs will no longer qualify for capitalization and these costs will be expensed as incurred.  Our projections for general and administrative expenses, capitalization of interest, and interest expense, net, are included in the tables on this page.  Our projections of net operating income are subject to a number of variables and uncertainties, including those discussed under the “Forward-looking Statements” section of Part I, the “Risk Factors” section of Item 1A, and the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section under Item 7, of our annual report on Form 10-K for the year ended December 31, 2011.  To the extent our full year earnings guidance is updated during the year, we will provide additional disclosure supporting reasons for any significant changes to such guidance.  Further, we believe net operating income is a key performance indicator and is useful to investors as a performance measure because, when compared across periods, net operating income reflects the impact on operations from trends in occupancy rates, rental rates, and operating costs, providing perspective not immediately apparent from income from continuing operations.

 

Three Months Ended December 31, 2012 (in millions, except per share amounts)

 

Reported on October 26, 2012

 

Reported on July 30, 2012

Net operating income:

 

 

 

 

Continuing operations

 

$107.5 - $109.5

 

$110.5 - $112.5

Incremental dispositions classified in discontinued operations

 

$3.0

 

Total net operating income

 

$110.5 - $112.5

 

$110.5 - $112.5

General and administrative

 

$11.0 - $12.0

 

$11.0 - $12.0

Capitalization of interest

 

$13.6 - $14.6

 

N/A

Interest

 

$18.0 - $20.0

 

$19.5 - $22.5

Depreciation and amortization

 

$42.6 - $47.7

 

$42.6 - $47.7

Preferred stock dividends

 

$6.5

 

$6.5

Other

 

$1.0 - $1.4

 

$1.0 - $1.4

Net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders

 

$26.9 - $30.9

 

$26.9 - $30.9

FFO

 

$72.0 - $73.0

 

$71.1 - $73.0

FFO per share – diluted

 

$1.15 - $1.17

 

$1.15 - $1.17

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

5

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Third Quarter Ended September 30, 2012, Financial and Operating Results

(Unaudited)

Sources and uses of capital

 

We expect that our principal liquidity needs for the year ended December 31, 2012, will be satisfied by the following multiple sources of capital as shown in the table below.  There can be no assurance that our sources and uses of capital will not be materially higher or lower than these expectations.  Our liquidity available under our unsecured senior line of credit and from cash equivalents was approximately $1.2 billion as of September 30, 2012.

 

 

 

Reported on
October 26, 2012

 

Reported on
July 30, 2012

 

Sources and Uses of Capital for the Year Ended December 31, 2012 (in millions)

 

Completed

 

Projected

 

Total

 

Total

 

Sources of capital:

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities less dividends

 

$

53

 

$

28

 

$

81

 (1)

$

81

 

Asset and land sales

 

75

 

76 - 81

 (2)

151 - 156

 

112

 

Unsecured senior notes payable

 

550

 

 

550

 

550

 

Borrowings on secured construction financing

 

2

 

22

 

24

 

24

 

Series E Preferred Stock issuance

 

125

 

 

125

 

125

 

Issuances under “at the market” common stock offering program

 

98

 

 (3)

98

 

40

 

Debt, equity, and joint venture capital

 

51

 (4)

57 - 84

 (4)

108 - 135

 

236

 

Total sources of capital

 

$

954

 

$

183 - 215

 

$

1,137 - 1,169

 

$

1,168

 

 

 

 

 

 

 

 

 

 

 

Uses of capital:

 

 

 

 

 

 

 

 

 

Development, redevelopment, and construction

 

$

429

 

$

167

 

$

596

 (5)

$

646

 

Notes receivable from asset and land sales

 

6

 

13 - 45

 

19 - 51

 

 

Acquisitions

 

46

 

 

46

 

46

 

Secured debt repayments

 

8

 

3

 

11

 (6)

11

 

2012 Unsecured Senior Bank Term Loan repayment

 

250

 

 

250

 

250

 

3.70% Unsecured Senior Convertible Notes repurchase

 

85

 

 

85

 

85

 

Series C Preferred Stock redemption

 

130

 

 

130

 

130

 

Total uses of capital

 

$

954

 

$

183 - 215

 

$

1,137 - 1,169

 

$

1,168

 

 

(1)

See table of “Key Net Operating Income Projection Assumptions” and projections table in the “Net Operating Income, Net Income, and FFO for the Three Months Ended December 31, 2012” section on the preceding page.

(2)

Represents an estimate of sources of capital from pending asset and land sales. As noted in “Real Estate Asset Sales” on page 3, we have other incremental dispositions in process aggregating $84.5 million, a portion of which may close during the three months ended December 31, 2012.

(3)

See “Debt, equity, and joint venture capital.”

(4)

Represents an estimate of sources of capital primarily consisting of borrowings under our unsecured senior line of credit and proceeds from our “at the market” common stock offering program.

(5)

See “Investment to Complete” columns in the “Development and Redevelopment Projects in North America” table on the following page for additional details underlying this estimate. The decrease of approximately $50 million from the approximately $646 million previously reported on July 30, 2012, is primarily attributable to the timing of the spending moving from the three months ended December 31, 2012, to the year ended December 31, 2013.

(6)

Based upon contractually scheduled payments or maturity dates.

 

The key assumptions behind the sources and uses of capital in the table above are a favorable capital market environment and performance of our core operations in areas such as delivery of current and future development and redevelopment projects, leasing activity, and renewals.  Our expected sources and uses of capital are subject to a number of variables and uncertainties, including those discussed under the “Forward-looking statements” section of Part I, the “Risk Factors” section of Item 1A, and the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section under Item 7, of our annual report on Form 10-K for the year ended December 31, 2011.  We expect to update our forecast of sources and uses of capital on a quarterly basis.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

6

 

 



 

Development and Redevelopment Projects in North America
September 30, 2012

(Tabular dollar amounts in thousands)

(Unaudited)

 

 

 

Project RSF

 

Leased Status RSF

 

Investment

 

Initial Stabilized

 

Project

 

Occu-

 

Stabili-

 

Market – Submarket/

 

In

 

 

 

 

 

 

 

 

 

 

 

 

 

% Leased/

 

September 30, 2012

 

To Complete

 

Total at

 

Yield (1)

 

Start

 

pancy

 

zation

 

Property

 

Service

 

CIP

 

Total

 

Leased

 

Negotiating

 

Marketing

 

Total

 

Negotiating

 

In Service

 

CIP

 

2012

 

Thereafter

 

Completion

 

Cash

 

GAAP

 

Date

 

Date

 

Date

 

Development projects in North America

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater Boston – Cambridge

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

225 Binney Street

 

 

303,143

 

303,143

 

303,143

 

 

 

303,143

 

100%

 

$

 

$

84,163

 

$

8,788

 

$

87,322

 

$

180,273

 

7.5%

 

8.1%

 

4Q11

 

4Q13

 

4Q13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Francisco Bay – Mission Bay

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

499 Illinois Street (2)

 

 

222,780

 

222,780

 

 

 

222,780

 

222,780

 

 

$

 

$

111,219

 

$

2,867

 

$

39,123

 

$

153,209

 

6.4%

 

7.2%

 

2Q11

 

2Q14

 

1Q15

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Francisco Bay – South SF

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

259 East Grand Avenue (3)

 

 

170,618

 

170,618

 

170,618

 

 

 

170,618

 

100%

 

$

 

$

45,226

 

$

13,498

 (3)

$

22,137

 (3)

$

80,861

 

7.8-8.2%

 

7.8-8.2%

 

1Q12

 

4Q12

 

4Q12

 

400/450 East Jamie Court

 

99,694

 

63,342

 

163,036

 

127,732

 

 

35,304

 

163,036

 

78%

 

$

58,481

 

$

39,340

 

$

5,962

 

$

9,230

 

$

113,013

 

4.2%

 

4.3%

 

4Q06

 

3Q11

 

2Q13

 

Other - 400/450 East Jamie Court (4)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

20,659

 

$

(20,659

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Diego – University Town Center

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5200 Illumina Way

 

 

127,373

 

127,373

 

127,373

 

 

 

127,373

 

100%

 

$

 

$

45,330

 

$

2,229

 

$

1,741

 

$

49,300

 

7.0%

 

10.8%

 

4Q10

 

4Q12

 

4Q12

 

Development projects in North America

 

99,694

 

887,256

 

986,950

 

728,866

 

 

258,084

 

986,950

 

74%

 

$

79,140

 

$

304,619

 

$

33,344

 

$

159,553

 

$

576,656

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redevelopment projects in North America

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater Boston – Cambridge

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

400 Technology Square

 

 

212,123

 

212,123

 

169,939

 

 

42,184

 

212,123

 

80%

 

$

 

$

111,297

 

$

15,891

 

$

17,500

 

$

144,688

 

8.1%

 

8.9%

 

4Q11

 

4Q12

 

4Q13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Seattle – Lake Union

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1551 Eastlake Avenue

 

65,342

 

52,141

 

117,483

 

74,914

 

8,000

 

34,569

 

117,483

 

71%

 

$

36,148

 

$

20,366

 

$

2,730

 

$

4,766

 

$

64,010

 

6.7%

 

6.7%

 

4Q11

 

4Q11

 

4Q13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Suburban and other redevelopment projects

 

18,461

 

326,262

 

344,723

 

211,388

 

55,270

 

78,065

 

344,723

 

77%

 

$

11,840

 

$

151,650

 

$

7,504

 

$

37,590

 

$

208,584

 

 

 

 

 

 

 

 

 

 

 

Other – suburban and other redevelopment projects (4)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

5,807

 

$

(5,807

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redevelopment projects in North America

 

83,803

 

590,526

 

674,329

 

456,241

 

63,270

 

154,818

 

674,329

 

77%

 

$

53,795

 

$

277,506

 

$

26,125

 

$

59,856

 

$

417,282

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total development and redevelopment projects in North America

 

183,497

 

1,477,782

 

1,661,279

 

1,185,107

 

63,270

 

412,902

 

1,661,279

 

75%

 

$

132,935

 

$

582,125

 

$

59,469

 

$

219,409

 

$

993,938

 

 

 

 

 

 

 

 

 

 

 

 

(1)

As of September 30, 2012, 96% of our overall leases contained annual rent escalations that were either fixed or based on a consumer price index or another index. Our Initial Stabilized Yield on a cash basis reflects cash rents upon stabilization and does not reflect contractual rent escalations beyond the stabilization date. We expect, on average, our contractual cash rents related to our value-added projects to increase over time.

(2)

The cash and GAAP Initial Stabilized Yields related to the development of 499 Illinois Street declined by approximately 0.3% and 0.2%, respectively, to allow for a slightly longer absorption period. Despite this change, we still expect to achieve overall yields for the entire project (including the occupied portion of 409 Illinois) within our original expectations of 6.5%-7.0% and 7.2%-7.6% for cash and GAAP, respectively.

(3)

Funding for this project will be provided primarily by the $55 million secured construction loan we closed in June 2012.

(4)

As of the period end, some portion of the real estate basis associated with the rentable square feet under development or redevelopment was classified as in service because activities necessary to prepare the asset for its intended use were no longer in process. In the near future, we anticipate recommencing activities necessary to prepare the asset for its intended use upon execution of leasing and final decisions related to design of each space.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

7

 

 



 

Third Quarter Ended September 30, 2012, Financial and Operating Results

 

EARNINGS CALL INFORMATION

 

We will host a conference call on Monday, October 29, 2012, at 3:00 p.m. Eastern Time (“ET”)/12:00 p.m. noon Pacific Time (“PT”) that is open to the general public to discuss our financial and operating results for the three months and nine months ended September 30, 2012.  To participate in this conference call, dial (800) 447-0521 or (847) 413-3238 and confirmation code 33218271, shortly before 3:00 p.m. ET/12:00 p.m. noon PT.  The audio web cast can be accessed at: www.are.com, in the “For Investors” section.  A replay of the call will be available for a limited time from 5:30 p.m. ET/2:30 p.m. PT on Monday, October 29, 2012.  The replay number is (888) 843-7419 or (630) 652-3042 and the confirmation code is 33218271.

 

Additionally, a copy of this Earnings Press Release and Supplemental Information for the third quarter ended September 30, 2012, are available in the “For Investors” section of our website at www.are.com.

 

About the Company

 

Alexandria Real Estate Equities, Inc. (NYSE: ARE), a self-administered and self-managed REIT, is the largest and leading investment-grade REIT focused principally on owning, operating, developing, redeveloping, and acquiring high-quality, sustainable real estate for the broad and diverse life science industry.  Founded in 1994, Alexandria was the first REIT to identify and pursue the laboratory niche and has since had the first-mover advantage in every core life science cluster location including Greater Boston, San Francisco Bay, San Diego, New York City, Seattle, Suburban Washington, D.C., and Research Triangle Park. Alexandria’s high-credit client tenants span the life science industry, including renowned academic and medical institutions, multinational pharmaceutical companies, public and private biotechnology entities, United States government research agencies, medical device companies, industrial biotech companies, venture capital firms, and life science product and service companies. As the recognized real estate partner of the life science industry, Alexandria has a superior track record in driving client tenant productivity and innovation through its best-in-class laboratory and office space, collaborative locations adjacent to leading academic and medical institutions, unparalleled life science real estate expertise and services, and longstanding and expansive network in the life science community, which we believe result in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For additional information on Alexandria Real Estate Equities, Inc., please visit www.are.com.

 

***********

 

This press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  Such forward-looking statements include, without limitation, statements regarding our 2012 earnings per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, 2012 FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, net operating income, and net income, for the year ended December 31, 2012, and our projected sources and uses of capital in 2012.  Our actual results may differ materially from those projected in such forward-looking statements.  Factors that might cause such a difference include, without limitation, our failure to obtain capital (debt, construction financing, and/or equity) or refinance debt maturities, increased interest rates and operating costs, adverse economic or real estate developments in our markets, our failure to successfully complete and lease our existing space held for redevelopment and new properties acquired for that purpose and any properties undergoing development, our failure to successfully operate or lease acquired properties, decreased rental rates or increased vacancy rates or failure to renew or replace expiring leases, defaults on or non-renewal of leases by client tenants, general and local economic conditions, and other risks and uncertainties detailed in our filings with the SEC.  All forward-looking statements are made as of the date of this press release, and we assume no obligation to update this information.  For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in our forward-looking statements, and risks to our business in general, please refer to our SEC filings, including our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

8

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Condensed Consolidated Statements of Income

(Dollars in thousands, except per share amounts)

(Unaudited)

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

9/30/12

 

6/30/12

 

3/31/12

 

12/31/11

 

9/30/11

 

9/30/12

 

9/30/11

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rental

 

$

108,367

 

$

106,463

 

$

103,417

 

$

104,634

 

$

102,353

 

$

318,247

 

$

309,532

 

Tenant recoveries

 

34,448

 

32,172

 

32,386

 

33,031

 

33,226

 

99,006

 

95,270

 

Other income

 

2,640

 

9,381

 

2,629

 

1,584

 

2,475

 

14,650

 

4,178

 

Total revenues

 

145,455

 

148,016

 

138,432

 

139,249

 

138,054

 

431,903

 

408,980

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rental operations

 

44,614

 

42,359

 

40,911

 

41,553

 

40,859

 

127,884

 

118,014

 

General and administrative

 

12,485

 

12,309

 

10,358

 

10,601

 

10,289

 

35,152

 

30,528

 

Interest

 

17,094

 

17,922

 

16,227

 

14,757

 

14,273

 

51,243

 

48,621

 

Depreciation and amortization

 

47,176

 

51,276

 

42,326

 

39,762

 

38,747

 

140,778

 

113,326

 

Total expenses

 

121,369

 

123,866

 

109,822

 

106,673

 

104,168

 

355,057

 

310,489

 

Income from continuing operations before loss on early extinguishment of debt

 

24,086

 

24,150

 

28,610

 

32,576

 

33,886

 

76,846

 

98,491

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss on early extinguishment of debt

 

 

(1,602

)

(623

)

 

(2,742

)

(2,225

)

(6,485

)

Income from continuing operations

 

24,086

 

22,548

 

27,987

 

32,576

 

31,144

 

74,621

 

92,006

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Loss) income from discontinued operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from discontinued operations before impairment of real estate

 

4,018

 

3,093

 

2,924

 

2,886

 

2,799

 

10,035

 

8,873

 

Impairment of real estate

 

(9,799

)

 

 

 

(994

)

(9,799

)

(994

)

(Loss) income from discontinued operations, net

 

(5,781

)

3,093

 

2,924

 

2,886

 

1,805

 

236

 

7,879

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain on sale of land parcel

 

 

 

1,864

 

 

46

 

1,864

 

46

 

Net income

 

18,305

 

25,641

 

32,775

 

35,462

 

32,995

 

76,721

 

99,931

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to noncontrolling interests

 

828

 

851

 

711

 

1,142

 

966

 

2,390

 

2,833

 

Dividends on preferred stock

 

6,471

 

6,903

 

7,483

 

7,090

 

7,089

 

20,857

 

21,267

 

Preferred stock redemption charge

 

 

 

5,978

 

 

 

5,978

 

 

Net income attributable to unvested restricted stock awards

 

360

 

271

 

235

 

270

 

278

 

866

 

818

 

Net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders

 

$

10,646

 

$

17,616

 

$

18,368

 

$

26,960

 

$

24,662

 

$

46,630

 

$

75,013

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic and diluted:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.26

 

$

0.24

 

$

0.25

 

$

0.39

 

$

0.37

 

$

0.75

 

$

1.15

 

Discontinued operations, net

 

(0.09

)

0.05

 

0.05

 

0.05

 

0.03

 

 

0.14

 

Earnings per share – basic and diluted

 

$

0.17

 

$

0.29

 

$

0.30

 

$

0.44

 

$

0.40

 

$

0.75

 

$

1.29

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares of common stock outstanding for calculating earnings per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic

 

62,364,210

 

61,663,367

 

61,507,807

 

61,427,495

 

61,295,659

 

61,847,023

 

58,271,270

 

Dilutive effect of stock options

 

 

173

 

1,160

 

3,939

 

8,310

 

448

 

13,475

 

Weighted average shares of common stock outstanding for calculating earnings per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted

 

62,364,210

 

61,663,540

 

61,508,967

 

61,431,434

 

61,303,969

 

61,847,471

 

58,284,745

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

9

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Condensed Consolidated Balance Sheets

(Dollars in thousands)

(Unaudited)

 

 

 

September 30,

 

June 30,

 

March 31,

 

December 31,

 

September 30,

 

 

 

2012

 

2012

 

2012

 

2011

 

2011

 

Assets

 

 

 

 

 

 

 

 

 

 

 

Investments in real estate, net

 

$

6,300,027

 

$

6,208,354

 

$

6,113,252

 

$

6,008,440

 

$

5,925,292

 

Cash and cash equivalents

 

94,904

 

80,937

 

77,361

 

78,539

 

73,056

 

Restricted cash

 

44,863

 

41,897

 

39,803

 

23,332

 

27,929

 

Tenant receivables

 

10,124

 

6,143

 

8,836

 

7,480

 

6,599

 

Deferred rent

 

160,914

 

155,295

 

150,515

 

142,097

 

132,954

 

Deferred leasing and financing costs, net

 

152,021

 

151,355

 

143,754

 

135,550

 

134,366

 

Investments

 

107,808

 

104,454

 

98,152

 

95,777

 

88,777

 

Other assets

 

94,356

 

93,304

 

86,418

 

82,914

 

66,583

 

Total assets

 

$

6,965,017

 

$

6,841,739

 

$

6,718,091

 

$

6,574,129

 

$

6,455,556

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities, Noncontrolling Interests, and Equity

 

 

 

 

 

 

 

 

 

 

 

Secured notes payable

 

$

719,350

 

$

719,977

 

$

721,715

 

$

724,305

 

$

760,882

 

Unsecured senior notes payable

 

549,794

 

549,783

 

550,772

 

84,959

 

84,484

 

Unsecured senior line of credit

 

413,000

 

379,000

 

167,000

 

370,000

 

814,000

 

Unsecured senior bank term loans

 

1,350,000

 

1,350,000

 

1,350,000

 

1,600,000

 

1,000,000

 

Accounts payable, accrued expenses, and tenant security deposits

 

376,785

 

348,037

 

323,002

 

325,393

 

330,044

 

Dividends payable

 

39,468

 

38,357

 

36,962

 

36,579

 

35,287

 

Preferred stock redemption liability

 

 

 

129,638

 

 

 

Total liabilities

 

3,448,397

 

3,385,154

 

3,279,089

 

3,141,236

 

3,024,697

 

 

 

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redeemable noncontrolling interests

 

15,610

 

15,817

 

15,819

 

16,034

 

15,931

 

 

 

 

 

 

 

 

 

 

 

 

 

Alexandria Real Estate Equities, Inc.’s stockholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

Series C Preferred Stock

 

 

 

 

129,638

 

129,638

 

Series D Convertible Preferred Stock

 

250,000

 

250,000

 

250,000

 

250,000

 

250,000

 

Series E Preferred Stock

 

130,000

 

130,000

 

130,000

 

 

 

Common stock

 

632

 

622

 

616

 

616

 

614

 

Additional paid-in capital

 

3,094,987

 

3,053,269

 

3,022,242

 

3,028,558

 

3,025,444

 

Accumulated other comprehensive loss

 

(19,729

)

(37,370

)

(23,088

)

(34,511

)

(32,202

)

Alexandria Real Estate Equities, Inc.’s stockholders’ equity

 

3,455,890

 

3,396,521

 

3,379,770

 

3,374,301

 

3,373,494

 

Noncontrolling interests

 

45,120

 

44,247

 

43,413

 

42,558

 

41,434

 

Total equity

 

3,501,010

 

3,440,768

 

3,423,183

 

3,416,859

 

3,414,928

 

Total liabilities, noncontrolling interests, and equity

 

$

6,965,017

 

$

6,841,739

 

$

6,718,091

 

$

6,574,129

 

$

6,455,556

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

10

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Funds From Operations and Adjusted Funds From Operations

(Dollars in thousands, except per share amounts)

(Unaudited)

 

The following table presents a reconciliation of net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic, the most directly comparable financial measure presented in accordance with GAAP, to FFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, FFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, as adjusted, and AFFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted for the periods below:

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

9/30/12

 

6/30/12

 

3/31/12

 

12/31/11

 

9/30/11

 

9/30/12

 

9/30/11

 

Net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic

 

$

10,646

 

$

17,616

 

$

18,368

 

$

26,960

 

$

24,662

 

$

46,630

 

$

75,013

 

Depreciation and amortization

 

48,173

 

52,355

 

43,405

 

40,966

 

39,990

 

143,933

 

117,060

 

Gain on sale of real estate

 

(1,562

)

(2

)

 

 

 

(1,564

)

 

Impairment of real estate

 

9,799

 

 

 

 

994

 

9,799

 

994

 

Gain on sale of land parcel

 

 

 

(1,864

)

 

(46

)

(1,864

)

(46

)

Amount attributable to noncontrolling interests/unvested stock awards:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

1,188

 

1,122

 

946

 

1,412

 

1,244

 

3,256

 

3,651

 

FFO

 

(1,148

)

(1,133

)

(1,156

)

(1,539

)

(1,580

)

(3,452

)

(4,877

)

FFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic

 

67,096

 

69,958

 

59,699

 

67,799

 

65,264

 

196,738

 

191,795

 

Assumed conversion of 8.00% Unsecured Senior Convertible Notes

 

5

 

6

 

5

 

5

 

4

 

16

 

16

 

FFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted

 

67,101

 

69,964

 

59,704

 

67,804

 

65,268

 

196,754

 

191,811

 

Realized gain on equity investment primarily related to one non-tenant life science entity

 

 

(5,811

)

 

 

 

(5,811

)

 

Loss on early extinguishment of debt

 

 

1,602

 

623

 

 

2,742

 

2,225

 

6,485

 

Preferred stock redemption charge

 

 

 

5,978

 

 

 

5,978

 

 

Allocation to unvested restricted stock awards

 

 

35

 

(53

)

 

(38

)

(21

)

(59

)

FFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, as adjusted

 

$

67,101

 

$

65,790

 

$

66,252

 

$

67,804

 

$

67,972

 

$

199,125

 

$

198,237

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-incremental revenue-enhancing capital expenditures:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Building improvements

 

(935

)

(594

)

(210

)

(675

)

(550

)

(1,739

)

(1,856

)

Tenant improvements and leasing commissions

 

(1,844

)

(2,148

)

(2,019

)

(6,083

)

(2,119

)

(6,011

)

(4,517

)

Straight-line rent

 

(5,225

)

(5,195

)

(8,796

)

(9,558

)

(7,647

)

(19,216

)

(17,239

)

Straight-line rent on ground leases

 

201

 

1,207

 

1,406

 

1,221

 

1,143

 

2,814

 

3,483

 

Capitalized income from development projects

 

50

 

72

 

478

 

537

 

930

 

600

 

3,436

 

Amortization of acquired above and below market leases

 

(778

)

(778

)

(800

)

(812

)

(940

)

(2,356

)

(8,520

)

Amortization of loan fees

 

2,470

 

2,214

 

2,643

 

2,551

 

2,144

 

7,327

 

6,749

 

Amortization of debt premiums/discounts

 

112

 

110

 

179

 

565

 

750

 

401

 

3,254

 

Stock compensation

 

3,845

 

3,274

 

3,293

 

3,306

 

3,344

 

10,412

 

8,449

 

Allocation to unvested restricted stock awards

 

19

 

15

 

31

 

80

 

31

 

67

 

61

 

AFFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted

 

$

65,016

 

$

63,967

 

$

62,457

 

$

58,936

 

$

65,058

 

$

191,424

 

$

191,537

 

 

The following table presents a reconciliation of net income per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders - basic, to FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders - diluted, FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, as adjusted, and AFFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders - diluted for the periods below.  For the computation of the weighted average shares used to compute the per share information, refer to the “Definitions and Other Information” section in our supplemental information:

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

9/30/12

 

6/30/12

 

3/31/12

 

12/31/11

 

9/30/11

 

9/30/12

 

9/30/11

 

Net income per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic

 

$

0.17

 

$

0.29

 

$

0.30

 

$

0.44

 

$

0.40

 

$

0.75

 

$

1.29

 

Depreciation and amortization

 

0.78

 

0.84

 

0.70

 

0.67

 

0.65

 

2.34

 

2.00

 

Gain on sale of real estate

 

(0.03

)

 

 

 

 

(0.03

)

 

Impairment of real estate

 

0.16

 

 

 

 

0.02

 

0.16

 

0.02

 

Gain on sale of land parcel

 

 

 

(0.03

)

 

 

(0.03

)

 

Amount attributable to noncontrolling interests/unvested stock awards:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

0.02

 

0.02

 

0.02

 

0.02

 

0.02

 

0.05

 

0.06

 

FFO

 

(0.02

)

(0.02

)

(0.02

)

(0.03

)

(0.03

)

(0.06

)

(0.08

)

FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic

 

1.08

 

1.13

 

0.97

 

1.10

 

1.06

 

3.18

 

3.29

 

Assumed conversion of 8.00% Unsecured Senior Convertible Notes

 

 

 

 

 

 

 

 

FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted

 

1.08

 

1.13

 

0.97

 

1.10

 

1.06

 

3.18

 

3.29

 

Realized gain on equity investment primarily related to one non-tenant life science entity

 

 

(0.09

)

 

 

 

(0.09

)

 

Loss on early extinguishment of debt

 

 

0.03

 

0.01

 

 

0.05

 

0.03

 

0.11

 

Preferred stock redemption charge

 

 

 

0.10

 

 

 

0.10

 

 

FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, as adjusted

 

$

1.08

 

$

1.07

 

$

1.08

 

$

1.10

 

$

1.11

 

$

3.22

 

$

3.40

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-incremental revenue-enhancing capital expenditures:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Building improvements

 

(0.01

)

(0.01

)

 

(0.01

)

(0.01

)

(0.03

)

(0.03

)

Tenant improvements and leasing commissions

 

(0.03

)

(0.03

)

(0.03

)

(0.10

)

(0.03

)

(0.10

)

(0.08

)

Straight-line rent

 

(0.08

)

(0.08

)

(0.14

)

(0.16

)

(0.12

)

(0.31

)

(0.30

)

Straight-line rent on ground leases

 

 

0.02

 

0.02

 

0.02

 

0.02

 

0.05

 

0.06

 

Capitalized income from development projects

 

 

 

0.01

 

0.01

 

0.02

 

0.01

 

0.06

 

Amortization of acquired above and below market leases

 

(0.01

)

(0.01

)

(0.01

)

(0.01

)

(0.02

)

(0.04

)

(0.15

)

Amortization of loan fees

 

0.03

 

0.03

 

0.04

 

0.05

 

0.03

 

0.11

 

0.13

 

Amortization of debt premiums/discounts

 

 

 

 

0.01

 

0.01

 

0.01

 

0.06

 

Stock compensation

 

0.06

 

0.05

 

0.05

 

0.05

 

0.05

 

0.17

 

0.14

 

AFFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted

 

$

1.04

 

$

1.04

 

$

1.02

 

$

0.96

 

$

1.06

 

$

3.09

 

$

3.29

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

11

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Non-GAAP Measures

(Tabular dollar amounts in thousands)

(Unaudited)

Funds from operations and funds from operations, as adjusted

 

GAAP basis accounting for real estate assets utilizes historical cost accounting and assumes real estate values diminish over time.  In an effort to overcome the difference between real estate values and historical cost accounting for real estate assets, the Board of Governors of the National Association of Real Estate Investment Trusts (“NAREIT”) established the measurement tool of FFO.  Since its introduction, FFO has become a widely used non-GAAP financial measure among equity REITs.  We believe that FFO is helpful to investors as an additional measure of the performance of an equity REIT.  Moreover, we believe that FFO, as adjusted, is also helpful because it allows investors to compare our performance to the performance of other real estate companies between periods, and on a consistent basis, without having to account for differences caused by investment decisions, financing decisions, terms of securities, capital structures, and capital market transactions. We compute FFO in accordance with standards established by the Board of Governors of NAREIT in its April 2002 white paper and related implementation guidance (“NAREIT White Paper”). The NAREIT White Paper defines FFO as net income (computed in accordance with GAAP), excluding gains (losses) from sales and impairments of real estate, plus real estate related depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures.  Impairments of real estate relate to decreases in the estimated fair value of real estate due to changes in general market conditions and do not necessarily reflect the operating performance of the properties during the corresponding period.  Impairments of real estate represent the non-cash write-down of assets when fair value over the recoverability period is less than the carrying value.  We compute FFO, as adjusted, as FFO calculated in accordance with the NAREIT White Paper, plus losses from early extinguishment of debt and preferred stock redemption charges, less realized gain on equity investment primarily related to one non-tenant life science entity, and the amount of such items which are allocable to our unvested restricted stock awards. Our calculations of both FFO and FFO, as adjusted, may differ from those methodologies utilized by other equity REITs for similar performance measurements, and, accordingly, may not be comparable to other equity REITs.  Neither FFO nor FFO, as adjusted, should be considered as an alternative to net income (determined in accordance with GAAP) as an indication of financial performance, or to cash flows from operating activities (determined in accordance with GAAP) as a measure of liquidity, nor are they indicative of the availability of funds for our cash needs, including funds available to make distributions.

 

Adjusted funds from operations

 

AFFO is a non-GAAP financial measure that we use as a supplemental measure of our performance.  We compute AFFO by adding to or deducting from FFO, as adjusted: (1) non-incremental revenue-enhancing capital expenditures, tenant improvements, and leasing commissions (excludes redevelopment expenditures); (2) effects of straight-line rent and straight-line rent on ground leases; (3) capitalized income from development projects; (4) amortization of acquired above and below market leases, loan fees, and debt premiums/discounts; (5) non-cash compensation expense; and (6) allocation of AFFO attributable to unvested restricted stock awards.

 

We believe that AFFO is a useful supplemental performance measure because it further adjusts to: (1) deduct certain expenditures which, although capitalized and included in depreciation expense, do not enhance the revenue or cash flows of our properties; (2) eliminate the effect of straight-lining our rental income and capitalizing income from development projects in order to reflect the actual amount of contractual rents due in the period presented; and (3) eliminate the effect of non-cash items that are not indicative of our core operations and do not actually reduce the amount of cash generated by our operations.  We believe that eliminating the effect of non-cash charges related to stock-based compensation facilitates a comparison of our operations across periods and among other equity REITs without the variances caused by different valuation methodologies, the volatility of the expense (which depends on market forces outside of our control), and the assumptions and the variety of award types that a company can use.  We believe that AFFO provides useful information by excluding certain items that are not representative of our core operating results because such items are dependent upon historical costs or subject to judgmental valuation inputs and the timing of our decisions.

 

AFFO is not intended to represent cash flow for the period, and is only intended to provide an additional measure of performance.  We believe that net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders is the most directly comparable GAAP financial measure to AFFO.  We believe that AFFO is a widely recognized measure of the operations of equity REITs, and presenting AFFO will enable investors to assess our performance in comparison to other equity REITs.  However, other equity REITs may use different methodologies for calculating AFFO and, accordingly, our AFFO may not be comparable to AFFO calculated by other equity REITs.  AFFO should not be considered as an alternative to net income (determined in accordance with GAAP) as an indication of financial performance, or to cash flows from operating activities (determined in accordance with GAAP) as a measure of our liquidity, nor is it indicative of funds available to fund our cash needs, including our ability to make distributions.

 

Net operating income

 

Net operating income is a non-GAAP financial measure equal to income from continuing operations, the most directly comparable GAAP financial measure, plus loss on early extinguishment of debt, depreciation and amortization, interest expense, and general and administrative expense.  We believe net operating income provides useful information to investors regarding our financial condition and results of operations because it reflects primarily those income and expense items that are incurred at the property level.  Therefore, we believe net operating income is a useful measure for evaluating the operating performance of our real estate assets.  Net operating income on a cash basis is net operating income on a GAAP basis, adjusted to exclude the effect of straight-line rent adjustments required by GAAP.  We believe that net operating income on a cash basis is helpful to investors as an additional measure of operating performance because it eliminates straight-line rent adjustments to rental revenue.

 

Further, we believe net operating income is useful to investors as a performance measure, because when compared across periods, net operating income reflects the impact on operations from trends in occupancy rates, rental rates, and operating costs, providing perspective not immediately apparent from income from continuing operations.  Net operating income excludes certain components from income from continuing operations in order to provide results that are more closely related to the results of operations of our properties.  For example, interest expense is not necessarily linked to the operating performance of a real estate asset and is often incurred at the corporate level rather than at the property level.  In addition, depreciation and amortization, because of historical cost accounting and useful life estimates, may distort operating performance at the property level.  Property operating expenses that are included in determining net operating income consist of costs that are related to our operating properties, such as utilities, repairs and maintenance, rental expense related to ground leases, contracted services, such as janitorial, engineering, and landscaping, property taxes and insurance, and property level salaries.  General and administrative expenses consist primarily of accounting and corporate compensation, corporate insurance, professional fees, office rent, and office supplies, that are incurred as part of corporate office management. Net operating income presented by us may not be comparable to net operating income reported by other equity REITs that define net operating income differently.  We believe that in order to facilitate a clear understanding of our operating results, net operating income should be examined in conjunction with income from continuing operations as presented in our condensed consolidated statements of income.  Net operating income should not be considered as an alternative to income from continuing operations as an indication of our performance, or as an alternative to cash flows as a measure of liquidity, or our ability to make distributions.  The following table presents a reconciliation of net operating income to income from continuing operations:

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

September 30, 2012

 

September 30, 2011

 

September 30, 2012

 

September 30, 2011

 

Total revenues

 

$

145,455

 

$

138,054

 

$

431,903

 

$

408,980

 

Rental operating expenses

 

44,614

 

40,859

 

127,884

 

118,014

 

Net operating income

 

100,841

 

97,195

 

304,019

 

290,966

 

Operating margins

 

69%

 

70%

 

70%

 

71%

 

General and administrative

 

12,485

 

10,289

 

35,152

 

30,528

 

Interest

 

17,094

 

14,273

 

51,243

 

48,621

 

Depreciation and amortization

 

47,176

 

38,747

 

140,778

 

113,326

 

Loss on early extinguishment of debt

 

 

2,742

 

2,225

 

6,485

 

Income from continuing operations

 

$

24,086

 

$

31,144

 

$

74,621

 

$

92,006

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

12

 

 


Exhibit 99.2

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Table of Contents

September 30, 2012

 

 

Page

Company Profile

ii

Investor Information

iii

 

 

EARNINGS PRESS RELEASE

 

Third Quarter Ended September 30, 2012, Financial and Operating Results

1

Guidance

5

Condensed Consolidated Statements of Income

9

Condensed Consolidated Balance Sheets

10

Funds From Operations and Adjusted Funds From Operations

11

Non-GAAP Measures

12

 

 

SUPPLEMENTAL INFORMATION

 

Financial and Asset Base Highlights

13

 

 

Core Operating Metrics

 

Core Operating Metrics

14

Summary of Same Property Comparisons

15

Summary of Leasing Activity

16

Summary of Lease Expirations

17

Summary of Properties and Occupancy

18

Property Listing

19

Top 20 Client Tenants and Client Tenant Mix

22

 

 

Value-Added Opportunities and External Growth

 

Significant Future Growth Opportunities

23

Summary of Investments in Real Estate

24

Development and Redevelopment Projects in North America

25

Investment in Unconsolidated Real Estate Entity and Future Value-Added Projects in North America

26

Summary of Capital Expenditures

27

Summary of Real Estate Investment in Asia

28

 

 

Balance Sheet

 

Credit Metrics

29

Summary of Debt

30

 

 

Definitions and Other Information

 

Definitions and Other Information

32

 

This document includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  You can identify the forward-looking statements by their use of forward-looking words, such as “believes,” “expects,” “may,” “will,” “should,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” or “anticipates,” or the negative of those words or similar words.  Our actual results may differ materially from those projected in such forward-looking statements.  Factors that might cause such a difference include, without limitation, our failure to obtain capital (debt, construction financing, and/or equity) or refinance debt maturities, increased interest rates and operating costs, adverse economic or real estate developments in our markets, our failure to successfully complete and lease our existing space held for redevelopment and new properties acquired for that purpose and any properties undergoing development, our failure to successfully operate or lease acquired properties, lower rental rates or higher vacancy rates or failure to renew or replace expiring leases, defaults on or non-renewal of leases by client tenants, general and local economic conditions, and other risks and uncertainties detailed in our filings with the Securities and Exchange Commission (“SEC”).  All forward-looking statements are made as of October 26, 2012, the date this document was first made available on our website, and we assume no obligation to update this information.  For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in our forward-looking statements, and risks to our business in general, please refer to our SEC filings, including our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.  Note that certain figures are rounded to the nearest thousands throughout this document, which may impact footing and/or crossfooting of totals and subtotals.

 

This document is not an offer to sell or solicitation to buy securities of Alexandria Real Estate Equities, Inc.  Any offers to sell or solicitations to buy securities of Alexandria Real Estate Equities, Inc. shall be made only by means of a prospectus approved for that purpose.  Unless otherwise indicated, the “Company,” “Alexandria,” “we,” “us,” and “our” refer to Alexandria Real Estate Equities, Inc. and its consolidated subsidiaries.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

i

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Company Profile

September 30, 2012

 

The Company

 

Alexandria Real Estate Equities, Inc. (NYSE: ARE), a self-administered and self-managed real estate investment trust (“REIT”), is the largest and leading investment-grade REIT focused principally on owning, operating, developing, redeveloping, and acquiring high-quality, sustainable real estate for the broad and diverse life science industry.  Founded in 1994, Alexandria was the first REIT to identify and pursue the laboratory niche and has since had the first-mover advantage in the core life science cluster locations including Greater Boston, San Francisco Bay, San Diego, New York City, Seattle, Suburban Washington, D.C., and Research Triangle Park. Alexandria’s high-credit client tenants span the life science industry, including renowned academic and medical institutions, multinational pharmaceutical companies, public and private biotechnology entities, United States government research agencies, medical device companies, industrial biotech companies, venture capital firms, and life science product and service companies. As the recognized real estate partner of the life science industry, Alexandria has a superior track record in driving client tenant productivity and innovation through its best-in-class laboratory and office space, collaborative locations adjacent to leading academic and medical institutions, unparalleled life science real estate expertise and services, and longstanding and expansive network in the life science community, which we believe result in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For additional information on Alexandria Real Estate Equities, Inc., please visit www.are.com.

 

Unique Niche Strategy

 

Alexandria’s primary business objective is to maximize stakeholder value by providing its stakeholders with the greatest possible total return and long-term asset value based on a multifaceted platform of internal and external growth.  The key elements to our strategy include our consistent focus on high-quality assets and operations in the top life science cluster locations with our properties located adjacent to life science entities driving growth and technological advances within each cluster.  These adjacency locations are characterized by high barriers to entry and exit, limited supply of available space, and represent highly desirable locations for tenancy by life science entities.  Alexandria’s strategy also includes drawing on its deep and broad life science and real estate relationships in order to attract new and leading life science client tenants and value-added real estate opportunities.  Alexandria was founded in 1994 by Jerry M. Sudarsky and Joel S. Marcus.  Alexandria executed its initial public offering in 1997 and received its investment-grade ratings in 2011.

 

Management

 

Alexandria’s executive and senior management team is highly experienced in the REIT industry (uniquely with life science and real estate development, construction, operations, ownership, and expertise) and is the most accomplished team focused on providing high-quality, environmentally sustainable real estate, technical infrastructure, and unique expertise to the broad and diverse life science industry.  Our deep and talented team has decades of life science industry experience.  Our management team also includes highly experienced regional market directors averaging over 20 years of real estate experience, including approximately 10 years with Alexandria.  We believe that our expertise, experience, reputation, and key life science relationships provide Alexandria significant competitive advantages in attracting new business opportunities.

 

Client Tenant Base

 

The quality, diversity, breadth, and depth of our significant relationships with our life science client tenants provide Alexandria with solid and stable cash flows.  Investment-grade client tenants represented 48% of Alexandria’s annualized base rent as of September 30, 2012.  As of September 30, 2012, our multinational pharmaceutical client tenants represented approximately 27.5% of our annualized base rent, led by Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline plc, Novartis AG, Pfizer Inc., and Roche; revenue-producing life science product and service, medical device, and industrial biotech companies represented approximately 22.2%, led by Illumina, Inc., Laboratory Corporation of America Holdings, Monsanto Company, Qiagen N.V., and Quest Diagnostics Incorporated; non-profit, renowned medical and research institutions, and government agencies represented approximately 15.7% and included Fred Hutchinson Cancer Research Center, Massachusetts Institute of Technology, The Regents of the University of California, Sanford-Burnham Medical Research Institute, The Scripps Research Institute, the United States Government, and University of Washington; public biotechnology companies represented approximately 16.3% and included Amgen Inc., Biogen Idec Inc., Celgene Corporation, and Gilead Sciences, Inc.; private biotechnology companies represented approximately 14.1% and included high-quality, leading-edge companies with blue-chip venture and institutional investors, including Constellation Pharmaceuticals, Inc., Epizyme, Inc., FibroGen, Inc., and FORMA Therapeutics, Inc.; and the remaining approximately 4.2% consisted of traditional office client tenants.  Alexandria’s strong life science underwriting skills, long-term life science industry relationships, and sophisticated management with both real estate and life science operating expertise positively distinguish Alexandria from all other publicly traded real estate investment trusts and real estate companies.

 

Company Information

 

Corporate Headquarters

 

Trading Symbols

 

Information Requests

385 East Colorado Boulevard, Suite 299

 

New York Stock Exchange

 

Phone:   (626) 396-4828

Pasadena, California 91101

 

Common stock: ARE

 

E-mail:   [email protected]

 

 

Series E preferred stock: ARE–E

 

Web:      www.are.com

 

Summary Data

 

Cluster markets

Greater Boston, San Francisco Bay, San Diego, Greater NYC, Suburban Washington, D.C., Seattle, Research Triangle Park, Canada, India, and China

 

 

Fiscal year-end

December 31

 

 

Total properties

177

 

 

Total rentable square feet

16.6 million

 

Common Stock Data

 

 

 

3Q12

 

2Q12

 

1Q12

 

4Q11

 

3Q11

 

High trading price

 

$

77.10

 

$

76.50

 

$

74.45

 

$

71.07

 

$

85.33

 

Low trading price

 

$

70.97

 

$

67.40

 

$

66.90

 

$

56.10

 

$

59.33

 

Closing stock price, average for period

 

$

73.65

 

$

71.67

 

$

71.70

 

$

65.83

 

$

72.68

 

Closing stock price, at the end of the quarter

 

$

73.52

 

$

72.72

 

$

73.13

 

$

68.97

 

$

61.39

 

Dividend per share – quarter/annualized

 

$

0.53/2.12

 

$

0.51/2.04

 

$

0.49/1.96

 

$

0.49/1.96

 

$

0.47/1.88

 

Closing dividend yield – annualized

 

2.9%

 

2.8%

 

2.7%

 

2.8%

 

3.1%

 

Common shares outstanding at the end of the quarter

 

63,161,177

 

62,249,973

 

61,634,645

 

61,560,472

 

61,463,839

 

Closing market value of outstanding common shares (in thousands)

 

$

4,643,610

 

$

4,526,818

 

$

4,507,342

 

$

4,245,826

 

$

3,773,265

 

Total market capitalization (in thousands)

 

$

8,064,386

 

$

7,912,286

 

$

7,673,553

 

$

7,412,402

 

$

6,815,380

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

ii

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Investor Information

September 30, 2012

 

 

Executive/Senior Management

Joel S. Marcus

Chairman, Chief Executive Officer, & Founder

Thomas J. Andrews

EVP – Regional Market Director-Greater Boston

Dean A. Shigenaga

Chief Financial Officer, EVP, & Treasurer

Daniel J. Ryan

EVP – Regional Market Director-San Diego & Strategic Operations

Stephen A. Richardson

Chief Operating Officer & Regional Market Director-San Francisco

John J. Cox

SVP – Regional Market Director-Seattle

Peter M. Moglia

Chief Investment Officer

John H. Cunningham

SVP – Regional Market Director-NY & Strategic Operations

Jennifer J. Pappas

SVP, General Counsel, & Corporate Secretary

Larry J. Diamond

SVP – Regional Market Director-Mid Atlantic

Marc E. Binda

SVP – Finance

Vincent R. Ciruzzi

SVP – Construction & Development

Andres R. Gavinet

Chief Accounting Officer

 

 

 

Equity Research Coverage

 

Alexandria Real Estate Equities, Inc. is currently covered by the following research analysts.  This list may not be complete and is subject to change as firms initiate or discontinue coverage of our company.  Please note that any opinions, estimates, or forecasts regarding our historical or predicted performance made by these analysts are theirs alone and do not represent opinions, forecasts, or predictions of Alexandria Real Estate Equities, Inc. or its management.  Alexandria Real Estate Equities, Inc. does not by its reference below or distribution imply its endorsement of or concurrence with such information, conclusions, or recommendations.  Interested persons may obtain copies of analysts’ reports on their own as we do not distribute these reports.  Several of these firms may from time-to-time own our stock and/or hold other long or short positions in our stock, and may provide compensated services to us.

 

Argus Research Group, Inc.

 

 

 

Evercore Partners

 

 

 

Morningstar Inc.

 

 

William Eddleman, Jr.

 

(212) 425-7500

 

Sheila McGrath

 

(212) 497-0882

 

Philip Martin

 

(312) 384-3920

 

 

 

 

 

 

 

 

 

 

 

Banc of America Securities-Merrill Lynch

 

Green Street Advisors, Inc.

 

 

 

Robert W. Baird & Company

James Feldman

 

(646) 855-5808

 

John Stewart

 

(949) 640-8780

 

Mathew R. Spencer

 

(414) 298-5053

Jeffrey Spector

 

(646) 855-1363

 

John Hornbeak

 

(949) 640-8780

 

 

 

 

Ji Zhang

 

(646) 855-2926

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Barclays Capital Inc.

 

 

 

International Strategy & Investment Group Inc.

 

Standard & Poor’s

 

 

Ross Smotrich

 

(212) 526-2306

 

George Auerbach

 

(212) 446-9459

 

Ray Sheppard

 

(212) 438-1947

Michael R. Lewis

 

(212) 526-3098

 

Steve Sakwa

 

(212) 446-9462

 

 

 

 

 

 

 

 

Gwen Clark

 

(212) 446-5611

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Citigroup Global Markets Inc.

 

 

 

JMP Securities – JMP Group, Inc.

 

UBS Financial Services Inc.

Michael Bilerman

 

(212) 816-1383

 

William Marks

 

(415) 835-8944

 

Ross Nussbaum

 

(212) 713-2484

Quentin Velleley

 

(212) 816-6981

 

Whitney Stevenson

 

(415) 835-8948

 

Gabriel Hilmoe

 

(212) 713-3876

 

 

 

 

 

 

 

 

Weina Hou

 

(212) 713-4057

Cowen and Company, LLC

 

 

 

JP Morgan Securities, LLC

 

 

 

 

 

 

James Sullivan

 

(646) 562-1380

 

Anthony Paolone

 

(212) 622-6682

 

 

 

 

Michael Gorman

 

(646) 562-1381

 

Joseph Dazio

 

(212) 622-6416

 

 

 

 

 

 

Rating Agencies

Moody’s Investors Service

 

 

 

Standard & Poor’s

 

 

 

 

 

 

Philip Kibel

 

(212) 553-4569

 

Lisa Sarajian

 

(212) 438-2597

 

 

 

 

Maria Maslovsky

 

(212) 553-4831

 

George Skoufis

 

(212) 438-2608

 

 

 

 

 

 

Rating

Moody’s Investors Service

 

 

 

Standard & Poor’s

 

 

 

 

 

 

Issuer Rating

 

Baa2
Stable Outlook

 

Corporate Credit Rating

 

BBB-
Stable Outlook

 

 

 

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

iii

 

 



 

 



 

 

Contact:

Joel S. Marcus

 

Chairman, Chief Executive Officer, & Founder

 

Alexandria Real Estate Equities, Inc.

 

(626) 578-9693

 

Alexandria Real Estate Equities, Inc.

Reports

 

Third Quarter Ended September 30, 2012

Financial and Operating Results

 

FFO Per Share – Diluted of $1.08 and $3.18 for Three and Nine Months Ended 3Q12

EPS – Diluted of $0.17 and $0.75 for Three and Nine Months Ended 3Q12

Significant Progress Converting Non-Income-Producing Assets into Income-Producing Operating Assets

 

PASADENA, CA. – October 26, 2012 – Alexandria Real Estate Equities, Inc. (NYSE: ARE) today announced financial and operating results for the third quarter ended September 30, 2012.

 

Third Quarter Ended September 30, 2012, Highlights

 

Results

 

·                   Funds From Operations (“FFO”) Attributable to Alexandria Real Estate Equities, Inc.’s Common Stockholders – Diluted, for the Three Months Ended September 30, 2012, was $67.1 Million, or $1.08 Per Share;  FFO Attributable to Alexandria Real Estate Equities, Inc.’s Common Stockholders – Diluted, for the Nine Months Ended September 30, 2012, was $196.8 Million, or $3.18 Per Share

·                   Adjusted Funds From Operations (“AFFO”) Attributable to Alexandria Real Estate Equities, Inc.’s Common Stockholders – Diluted, for the Three Months Ended September 30, 2012, was $65.0 Million, or $1.04 Per Share;  AFFO Attributable to Alexandria Real Estate Equities, Inc.’s Common Stockholders – Diluted, for the Nine Months Ended September 30, 2012, was $191.4 Million, or $3.09 Per Share

·                   Net Income Attributable to Alexandria Real Estate Equities, Inc.’s Common Stockholders – Diluted, for the Three Months Ended September 30, 2012, was $10.6 Million, or $0.17 Per Share; Net Income Attributable to Alexandria Real Estate Equities, Inc.’s Common Stockholders – Diluted, for the Three Months Ended September 30, 2012, Excluding $9.8 Million, or $0.16 Per Share, Related to Impairment of Real Estate, and Excluding $1.6 Million, or $0.03 Per Share, Related to Gain on Sale of Real Estate, was $18.8 Million, or $0.30 Per Share;  Net Income Attributable to Alexandria Real Estate Equities, Inc.’s Common Stockholders – Diluted, for the Nine Months Ended September 30, 2012, was $46.6 Million, or $0.75 Per Share; Net Income Attributable to Alexandria Real Estate Equities, Inc.’s Common Stockholders – Diluted, for the Nine Months Ended September 30, 2012, Excluding $9.8 Million, or $0.16 Per Share, Related to Impairment of Real Estate, Excluding $2.2 Million, or $0.03 Per Share, Related to Loss on Early Extinguishment of Debt, and Excluding $1.6 Million, or $0.03 Per Share, Related to Gain on Sale of Real Estate, was $57.0 Million, or $0.91 Per Share

 

Core Operating Metrics

 

·                   Total Revenues for the Three Months Ended September 30, 2012, were $145.5 Million, Compared to Total Revenues for the Three Months Ended September 30, 2011, of $138.1 Million; Total Revenues for the Nine Months Ended September 30, 2012, were $431.9 Million, Compared to Total Revenues for the Nine Months Ended September 30, 2011, of $409.0 Million

·                   Net Operating Income (“NOI”) for the Three Months Ended September 30, 2012, was $100.8 Million, Compared to NOI for the Three Months Ended September 30, 2011, of $97.2 Million; NOI for the Nine Months Ended September 30, 2012, was $304.0 Million, Compared to NOI for the Nine Months Ended September 30, 2011, of $291.0 Million

·                   Operating Margins at 69% for the Three Months Ended September 30, 2012

·                   Cash and GAAP Same Property Net Operating Income Increase of 4.3% and Decrease of 0.9%, Respectively, for the Three Months Ended September 30, 2012

·                   Cash and GAAP Same Property Net Operating Income Increase of 2.6% and Decrease of 0.8%, Respectively, for the Nine Months Ended September 30, 2012

·                   48% of Annualized Base Rent from Investment-Grade Client Tenants

·                   During the Three Months Ended September 30, 2012, Executed 47 Leases for 732,000 Rentable Square Feet, Including 266,000 Rentable Square Feet of Development and Redevelopment Space; Rental Rate Decrease of 2.9% and Increase of 7.6% on a Cash and GAAP Basis, Respectively, on Renewed/Re-Leased Space

·                   During the Nine Months Ended September 30, 2012, Executed 146 Leases for 2,603,000 Rentable Square Feet, Including 829,000 Rentable Square Feet of Development and Redevelopment Space; Rental Rate Decrease of 1.9% and Increase of 5.9% on a Cash and GAAP Basis, Respectively, on Renewed/Re-Leased Space; Excluding One Lease for 48,000 Rentable Square Feet Related to One Client Tenant in the Research Triangle Park Market and One Lease for 71,000 Rentable Square Feet Related to One Client Tenant in the Suburban Washington, D.C. Market, Rental Rates for Renewed/Re-Leased Space were, on Average, 0.1% Higher and 7.3% Higher than Rental Rates for Expiring Leases on a Cash and GAAP Basis, Respectively

·                   Occupancy Percentage for North America Operating Properties of 94.2% and Occupancy Percentage for North America Operating and Redevelopment Properties of 90.0%; Occupancy Percentage for All Operating Properties of 93.0%, Including Asia Properties, and Occupancy Percentage for All Operating and Redevelopment Properties of 88.3%, Including Asia Properties

 

Value-Added Opportunities and External Growth

 

·                   From November 2011 to September 2012, Completed Redevelopment of 10300 Campus Point Drive, Located in the San Diego Market, a 96% Leased Project with 279,138 Rentable Square Feet, Including the Completion of 189,562 Rentable Square Feet in September 2012

·                   In September 2012, Completed Development of 4755 Nexus Center Drive, Located in the San Diego Market, a 100% Leased Project with 45,255 Rentable Square Feet

·                   In June 2012, Completed Redevelopment of 3530/3550 John Hopkins Court, Located in the San Diego Market, a 100% Leased Project with 98,320 Rentable Square Feet

·                   In April 2012, Completed Development Located in the Canadian Market, a 100% Leased Project with 26,426 Rentable Square Feet

·                   In April 2012, Commenced Unconsolidated Joint Venture Development of 360 Longwood Avenue, Located in the Greater Boston Market, a 37% Pre-Leased Project with 414,000 Rentable Square Feet

·                   In January 2012, Commenced Development of 259 East Grand Avenue, Located in the San Francisco Bay Market, a 100% Pre-Leased Building with 170,618 Rentable Square Feet

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

1

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Third Quarter Ended September 30, 2012, Financial and Operating Results

(Unaudited)

 

Significant Balance Sheet Milestones

 

·                   Completed $75.1 Million of Asset Sales Year to Date with Additional $34.0 Million of Land Sales Forecasted in Fourth Quarter 2012 for a Total of $109.1 Million; Additional $84.5 Million Sales of Income-Producing Assets in Process

·                   Established an “At The Market” Common Stock Offering Program Under Which We May Sell Up to $250.0 Million of Our Common Stock; and Raised $98.4 Million in Net Proceeds from Sales Under This Program for the Nine Months Ended September 30, 2012, including $58.5 Million in Net Proceeds from Sales Under This Program for the Three Months Ended September 30, 2012

·                   In June 2012, Closed a Secured Construction Loan with Aggregate Commitments of $55 Million for a Development Project at 259 East Grand Avenue located in the San Francisco Bay Market

·                   In April 2012, Amended Our $1.5 Billion Unsecured Senior Line of Credit to Reduce Its Interest Rate and Extend Its Maturity Date to April 2017, Assuming We Exercise Our Sole Right to Extend the Maturity Date Twice

·                   In April 2012, Redeemed All $129.6 Million of Our Outstanding 8.375% Series C Preferred Stock

·                   In March 2012, Completed a 6.45% Series E Preferred Stock Offering with Net Proceeds of $124.9 Million

·                   In February 2012, Completed Our Debut 4.60% Unsecured Senior Notes Offering with Net Proceeds of $544.6 Million; Net Proceeds from the Offering Were Used to Repay Certain Outstanding Variable Rate Bank Debt

·                   In February 2012, Repaid All $250 Million of Our 2012 Unsecured Senior Bank Term Loan

·                   In January and April 2012, Retired All $84.8 Million of Our 3.70% Unsecured Senior Convertible Notes

 

Events Subsequent to Quarter End

 

·                   In the Fourth Quarter of 2012, We Expect to Commence Vertical Construction of the Ground-Up Development of 430 East 29th Street, the West Tower of the Alexandria Center for Life Science – New York City, a Project with 419,806 Rentable Square Feet Located in the Greater NYC Market

 

VALUE-ADDED OPPORTUNITIES AND EXTERNAL GROWTH

 

Development and redevelopment

 

As of September 30, 2012, 96% of our overall leases contained annual rent escalations that were either fixed or based on a consumer price index or another index.  Our initial stabilized yield on a cash basis reflects cash rents upon stabilization and does not reflect contractual rent escalations beyond the stabilization date.  We expect, on average, our contractual cash rents related to our value-added projects to increase over time.  Initial stabilized yield is calculated as the quotient of net operating income and our investment in the property at stabilization (“Initial Stabilized Yield”).

 

During the three and nine months ended September 30, 2012, we executed leases aggregating 266,000 and 829,000 rentable square feet, respectively, related to our development and redevelopment projects.

 

In the fourth quarter of 2012, we expect to commence a ground-up development of a multi-tenant laboratory building with 419,806 rentable square feet at 430 East 29th Street, the West Tower of the Alexandria Center for Life Science – New York City.  We expect to provide an estimate of our Initial Stabilized Yields next quarter upon commencement of ground-up development.

 

From November 2011 to September 2012, we completed the redevelopment of 279,138 rentable square feet, including the completion of 189,562 rentable square feet in September 2012, at 10300 Campus Point Drive, located in the San Diego market.  This property is a multi-tenant campus with 449,759 rentable square feet that is 96% leased to (1) Eli Lilly and Company, (2) The Regents of the University of California, (3) Celgene Corporation, and (4) Covance Inc.  The Initial Stabilized Yield on a cash and GAAP basis for the 279,138 rentable square feet redevelopment project was approximately 7.9% and 7.7%, respectively.

 

In September 2012, we completed the development of 4755 Nexus Center Drive, located in the San Diego market, a single-tenant building with 45,255 rentable square feet that is 100% leased to Optimer Pharmaceuticals, Inc.  The Initial Stabilized Yield on a cash and GAAP basis for this project was approximately 6.8% and 7.5%, respectively.

 

In June 2012, we completed the redevelopment of 3530/3550 John Hopkins Court, located in the San Diego market, a multi-tenant campus with 98,320 rentable square feet that is 100% leased to (1) Genomics Institute of the Novartis Research Foundation, a non-profit research institute, and (2) a leading industrial biotechnology company.  The Initial Stabilized Yield on a cash and GAAP basis for this project was approximately 8.9% and 9.1%, respectively.

 

In April 2012, we completed the development of a building located in the Canadian market with 26,426 rentable square feet that is 100% leased to GlaxoSmithKline plc.  The Initial Stabilized Yield on a cash and GAAP basis for this project was approximately 7.7% and 8.3%, respectively.

 

In April 2012, we commenced ground-up development of 360 Longwood Avenue, located in the Longwood Medical Area of the Greater Boston market, our 414,000 rentable square feet unconsolidated joint venture development project that is 37% pre-leased to the Dana-Farber Cancer Institute, Inc.  Dana-Farber Cancer Institute, Inc. also has an option to lease an additional two floors of approximately 99,000 rentable square feet, or an additional 24% of the total rentable square feet of the project.  We expect to achieve an unlevered Initial Stabilized Yield on a cash and GAAP basis in a range from 8.1% to 8.5% and 8.7% to 9.1%, respectively.  Funding for this project is provided primarily by capital from our joint venture partner and a $213.2 million non-recourse secured construction loan.  Additionally, our share of the future funding is expected to be less than the $22.3 million distribution we received in March 2012, upon admittance of the new partner and refinancing of the project.

 

In January 2012, we commenced a ground-up development of a single-tenant building with 170,618 rentable square feet at 259 East Grand Avenue, located in the San Francisco Bay market, which is 100% pre-leased to Onyx Pharmaceuticals Inc.  We expect to achieve an Initial Stabilized Yield on both a cash and GAAP basis for this property in a range from 7.8% to 8.2%.  Funding for this project will be provided primarily by the $55 million secured construction loan we closed in June 2012.

 

Acquisitions

 

In April 2012, we acquired 3013/3033 Science Park Road located in the San Diego market, which consists of two life science laboratory buildings aggregating 176,500 rentable square feet, for approximately $13.7 million.  The property was 100% leased on a short-term basis, and thereafter, we expect to redevelop approximately 98,000 rentable square feet.  The remaining square footage will be classified as future developable square feet once the existing client tenant vacates.  We expect to provide an estimate of our Initial Stabilized Yields in the future upon commencement of development/redevelopment activity.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

2

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Third Quarter Ended September 30, 2012, Financial and Operating Results

(Tabular dollar amounts in thousands, except per square foot amounts)

(Unaudited)

 

SIGNIFICANT BALANCE SHEET MILESTONES

 

Real estate asset sales

 

In September 2012, four properties aggregating 504,130 rentable square feet met the classification requirements for held for sale.  The current buyers are expected to reposition these assets and/or incur significant investments to re-tenant the properties.  During the three months ended September 30, 2012, we recorded impairment charges aggregating approximately $9.8 million to reduce the aggregate carrying value of the properties to the estimated sales price less costs to sell.

 

 

 

 

 

 

 

Rentable/

 

Sales

 

Occupancy

 

Annualized

 

 

 

 

 

 

 

 

 

Date

 

Developable

 

Price

 

at Date

 

GAAP

 

Sales

 

Gain

 

Description

 

Location

 

of Sale

 

Square Feet

 

per SF

 

of Sale

 

NOI (1)

 

Price (2)

 

on Sale

 

Land parcels and assets with a previous operating component:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1201/1209 Mercer Street (3)

 

Seattle

 

September 2012

 

76,029

 

$

73

 

0%

 

$

45

 

$

5,570

 

$

54

 

801 Dexter Avenue North (3)

 

Seattle

 

August 2012

 

120,000

 

$

72

 

0%

 

$

(96

)

8,600

 

$

55

 

Land parcel

 

Greater Boston

 

March 2012

 

(4)

 

$

275

 

N/A

 

N/A

 

31,360

 

$

1,864

 

Sale of land parcels and assets with a previous operating component

 

 

 

 

 

 

 

 

 

 

 

 

 

45,530

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income-producing properties:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

200 Lawrence Drive/210 Welsh Pool Road

 

Pennsylvania

 

July 2012

 

210,866

 

$

94

 

100%

 

$

2,193

 

19,750

(5)

$

103

 

155 Fortune Boulevard (6)

 

Route 495/Worcester

 

July 2012

 

36,000

 

$

222

 

100%

 

$

804

 

8,000

 

$

1,350

 

5110 Campus Drive (6)

 

Pennsylvania

 

May 2012

 

21,000

 

$

86

 

71%

 

$

77

 

1,800

 

$

2

 

Sales of income-producing properties

 

 

 

 

 

 

 

 

 

 

 

 

 

29,550

(7)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Completed sales subtotal

 

 

 

 

 

 

 

 

 

 

 

 

 

75,080

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales in process

 

Various

 

Pending

 

261,000

 

$

130

 

N/A

 

$

(470

)

34,000

(8)

TBD

 

Subtotal

 

 

 

 

 

 

 

 

 

 

 

 

 

109,080

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other incremental dispositions:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales in process (9)

 

Various

 

Pending

 

504,130

 

$

174

 

N/A

 

$

12,798

 

84,500

 

TBD

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total projected dispositions

 

 

 

 

 

 

 

 

 

 

 

 

 

$

193,580

 

 

 

 

(1)

Annualized using actual year to date results as of the quarter end prior to date of sale or September 30, 2012.

(2)

Represents contractual sales price for assets sold or contractual/estimated sale price for sales in process.

(3)

Properties sold to residential developers.

(4)

In March 2012, we sold one-half of our 55% interest in a land parcel supporting a 414,000 rentable square feet project for approximately $31.4 million, or approximately $275 per rentable square foot.

(5)

Sales price reflects the near-term lease expiration of a client tenant occupying 38,513 rentable square feet, or 18% of the total rentable square feet, on the date of sale. In connection with the sale, we received an interest-only secured note receivable for $6.1 million due in 2018.

(6)

Properties were sold to client tenants.

(7)

The weighted average capitalization rate (Annualized GAAP NOI divided by Sales Price) related to sales of income-producing assets in the nine months ended September 30, 2012, was 10.4%.

(8)

Includes a $13.3 million amortizing secured note receivable due in 2014.

(9)

Includes four properties, which the buyers expect to renovate. During the three months ended September 30, 2012, we recognized an aggregate charge for impairment of real estate of approximately $9.8 million to adjust the carrying values of the four properties to their fair value, less costs to sell. We may receive a note receivable in connection with sale of one property. One sale ranging from $42 million to $47 million may close during the three months ended December 31, 2012.

 

Sale of land parcel

 

In March 2012, we contributed our 55% ownership interest in a land parcel supporting a future building with 414,000 rentable square feet in the Longwood Medical Area of the Greater Boston market to a newly formed joint venture (the “Restated JV”) with National Development and Charles River Realty Investors, and admitted as a 50% member, Clarion Partners, LLC, resulting in a reduction of our ownership interest from 55% to 27.5%.  The transfer of one-half of our 55% ownership interest in this real estate venture to Clarion Partners, LLC, was accounted for as an in-substance partial sale of an interest in the underlying real estate.  In connection with the sale of one-half of our 55% ownership interest in the land parcel, we received a special distribution of approximately $22.3 million, which included the recognition of a $1.9 million gain on sale of land and approximately $5.4 million from our share of loan refinancing proceeds.  The land parcel we sold in March 2012 did not meet the criteria for discontinued operations since the parcel did not have any significant operations prior to disposition. Pursuant to the presentation and disclosure literature on gains/losses on sales or disposals by REITs required by the Securities and Exchange Commission (“SEC”), gains or losses on sales or disposals by a REIT that do not qualify as discontinued operations are classified below (loss) income from discontinued operations in the income statement.  Accordingly, we classified the $1.9 million gain on sale of land below (loss) income from discontinued operations, net, in the condensed consolidated statements of income.  Our 27.5% share of the land was sold at approximately $31 million (including closing costs), or approximately $275 per rentable square foot.  Upon formation of the Restated JV, the existing $38.4 million secured loan was refinanced with a seven-year (including two one-year extension options) non-recourse $213 million secured construction loan with initial loan proceeds of $50 million.  As of September 30, 2012, the outstanding balance on the construction loan was $56.4 million.  We do not expect our share of capital contributions through the completion of the project to exceed the approximate $22.3 million in net proceeds received in this transaction.  Construction of this $350 million project commenced in April 2012.  The initial occupancy date for this project is expected to be in the fourth quarter of 2014.  The project is 37% pre-leased to Dana-Farber Cancer Institute, Inc.  In addition, Dana-Farber Cancer Institute, Inc. has an option to lease an additional two floors approximating 99,000 rentable square feet, or 24% of the total rentable square feet of the project.  In addition to our economic share of the joint venture, we also expect to earn development and other fees of approximately $3.5 million through 2015, and recurring annual property management fees thereafter, from this project.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

3

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Third Quarter Ended September 30, 2012, Financial and Operating Results

(Unaudited)

 

“At the market” common stock offering program

 

In June 2012, we established an “at the market” common stock offering program under which we may sell, from time to time, up to an aggregate of $250.0 million of our common stock through our sales agents, BNY Mellon Capital Markets, LLC and Credit Suisse Securities (USA) LLC, during a three-year period.  During the nine months ended September 30, 2012, we sold an aggregate of 1,366,977 shares of common stock for gross proceeds of approximately $100.0 million at an average stock price of $73.15 and net proceeds of approximately $98.4 million.  This includes the sale of an aggregate of 793,291 shares of common stock for gross proceeds of approximately $59.5 million at an average stock price of $74.97 and net proceeds of approximately $58.5 million during the three months ended September 30, 2012.  As of September 30, 2012, approximately $150.0 million of our common stock remained available for issuance under the “at the market” common stock offering program.

 

Secured construction loan for development project in San Francisco Bay market

 

In June 2012, we closed a secured construction loan with aggregate commitments of $55 million.  The construction loan matures in July 2015, and we have an option to extend the stated maturity date of July 1, 2015, by one year, twice, to July 1, 2017.  The construction loan will be used to fund the majority of the cost to complete the development of a 100% pre-leased life science laboratory building with 170,618 rentable square feet at 259 East Grand Avenue in the San Francisco Bay market.  The construction loan bears interest at the London Interbank Offered Rate (“LIBOR”) or the base rate specified in the construction loan agreement, defined as the higher of either the prime rate being offered by our lender or the federal funds rate in effect on the day of borrowing (“Base Rate”), plus in either case a specified margin of 1.50% for LIBOR borrowings or 0.25% for Base Rate borrowings.  As of September 30, 2012, commitments of $53.0 million were available.

 

Debut 4.60% unsecured senior notes payable offering

 

In February 2012, we completed the issuance of our 4.60% unsecured senior notes payable due in February 2022.  Net proceeds of approximately $544.6 million were used to repay certain outstanding variable rate bank debt, including the entire $250 million of our 2012 unsecured senior bank term loan (“2012 Unsecured Senior Bank Term Loan”), and approximately $294.6 million of outstanding borrowings under our unsecured senior line of credit.  In connection with the retirement of our 2012 Unsecured Senior Bank Term Loan, we recognized a loss on early extinguishment of debt of approximately $0.6 million related to the write-off of unamortized loan fees for the three months ended March 31, 2012.

 

Retirement of 3.70% unsecured senior convertible notes

 

During January 2012, we repurchased approximately $83.8 million in principal amount of our 3.70% unsecured senior convertible notes (“3.70% Unsecured Senior Convertible Notes”) at par, pursuant to options exercised by holders thereof under the indenture governing the notes.  During April 2012, we repurchased the remaining outstanding $1.0 million in principal amount of the notes.  In aggregate, we repurchased approximately $84.8 million in principal amount of the notes and we did not recognize a gain or loss as a result during the six months ended June 30, 2012.

 

Amendment of $1.5 billion unsecured senior line of credit

 

In April 2012, we amended our $1.5 billion unsecured senior line of credit with Merrill Lynch, Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities Inc., and Citigroup Global Markets Inc. as joint lead arrangers, and certain lenders, to extend the maturity date of our unsecured senior line of credit, provide an accordion option for up to an additional $500 million, and reduce the interest rate for outstanding borrowings.  The maturity date of the unsecured senior line of credit was extended to April 2017, assuming we exercise our sole right to extend the stated maturity date twice by an additional six months after each exercise.  Borrowings under the unsecured senior line of credit bear interest at LIBOR or the base rate specified in the amended unsecured senior line of credit agreement, plus in either case a specified margin (the “Applicable Margin”).  The Applicable Margin for LIBOR borrowings under the unsecured senior line of credit was set at 1.20%, down from 2.40% in effect immediately prior to the modification.  In addition to the Applicable Margin, our unsecured senior line of credit is subject to an annual facility fee of 0.25%.  In connection with the modification of our unsecured senior line of credit in April 2012, we recognized a loss on early extinguishment of debt of approximately $1.6 million related to the write-off of a portion of unamortized loan fees for the three months ended June 30, 2012.

 

6.45% series E preferred stock offering

 

In March 2012, we completed a public offering of 5,200,000 shares of our 6.45% series E cumulative redeemable preferred stock (“Series E Preferred Stock”).  The shares were issued at a price of $25.00 per share, resulting in net proceeds of approximately $124.9 million (after deducting underwriters’ discounts and other offering costs).  The proceeds were initially used to reduce the outstanding borrowings under our unsecured senior line of credit.  We then borrowed funds under our unsecured senior line of credit to redeem our 8.375% series C cumulative redeemable preferred stock (“Series C Preferred Stock”) in April 2012.  The dividends on our Series E Preferred Stock are cumulative and accrue from the date of original issuance.  We pay dividends quarterly in arrears at an annual rate of 6.45%, or $1.6125 per share.  Our Series E Preferred Stock has no stated maturity date, is not subject to any sinking fund or mandatory redemption provisions, and is not redeemable before March 15, 2017, except to preserve our status as a REIT.  On and after March 15, 2017, we may, at our option, redeem the Series E Preferred Stock, in whole or in part, at any time for cash at a redemption price of $25.00 per share, plus any accrued and unpaid dividends on the Series E Preferred Stock up to, but excluding, the redemption date.  In addition, upon the occurrence of a change of control, we may, at our option, redeem the Series E Preferred Stock, in whole or in part within 120 days after the first date on which such change of control occurred, by paying $25.00 per share, plus any accrued and unpaid dividends up to, but excluding, the date of redemption.  Investors in our Series E Preferred Stock generally have no voting rights.

 

8.375% series C preferred stock redemption

 

In April 2012, we redeemed all 5,185,500 outstanding shares of our Series C Preferred Stock at a price equal to $25.00 per share, or approximately $129.6 million in aggregate, and paid $0.5234375 per share, representing accumulated and unpaid dividends to the redemption date on such shares.  We recognized a charge of approximately $6.0 million to net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders in March 2012, related to the write-off of original issuance costs of the Series C Preferred Stock.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

4

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Third Quarter Ended September 30, 2012, Financial and Operating Results

(Unaudited)

 

GUIDANCE

 

Earnings outlook

 

Based on our current view of existing market conditions and certain current assumptions, we expect that our earnings per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted and FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted for the year ended December 31, 2012, will be as set forth in the table below.  The table below provides a reconciliation of FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, as adjusted, a non-GAAP measure, to earnings per share, the most directly comparable GAAP measure.

 

Guidance for the Year Ended December 31, 2012

 

Reported on October 26, 2012

 

Reported on July 30, 2012

 

Earnings per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted

 

$1.16 - $1.26

 

$1.36 - $1.46

 

Depreciation and amortization

 

$3.00 - $3.06

 

$2.93 - $2.99

 

Gain on sales of property

 

$(0.06)

 

$(0.03)

 

Impairment of real estate

 

$0.16

 

 

FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted

 

$4.32 - $4.36

 

$4.32 - $4.36

 

Write-off of unamortized loan fees upon early retirement of the 2012 Unsecured Senior Bank Term Loan

 

$0.01

 

$0.01

 

Write-off of unamortized loan fees upon modification of unsecured senior line of credit

 

$0.03

 

$0.03

 

Preferred stock redemption charge

 

$0.10

 

$0.10

 

Realized gain on equity investment primarily related to one non-tenant life science entity

 

$ (0.09)

 

$(0.09)

 

FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, as adjusted

 

$4.37 - $4.41

 

$4.37 - $4.41

 

 

 

 

 

 

 

Key net operating income projection assumptions:

 

 

 

 

 

Same property net operating income growth – cash basis

 

3% to 4%

 

3% to 5%

 

Same property net operating income growth – GAAP basis

 

Slightly negative/positive

 

0% to 2%

 

Rental rate steps on lease renewals and re-leasing of space – cash basis

 

Slightly negative/positive

 

Slightly negative/positive

 

Rental rate steps on lease renewals and re-leasing of space – GAAP basis

 

Up to 5%

 

Up to 5%

 

Straight-line rents

 

$6.5 million/qtr

 

$6.5 million/qtr

 

Amortization of above and below market leases

 

$0.8 million/qtr

 

$0.8 million/qtr

 

Realized gain on equity investment primarily related to one non-tenant life science entity

 

$5.8 million

 

$5.8 million

 

 

Net operating income, net income, and FFO for the three months ended December 31, 2012

 

As of September 30, 2012, we had approximately $304.6 million and $277.5 million of construction in progress related to our five North American development and eight North American redevelopment projects, respectively. The completion of these projects, along with recently delivered projects, certain future projects, and contributions from same properties, are expected to contribute significant increases in rental income, net operating income, and cash flows.  Net operating income from continuing operations is projected to increase from $100.8 million for the three months ended September 30, 2012, to a range from $107.5 million to $109.5 million for the three months ended December 31, 2012 (after considering approximately $3.0 million in required reclassifications for discontinued operations).  Operating performance assumptions related to the completion of our North America development and redevelopment projects, including the timing of initial occupancy, stabilization dates, and Initial Stabilized Yields, are included on page 7.  Certain key assumptions regarding our projections, including the impact of various development and redevelopment projects, are included in the tables above, below, and on the following page.

 

The completion of our development and redevelopment projects will result in increased interest expense and other direct project costs, because these project costs will no longer qualify for capitalization and these costs will be expensed as incurred.  Our projections for general and administrative expenses, capitalization of interest, and interest expense, net, are included in the tables on this page.  Our projections of net operating income are subject to a number of variables and uncertainties, including those discussed under the “Forward-looking Statements” section of Part I, the “Risk Factors” section of Item 1A, and the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section under Item 7, of our annual report on Form 10-K for the year ended December 31, 2011.  To the extent our full year earnings guidance is updated during the year, we will provide additional disclosure supporting reasons for any significant changes to such guidance.  Further, we believe net operating income is a key performance indicator and is useful to investors as a performance measure because, when compared across periods, net operating income reflects the impact on operations from trends in occupancy rates, rental rates, and operating costs, providing perspective not immediately apparent from income from continuing operations.

 

Three Months Ended December 31, 2012 (in millions, except per share amounts)

 

Reported on October 26, 2012

 

Reported on July 30, 2012

 

Net operating income:

 

 

 

 

 

Continuing operations

 

$107.5 - $109.5

 

$110.5 - $112.5

 

Incremental dispositions classified in discontinued operations

 

$3.0

 

 

Total net operating income

 

$110.5 - $112.5

 

$110.5 - $112.5

 

General and administrative

 

$11.0 - $12.0

 

$11.0 - $12.0

 

Capitalization of interest

 

$13.6 - $14.6

 

N/A

 

Interest

 

$18.0 - $20.0

 

$19.5 - $22.5

 

Depreciation and amortization

 

$42.6 - $47.7

 

$42.6 - $47.7

 

Preferred stock dividends

 

$6.5

 

$6.5

 

Other

 

$1.0 - $1.4

 

$1.0 - $1.4

 

Net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders

 

$26.9 - $30.9

 

$26.9 - $30.9

 

FFO

 

$72.0 - $73.0

 

$71.1 - $73.0

 

FFO per share – diluted

 

$1.15 - $1.17

 

$1.15 - $1.17

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

5

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Third Quarter Ended September 30, 2012, Financial and Operating Results

(Unaudited)

 

Sources and uses of capital

 

We expect that our principal liquidity needs for the year ended December 31, 2012, will be satisfied by the following multiple sources of capital as shown in the table below.  There can be no assurance that our sources and uses of capital will not be materially higher or lower than these expectations.  Our liquidity available under our unsecured senior line of credit and from cash equivalents was approximately $1.2 billion as of September 30, 2012.

 

 

 

Reported on
October 26, 2012

 

Reported on
July 30, 2012

 

Sources and Uses of Capital for the Year Ended December 31, 2012 (in millions)

 

Completed

 

Projected

 

Total

 

Total

 

Sources of capital:

 

 

 

 

 

 

 

 

 

Net cash provided by operating activities less dividends

 

$

53

 

$

28

 

$

81

 (1)

$

81

 

Asset and land sales

 

75

 

76 - 81

(2)

151 - 156

 

112

 

Unsecured senior notes payable

 

550

 

 

550

 

550

 

Borrowings on secured construction financing

 

2

 

22

 

24

 

24

 

Series E Preferred Stock issuance

 

125

 

 

125

 

125

 

Issuances under “at the market” common stock offering program

 

98

 

(3)

98

 

40

 

Debt, equity, and joint venture capital

 

51

 (4)

57 - 84

(4)

108 - 135

 

236

 

Total sources of capital

 

$

954

 

$

183 - 215

 

$

1,137 - 1,169

 

$

1,168

 

 

 

 

 

 

 

 

 

 

 

Uses of capital:

 

 

 

 

 

 

 

 

 

Development, redevelopment, and construction

 

$

429

 

$

167

 

$

596

 (5)

$

646

 

Notes receivable from asset and land sales

 

6

 

13 - 45

 

19 - 51

 

 

Acquisitions

 

46

 

 

46

 

46

 

Secured debt repayments

 

8

 

3

 

11

 (6)

11

 

2012 Unsecured Senior Bank Term Loan repayment

 

250

 

 

250

 

250

 

3.70% Unsecured Senior Convertible Notes repurchase

 

85

 

 

85

 

85

 

Series C Preferred Stock redemption

 

130

 

 

130

 

130

 

Total uses of capital

 

$

954

 

$

183 - 215

 

$

1,137 - 1,169

 

$

1,168

 

 

(1)

See table of “Key Net Operating Income Projection Assumptions” and projections table in the “Net Operating Income, Net Income, and FFO for the Three Months Ended December 31, 2012” section on the preceding page.

(2)

Represents an estimate of sources of capital from pending asset and land sales. As noted in “Real Estate Asset Sales” on page 3, we have other incremental dispositions in process aggregating $84.5 million, a portion of which may close during the three months ended December 31, 2012.

(3)

See “Debt, equity, and joint venture capital.”

(4)

Represents an estimate of sources of capital primarily consisting of borrowings under our unsecured senior line of credit and proceeds from our “at the market” common stock offering program.

(5)

See “Investment to Complete” columns in the “Development and Redevelopment Projects in North America” table on the following page for additional details underlying this estimate. The decrease of approximately $50 million from the approximately $646 million previously reported on July 30, 2012, is primarily attributable to the timing of the spending moving from the three months ended December 31, 2012, to the year ended December 31, 2013.

(6)

Based upon contractually scheduled payments or maturity dates.

 

The key assumptions behind the sources and uses of capital in the table above are a favorable capital market environment and performance of our core operations in areas such as delivery of current and future development and redevelopment projects, leasing activity, and renewals.  Our expected sources and uses of capital are subject to a number of variables and uncertainties, including those discussed under the “Forward-looking statements” section of Part I, the “Risk Factors” section of Item 1A, and the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” section under Item 7, of our annual report on Form 10-K for the year ended December 31, 2011.  We expect to update our forecast of sources and uses of capital on a quarterly basis.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

6

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Development and Redevelopment Projects in North America
September 30, 2012

(Tabular dollar amounts in thousands)

(Unaudited)

 

 

 

Project RSF

 

Leased Status RSF

 

Investment

 

Initial Stabilized

 

Project

 

Occu-

 

Stabili-

 

Market – Submarket/

 

In

 

 

 

 

 

 

 

 

 

 

 

 

 

% Leased/

 

September 30, 2012

 

To Complete

 

Total at

 

Yield (1)

 

Start

 

pancy

 

zation

 

Property

 

Service

 

CIP

 

Total

 

Leased

 

Negotiating

 

Marketing

 

Total

 

Negotiating

 

In Service

 

CIP

 

2012

 

Thereafter

 

Completion

 

Cash

 

GAAP

 

Date

 

Date

 

Date

 

Development projects in North America

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater Boston – Cambridge

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

225 Binney Street

 

 

303,143

 

303,143

 

303,143

 

 

 

303,143

 

100

%

 

$

 

$

84,163

 

$

8,788

 

$

87,322

 

$

180,273

 

7.5%

 

8.1%

 

4Q11

 

4Q13

 

4Q13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Francisco Bay – Mission Bay

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

499 Illinois Street (2)

 

 

222,780

 

222,780

 

 

 

222,780

 

222,780

 

 

 

$

 

$

111,219

 

$

2,867

 

$

39,123

 

$

153,209

 

6.4%

 

7.2%

 

2Q11

 

2Q14

 

1Q15

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Francisco Bay – South SF

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

259 East Grand Avenue (3)

 

 

170,618

 

170,618

 

170,618

 

 

 

170,618

 

100

%

 

$

 

$

45,226

 

$

13,498

(3)

$

22,137

(3)

$

80,861

 

7.8-8.2%

 

7.8-8.2%

 

1Q12

 

4Q12

 

4Q12

 

400/450 East Jamie Court

 

99,694

 

63,342

 

163,036

 

127,732

 

 

35,304

 

163,036

 

78

%

 

$

58,481

 

$

39,340

 

$

5,962

 

$

9,230

 

$

113,013

 

4.2%

 

4.3%

 

4Q06

 

3Q11

 

2Q13

 

Other - 400/450 East Jamie Court (4)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

20,659

 

$

(20,659

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Diego – University Town Center

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5200 Illumina Way

 

 

127,373

 

127,373

 

127,373

 

 

 

127,373

 

100

%

 

$

 

$

45,330

 

$

2,229

 

$

1,741

 

$

49,300

 

7.0%

 

10.8%

 

4Q10

 

4Q12

 

4Q12

 

Development projects in North America

 

99,694

 

887,256

 

986,950

 

728,866

 

 

258,084

 

986,950

 

74

%

 

$

79,140

 

$

304,619

 

$

33,344

 

$

159,553

 

$

576,656

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redevelopment projects in North America

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater Boston – Cambridge

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

400 Technology Square

 

 

212,123

 

212,123

 

169,939

 

 

42,184

 

212,123

 

80

%

 

$

 

$

111,297

 

$

15,891

 

$

17,500

 

$

144,688

 

8.1%

 

8.9%

 

4Q11

 

4Q12

 

4Q13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Seattle – Lake Union

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1551 Eastlake Avenue

 

65,342

 

52,141

 

117,483

 

74,914

 

8,000

 

34,569

 

117,483

 

71

%

 

$

36,148

 

$

20,366

 

$

2,730

 

$

4,766

 

$

64,010

 

6.7%

 

6.7%

 

4Q11

 

4Q11

 

4Q13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Suburban and other redevelopment projects

 

18,461

 

326,262

 

344,723

 

211,388

 

55,270

 

78,065

 

344,723

 

77

%

 

$

11,840

 

$

151,650

 

$

7,504

 

$

37,590

 

$

208,584

 

 

 

 

 

 

 

 

 

 

 

Other – suburban and other redevelopment projects (4)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

5,807

 

$

(5,807

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redevelopment projects in North America

 

83,803

 

590,526

 

674,329

 

456,241

 

63,270

 

154,818

 

674,329

 

77

%

 

$

53,795

 

$

277,506

 

$

26,125

 

$

59,856

 

$

417,282

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total development and redevelopment projects in North America

 

183,497

 

1,477,782

 

1,661,279

 

1,185,107

 

63,270

 

412,902

 

1,661,279

 

75

%

 

$

132,935

 

$

582,125

 

$

59,469

 

$

219,409

 

$

993,938

 

 

 

 

 

 

 

 

 

 

 

 

(1)

As of September 30, 2012, 96% of our overall leases contained annual rent escalations that were either fixed or based on a consumer price index or another index. Our Initial Stabilized Yield on a cash basis reflects cash rents upon stabilization and does not reflect contractual rent escalations beyond the stabilization date. We expect, on average, our contractual cash rents related to our value-added projects to increase over time.

(2)

The cash and GAAP Initial Stabilized Yields related to the development of 499 Illinois Street declined by approximately 0.3% and 0.2%, respectively, to allow for a slightly longer absorption period. Despite this change, we still expect to achieve overall yields for the entire project (including the occupied portion of 409 Illinois) within our original expectations of 6.5%-7.0% and 7.2%-7.6% for cash and GAAP, respectively.

(3)

Funding for this project will be provided primarily by the $55 million secured construction loan we closed in June 2012.

(4)

As of the period end, some portion of the real estate basis associated with the rentable square feet under development or redevelopment was classified as in service because activities necessary to prepare the asset for its intended use were no longer in process. In the near future, we anticipate recommencing activities necessary to prepare the asset for its intended use upon execution of leasing and final decisions related to design of each space.

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

7

 

 


 

 


 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Third Quarter Ended September 30, 2012, Financial and Operating Results

 

EARNINGS CALL INFORMATION

 

We will host a conference call on Monday, October 29, 2012, at 3:00 p.m. Eastern Time (“ET”)/12:00 p.m. noon Pacific Time (“PT”) that is open to the general public to discuss our financial and operating results for the three months and nine months ended September 30, 2012.  To participate in this conference call, dial (800) 447-0521 or (847) 413-3238 and confirmation code 33218271, shortly before 3:00 p.m. ET/12:00 p.m. noon PT.  The audio web cast can be accessed at: www.are.com, in the “For Investors” section.  A replay of the call will be available for a limited time from 5:30 p.m. ET/2:30 p.m. PT on Monday, October 29, 2012.  The replay number is (888) 843-7419 or (630) 652-3042 and the confirmation code is 33218271.

 

Additionally, a copy of this Earnings Press Release and Supplemental Information for the third quarter ended September 30, 2012, are available in the “For Investors” section of our website at www.are.com.

 

About the Company

 

Alexandria Real Estate Equities, Inc. (NYSE: ARE), a self-administered and self-managed REIT, is the largest and leading investment-grade REIT focused principally on owning, operating, developing, redeveloping, and acquiring high-quality, sustainable real estate for the broad and diverse life science industry.  Founded in 1994, Alexandria was the first REIT to identify and pursue the laboratory niche and has since had the first-mover advantage in every core life science cluster location including Greater Boston, San Francisco Bay, San Diego, New York City, Seattle, Suburban Washington, D.C., and Research Triangle Park. Alexandria’s high-credit client tenants span the life science industry, including renowned academic and medical institutions, multinational pharmaceutical companies, public and private biotechnology entities, United States government research agencies, medical device companies, industrial biotech companies, venture capital firms, and life science product and service companies. As the recognized real estate partner of the life science industry, Alexandria has a superior track record in driving client tenant productivity and innovation through its best-in-class laboratory and office space, collaborative locations adjacent to leading academic and medical institutions, unparalleled life science real estate expertise and services, and longstanding and expansive network in the life science community, which we believe result in higher occupancy levels, longer lease terms, higher rental income, higher returns, and greater long-term asset value. For additional information on Alexandria Real Estate Equities, Inc., please visit www.are.com.

 

***********

 

This press release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended.  Such forward-looking statements include, without limitation, statements regarding our 2012 earnings per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, 2012 FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, net operating income, and net income, for the year ended December 31, 2012, and our projected sources and uses of capital in 2012.  Our actual results may differ materially from those projected in such forward-looking statements.  Factors that might cause such a difference include, without limitation, our failure to obtain capital (debt, construction financing, and/or equity) or refinance debt maturities, increased interest rates and operating costs, adverse economic or real estate developments in our markets, our failure to successfully complete and lease our existing space held for redevelopment and new properties acquired for that purpose and any properties undergoing development, our failure to successfully operate or lease acquired properties, decreased rental rates or increased vacancy rates or failure to renew or replace expiring leases, defaults on or non-renewal of leases by client tenants, general and local economic conditions, and other risks and uncertainties detailed in our filings with the SEC.  All forward-looking statements are made as of the date of this press release, and we assume no obligation to update this information.  For more discussion relating to risks and uncertainties that could cause actual results to differ materially from those anticipated in our forward-looking statements, and risks to our business in general, please refer to our SEC filings, including our most recent annual report on Form 10-K and any subsequent quarterly reports on Form 10-Q.

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

8

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Condensed Consolidated Statements of Income

(Dollars in thousands, except per share amounts)

(Unaudited)

 

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

9/30/12

 

6/30/12

 

3/31/12

 

12/31/11

 

9/30/11

 

9/30/12

 

9/30/11

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rental

 

$

108,367

 

$

106,463

 

$

103,417

 

$

104,634

 

$

102,353

 

$

318,247

 

$

309,532

 

Tenant recoveries

 

34,448

 

32,172

 

32,386

 

33,031

 

33,226

 

99,006

 

95,270

 

Other income

 

2,640

 

9,381

 

2,629

 

1,584

 

2,475

 

14,650

 

4,178

 

Total revenues

 

145,455

 

148,016

 

138,432

 

139,249

 

138,054

 

431,903

 

408,980

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rental operations

 

44,614

 

42,359

 

40,911

 

41,553

 

40,859

 

127,884

 

118,014

 

General and administrative

 

12,485

 

12,309

 

10,358

 

10,601

 

10,289

 

35,152

 

30,528

 

Interest

 

17,094

 

17,922

 

16,227

 

14,757

 

14,273

 

51,243

 

48,621

 

Depreciation and amortization

 

47,176

 

51,276

 

42,326

 

39,762

 

38,747

 

140,778

 

113,326

 

Total expenses

 

121,369

 

123,866

 

109,822

 

106,673

 

104,168

 

355,057

 

310,489

 

Income from continuing operations before loss on early extinguishment of debt

 

24,086

 

24,150

 

28,610

 

32,576

 

33,886

 

76,846

 

98,491

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Loss on early extinguishment of debt

 

 

(1,602

)

(623

)

 

(2,742

)

(2,225

)

(6,485

)

Income from continuing operations

 

24,086

 

22,548

 

27,987

 

32,576

 

31,144

 

74,621

 

92,006

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(Loss) income from discontinued operations:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Income from discontinued operations before impairment of real estate

 

4,018

 

3,093

 

2,924

 

2,886

 

2,799

 

10,035

 

8,873

 

Impairment of real estate

 

(9,799

)

 

 

 

(994

)

(9,799

)

(994

)

(Loss) income from discontinued operations, net

 

(5,781

)

3,093

 

2,924

 

2,886

 

1,805

 

236

 

7,879

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Gain on sale of land parcel

 

 

 

1,864

 

 

46

 

1,864

 

46

 

Net income

 

18,305

 

25,641

 

32,775

 

35,462

 

32,995

 

76,721

 

99,931

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to noncontrolling interests

 

828

 

851

 

711

 

1,142

 

966

 

2,390

 

2,833

 

Dividends on preferred stock

 

6,471

 

6,903

 

7,483

 

7,090

 

7,089

 

20,857

 

21,267

 

Preferred stock redemption charge

 

 

 

5,978

 

 

 

5,978

 

 

Net income attributable to unvested restricted stock awards

 

360

 

271

 

235

 

270

 

278

 

866

 

818

 

Net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders

 

$

10,646

 

$

17,616

 

$

18,368

 

$

26,960

 

$

24,662

 

$

46,630

 

$

75,013

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic and diluted:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

$

0.26

 

$

0.24

 

$

0.25

 

$

0.39

 

$

0.37

 

$

0.75

 

$

1.15

 

Discontinued operations, net

 

(0.09

)

0.05

 

0.05

 

0.05

 

0.03

 

 

0.14

 

Earnings per share – basic and diluted

 

$

0.17

 

$

0.29

 

$

0.30

 

$

0.44

 

$

0.40

 

$

0.75

 

$

1.29

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares of common stock outstanding for calculating earnings per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic

 

62,364,210

 

61,663,367

 

61,507,807

 

61,427,495

 

61,295,659

 

61,847,023

 

58,271,270

 

Dilutive effect of stock options

 

 

173

 

1,160

 

3,939

 

8,310

 

448

 

13,475

 

Weighted average shares of common stock outstanding for calculating earnings per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted

 

62,364,210

 

61,663,540

 

61,508,967

 

61,431,434

 

61,303,969

 

61,847,471

 

58,284,745

 

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

9

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Condensed Consolidated Balance Sheets

(Dollars in thousands)

(Unaudited)

 

 

 

 

September 30,

 

June 30,

 

March 31,

 

December 31,

 

September 30,

 

 

 

2012

 

2012

 

2012

 

2011

 

2011

 

Assets

 

 

 

 

 

 

 

 

 

 

 

Investments in real estate, net

 

$

6,300,027

 

$

6,208,354

 

$

6,113,252

 

$

6,008,440

 

$

5,925,292

 

Cash and cash equivalents

 

94,904

 

80,937

 

77,361

 

78,539

 

73,056

 

Restricted cash

 

44,863

 

41,897

 

39,803

 

23,332

 

27,929

 

Tenant receivables

 

10,124

 

6,143

 

8,836

 

7,480

 

6,599

 

Deferred rent

 

160,914

 

155,295

 

150,515

 

142,097

 

132,954

 

Deferred leasing and financing costs, net

 

152,021

 

151,355

 

143,754

 

135,550

 

134,366

 

Investments

 

107,808

 

104,454

 

98,152

 

95,777

 

88,777

 

Other assets

 

94,356

 

93,304

 

86,418

 

82,914

 

66,583

 

Total assets

 

$

6,965,017

 

$

6,841,739

 

$

6,718,091

 

$

6,574,129

 

$

6,455,556

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities, Noncontrolling Interests, and Equity

 

 

 

 

 

 

 

 

 

 

 

Secured notes payable

 

$

719,350

 

$

719,977

 

$

721,715

 

$

724,305

 

$

760,882

 

Unsecured senior notes payable

 

549,794

 

549,783

 

550,772

 

84,959

 

84,484

 

Unsecured senior line of credit

 

413,000

 

379,000

 

167,000

 

370,000

 

814,000

 

Unsecured senior bank term loans

 

1,350,000

 

1,350,000

 

1,350,000

 

1,600,000

 

1,000,000

 

Accounts payable, accrued expenses, and tenant security deposits

 

376,785

 

348,037

 

323,002

 

325,393

 

330,044

 

Dividends payable

 

39,468

 

38,357

 

36,962

 

36,579

 

35,287

 

Preferred stock redemption liability

 

 

 

129,638

 

 

 

Total liabilities

 

3,448,397

 

3,385,154

 

3,279,089

 

3,141,236

 

3,024,697

 

 

 

 

 

 

 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redeemable noncontrolling interests

 

15,610

 

15,817

 

15,819

 

16,034

 

15,931

 

 

 

 

 

 

 

 

 

 

 

 

 

Alexandria Real Estate Equities, Inc.’s stockholders’ equity:

 

 

 

 

 

 

 

 

 

 

 

Series C Preferred Stock

 

 

 

 

129,638

 

129,638

 

Series D Convertible Preferred Stock

 

250,000

 

250,000

 

250,000

 

250,000

 

250,000

 

Series E Preferred Stock

 

130,000

 

130,000

 

130,000

 

 

 

Common stock

 

632

 

622

 

616

 

616

 

614

 

Additional paid-in capital

 

3,094,987

 

3,053,269

 

3,022,242

 

3,028,558

 

3,025,444

 

Accumulated other comprehensive loss

 

(19,729

)

(37,370

)

(23,088

)

(34,511

)

(32,202

)

Alexandria Real Estate Equities, Inc.’s stockholders’ equity

 

3,455,890

 

3,396,521

 

3,379,770

 

3,374,301

 

3,373,494

 

Noncontrolling interests

 

45,120

 

44,247

 

43,413

 

42,558

 

41,434

 

Total equity

 

3,501,010

 

3,440,768

 

3,423,183

 

3,416,859

 

3,414,928

 

Total liabilities, noncontrolling interests, and equity

 

$

6,965,017

 

$

6,841,739

 

$

6,718,091

 

$

6,574,129

 

$

6,455,556

 

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

10

 


 


 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Funds From Operations and Adjusted Funds From Operations

(Dollars in thousands, except per share amounts)

(Unaudited)

 

The following table presents a reconciliation of net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic, the most directly comparable financial measure presented in accordance with GAAP, to FFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, FFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, as adjusted, and AFFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted for the periods below:

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

9/30/12

 

6/30/12

 

3/31/12

 

12/31/11

 

9/30/11

 

9/30/12

 

9/30/11

 

Net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic

 

$

10,646

 

$

17,616

 

$

18,368

 

$

26,960

 

$

24,662

 

$

46,630

 

$

75,013

 

Depreciation and amortization

 

48,173

 

52,355

 

43,405

 

40,966

 

39,990

 

143,933

 

117,060

 

Gain on sale of real estate

 

(1,562

)

(2

)

 

 

 

(1,564

)

 

Impairment of real estate

 

9,799

 

 

 

 

994

 

9,799

 

994

 

Gain on sale of land parcel

 

 

 

(1,864

)

 

(46

)

(1,864

)

(46

)

Amount attributable to noncontrolling interests/unvested stock awards:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

1,188

 

1,122

 

946

 

1,412

 

1,244

 

3,256

 

3,651

 

FFO

 

(1,148

)

(1,133

)

(1,156

)

(1,539

)

(1,580

)

(3,452

)

(4,877

)

FFO attributable to Alexandria Real Estate Equities, Inc.’s common
stockholders – basic

 

67,096

 

69,958

 

59,699

 

67,799

 

65,264

 

196,738

 

191,795

 

Assumed conversion of 8.00% Unsecured Senior Convertible Notes

 

5

 

6

 

5

 

5

 

4

 

16

 

16

 

FFO attributable to Alexandria Real Estate Equities, Inc.’s common
stockholders – diluted

 

67,101

 

69,964

 

59,704

 

67,804

 

65,268

 

196,754

 

191,811

 

Realized gain on equity investment primarily related to one non-tenant
life science entity

 

 

(5,811

)

 

 

 

(5,811

)

 

Loss on early extinguishment of debt

 

 

1,602

 

623

 

 

2,742

 

2,225

 

6,485

 

Preferred stock redemption charge

 

 

 

5,978

 

 

 

5,978

 

 

Allocation to unvested restricted stock awards

 

 

35

 

(53

)

 

(38

)

(21

)

(59

)

FFO attributable to Alexandria Real Estate Equities, Inc.’s common
stockholders – diluted, as adjusted

 

$

67,101

 

$

65,790

 

$

66,252

 

$

67,804

 

$

67,972

 

$

199,125

 

$

198,237

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-incremental revenue-enhancing capital expenditures:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Building improvements

 

(935

)

(594

)

(210

)

(675

)

(550

)

(1,739

)

(1,856

)

Tenant improvements and leasing commissions

 

(1,844

)

(2,148

)

(2,019

)

(6,083

)

(2,119

)

(6,011

)

(4,517

)

Straight-line rent

 

(5,225

)

(5,195

)

(8,796

)

(9,558

)

(7,647

)

(19,216

)

(17,239

)

Straight-line rent on ground leases

 

201

 

1,207

 

1,406

 

1,221

 

1,143

 

2,814

 

3,483

 

Capitalized income from development projects

 

50

 

72

 

478

 

537

 

930

 

600

 

3,436

 

Amortization of acquired above and below market leases

 

(778

)

(778

)

(800

)

(812

)

(940

)

(2,356

)

(8,520

)

Amortization of loan fees

 

2,470

 

2,214

 

2,643

 

2,551

 

2,144

 

7,327

 

6,749

 

Amortization of debt premiums/discounts

 

112

 

110

 

179

 

565

 

750

 

401

 

3,254

 

Stock compensation

 

3,845

 

3,274

 

3,293

 

3,306

 

3,344

 

10,412

 

8,449

 

Allocation to unvested restricted stock awards

 

19

 

15

 

31

 

80

 

31

 

67

 

61

 

AFFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted

 

$

65,016

 

$

63,967

 

$

62,457

 

$

58,936

 

$

65,058

 

$

191,424

 

$

191,537

 

 

The following table presents a reconciliation of net income per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic, to FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, as adjusted, and AFFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted for the periods below.  For the computation of the weighted average shares used to compute the per share information, refer to the “Definitions and Other Information” section in our supplemental information:

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

9/30/12

 

6/30/12

 

3/31/12

 

12/31/11

 

9/30/11

 

9/30/12

 

9/30/11

 

Net income per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic

 

$

0.17

 

$

0.29

 

$

0.30

 

$

0.44

 

$

0.40

 

$

0.75

 

$

1.29

 

Depreciation and amortization

 

0.78

 

0.84

 

0.70

 

0.67

 

0.65

 

2.34

 

2.00

 

Gain on sale of real estate

 

(0.03

)

 

 

 

 

(0.03

)

 

Impairment of real estate

 

0.16

 

 

 

 

0.02

 

0.16

 

0.02

 

Gain on sale of land parcel

 

 

 

(0.03

)

 

 

(0.03

)

 

Amount attributable to noncontrolling interests/unvested stock awards:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income

 

0.02

 

0.02

 

0.02

 

0.02

 

0.02

 

0.05

 

0.06

 

FFO

 

(0.02

)

(0.02

)

(0.02

)

(0.03

)

(0.03

)

(0.06

)

(0.08

)

FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – basic

 

1.08

 

1.13

 

0.97

 

1.10

 

1.06

 

3.18

 

3.29

 

Assumed conversion of 8.00% Unsecured Senior Convertible Notes

 

 

 

 

 

 

 

 

FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted

 

1.08

 

1.13

 

0.97

 

1.10

 

1.06

 

3.18

 

3.29

 

Realized gain on equity investment primarily related to one non-tenant life science entity

 

 

(0.09

)

 

 

 

(0.09

)

 

Loss on early extinguishment of debt

 

 

0.03

 

0.01

 

 

0.05

 

0.03

 

0.11

 

Preferred stock redemption charge

 

 

 

0.10

 

 

 

0.10

 

 

FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted, as adjusted

 

$

1.08

 

$

1.07

 

$

1.08

 

$

1.10

 

$

1.11

 

$

3.22

 

$

3.40

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-incremental revenue-enhancing capital expenditures:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Building improvements

 

(0.01

)

(0.01

)

 

(0.01

)

(0.01

)

(0.03

)

(0.03

)

Tenant improvements and leasing commissions

 

(0.03

)

(0.03

)

(0.03

)

(0.10

)

(0.03

)

(0.10

)

(0.08

)

Straight-line rent

 

(0.08

)

(0.08

)

(0.14

)

(0.16

)

(0.12

)

(0.31

)

(0.30

)

Straight-line rent on ground leases

 

 

0.02

 

0.02

 

0.02

 

0.02

 

0.05

 

0.06

 

Capitalized income from development projects

 

 

 

0.01

 

0.01

 

0.02

 

0.01

 

0.06

 

Amortization of acquired above and below market leases

 

(0.01

)

(0.01

)

(0.01

)

(0.01

)

(0.02

)

(0.04

)

(0.15

)

Amortization of loan fees

 

0.03

 

0.03

 

0.04

 

0.05

 

0.03

 

0.11

 

0.13

 

Amortization of debt premiums/discounts

 

 

 

 

0.01

 

0.01

 

0.01

 

0.06

 

Stock compensation

 

0.06

 

0.05

 

0.05

 

0.05

 

0.05

 

0.17

 

0.14

 

AFFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted

 

$

1.04

 

$

1.04

 

$

1.02

 

$

0.96

 

$

1.06

 

$

3.09

 

$

3.29

 

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

ALL RIGHTS RESERVED © 2012

11

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Non-GAAP Measures

(Tabular dollar amounts in thousands)

(Unaudited)

Funds from operations and funds from operations, as adjusted

 

GAAP basis accounting for real estate assets utilizes historical cost accounting and assumes real estate values diminish over time.  In an effort to overcome the difference between real estate values and historical cost accounting for real estate assets, the Board of Governors of the National Association of Real Estate Investment Trusts (“NAREIT”) established the measurement tool of FFO.  Since its introduction, FFO has become a widely used non-GAAP financial measure among equity REITs.  We believe that FFO is helpful to investors as an additional measure of the performance of an equity REIT.  Moreover, we believe that FFO, as adjusted, is also helpful because it allows investors to compare our performance to the performance of other real estate companies between periods, and on a consistent basis, without having to account for differences caused by investment decisions, financing decisions, terms of securities, capital structures, and capital market transactions. We compute FFO in accordance with standards established by the Board of Governors of NAREIT in its April 2002 white paper and related implementation guidance (“NAREIT White Paper”). The NAREIT White Paper defines FFO as net income (computed in accordance with GAAP), excluding gains (losses) from sales and impairments of real estate, plus real estate related depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures.  Impairments of real estate relate to decreases in the estimated fair value of real estate due to changes in general market conditions and do not necessarily reflect the operating performance of the properties during the corresponding period.  Impairments of real estate represent the non-cash write-down of assets when fair value over the recoverability period is less than the carrying value.  We compute FFO, as adjusted, as FFO calculated in accordance with the NAREIT White Paper, plus losses from early extinguishment of debt and preferred stock redemption charges, less realized gain on equity investment primarily related to one non-tenant life science entity, and the amount of such items which are allocable to our unvested restricted stock awards. Our calculations of both FFO and FFO, as adjusted, may differ from those methodologies utilized by other equity REITs for similar performance measurements, and, accordingly, may not be comparable to other equity REITs.  Neither FFO nor FFO, as adjusted, should be considered as an alternative to net income (determined in accordance with GAAP) as an indication of financial performance, or to cash flows from operating activities (determined in accordance with GAAP) as a measure of liquidity, nor are they indicative of the availability of funds for our cash needs, including funds available to make distributions.

 

Adjusted funds from operations

 

AFFO is a non-GAAP financial measure that we use as a supplemental measure of our performance.  We compute AFFO by adding to or deducting from FFO, as adjusted: (1) non-incremental revenue-enhancing capital expenditures, tenant improvements, and leasing commissions (excludes redevelopment expenditures); (2) effects of straight-line rent and straight-line rent on ground leases; (3) capitalized income from development projects; (4) amortization of acquired above and below market leases, loan fees, and debt premiums/discounts; (5) non-cash compensation expense; and (6) allocation of AFFO attributable to unvested restricted stock awards.

 

We believe that AFFO is a useful supplemental performance measure because it further adjusts to: (1) deduct certain expenditures which, although capitalized and included in depreciation expense, do not enhance the revenue or cash flows of our properties; (2) eliminate the effect of straight-lining our rental income and capitalizing income from development projects in order to reflect the actual amount of contractual rents due in the period presented; and (3) eliminate the effect of non-cash items that are not indicative of our core operations and do not actually reduce the amount of cash generated by our operations.  We believe that eliminating the effect of non-cash charges related to stock-based compensation facilitates a comparison of our operations across periods and among other equity REITs without the variances caused by different valuation methodologies, the volatility of the expense (which depends on market forces outside of our control), and the assumptions and the variety of award types that a company can use.  We believe that AFFO provides useful information by excluding certain items that are not representative of our core operating results because such items are dependent upon historical costs or subject to judgmental valuation inputs and the timing of our decisions.

 

AFFO is not intended to represent cash flow for the period, and is only intended to provide an additional measure of performance.  We believe that net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders is the most directly comparable GAAP financial measure to AFFO.  We believe that AFFO is a widely recognized measure of the operations of equity REITs, and presenting AFFO will enable investors to assess our performance in comparison to other equity REITs.  However, other equity REITs may use different methodologies for calculating AFFO and, accordingly, our AFFO may not be comparable to AFFO calculated by other equity REITs.  AFFO should not be considered as an alternative to net income (determined in accordance with GAAP) as an indication of financial performance, or to cash flows from operating activities (determined in accordance with GAAP) as a measure of our liquidity, nor is it indicative of funds available to fund our cash needs, including our ability to make distributions.

 

Net operating income

 

Net operating income is a non-GAAP financial measure equal to income from continuing operations, the most directly comparable GAAP financial measure, plus loss on early extinguishment of debt, depreciation and amortization, interest expense, and general and administrative expense.  We believe net operating income provides useful information to investors regarding our financial condition and results of operations because it reflects primarily those income and expense items that are incurred at the property level.  Therefore, we believe net operating income is a useful measure for evaluating the operating performance of our real estate assets.  Net operating income on a cash basis is net operating income on a GAAP basis, adjusted to exclude the effect of straight-line rent adjustments required by GAAP.  We believe that net operating income on a cash basis is helpful to investors as an additional measure of operating performance because it eliminates straight-line rent adjustments to rental revenue.

 

Further, we believe net operating income is useful to investors as a performance measure, because when compared across periods, net operating income reflects the impact on operations from trends in occupancy rates, rental rates, and operating costs, providing perspective not immediately apparent from income from continuing operations.  Net operating income excludes certain components from income from continuing operations in order to provide results that are more closely related to the results of operations of our properties.  For example, interest expense is not necessarily linked to the operating performance of a real estate asset and is often incurred at the corporate level rather than at the property level.  In addition, depreciation and amortization, because of historical cost accounting and useful life estimates, may distort operating performance at the property level.  Property operating expenses that are included in determining net operating income consist of costs that are related to our operating properties, such as utilities, repairs and maintenance, rental expense related to ground leases, contracted services, such as janitorial, engineering, and landscaping, property taxes and insurance, and property level salaries.  General and administrative expenses consist primarily of accounting and corporate compensation, corporate insurance, professional fees, office rent, and office supplies, that are incurred as part of corporate office management. Net operating income presented by us may not be comparable to net operating income reported by other equity REITs that define net operating income differently.  We believe that in order to facilitate a clear understanding of our operating results, net operating income should be examined in conjunction with income from continuing operations as presented in our condensed consolidated statements of income.  Net operating income should not be considered as an alternative to income from continuing operations as an indication of our performance, or as an alternative to cash flows as a measure of liquidity, or our ability to make distributions.  The following table presents a reconciliation of net operating income to income from continuing operations:

 

 

Three Months Ended

 

Nine Months Ended

 

 

September 30, 2012

 

September 30, 2011

 

September 30, 2012

 

September 30, 2011

Total revenues

 

$

145,455

 

$

138,054

 

$

431,903

 

$

408,980

Rental operating expenses

 

44,614

 

40,859

 

127,884

 

118,014

Net operating income

 

100,841

 

97,195

 

304,019

 

290,966

Operating margins

 

69%

 

70%

 

70%

 

71%

General and administrative

 

12,485

 

10,289

 

35,152

 

30,528

Interest

 

17,094

 

14,273

 

51,243

 

48,621

Depreciation and amortization

 

47,176

 

38,747

 

140,778

 

113,326

Loss on early extinguishment of debt

 

 

2,742

 

2,225

 

6,485

Income from continuing operations

 

$

24,086

 

$

31,144

 

$

74,621

 

$

92,006

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

ALL RIGHTS RESERVED © 2012

12

 

 


 


 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Financial and Asset Base Highlights

(Dollars in thousands, except per share amounts)

(Unaudited)

 

 

 

Three Months Ended

 

Key Credit Metrics

 

9/30/12

 

6/30/12

 

3/31/12

 

12/31/11

 

9/30/11

 

Unencumbered net operating income as a percentage of total net operating income

 

73%

 

73%

 

70%

 

69%

 

66%

 

Percentage outstanding on unsecured senior line of credit at end of period

 

28%

 

25%

 

11%

 

25%

 

54%

 

Net debt to gross assets (excluding cash and restricted cash) at end of period

 

38%

 

38%

 

36%

 

37%

 

36%

 

Net debt to Adjusted EBITDA (1)

 

7.6x

 

7.1x

 (2)

7.1x

 

7.1x

 

6.8x

 

Fixed charge coverage ratio (1)

 

2.5x

 

2.6x

 

2.6x

 

2.7x

 

2.7x

 

Interest coverage ratio (1)

 

3.1x

 

3.2x

 

3.3x

 

3.4x

 

3.4x

 

Dividend payout ratio (common stock)

 

50%

 

49%

 

46%

 

45%

 

43%

 

 

 

 

 

 

 

 

 

 

 

 

 

Selected Balance Sheet Information

 

 

 

 

 

 

 

 

 

 

 

Investments in real estate (gross)

 

$

7,154,359

 

$

7,030,723

 

$

6,892,429

 

$

6,750,975

 

$

6,635,872

 

Total assets

 

$

6,965,017

 

$

6,841,739

 

$

6,718,091

 

$

6,574,129

 

$

6,455,556

 

Total unsecured debt

 

$

2,312,794

 

$

2,278,783

 

$

2,067,772

 

$

2,054,959

 

$

1,898,484

 

Total debt

 

$

3,032,114

 

$

2,998,760

 

$

2,789,487

 

$

2,779,264

 

$

2,659,366

 

Net debt

 

$

2,892,377

 

$

2,875,926

 

$

2,672,323

 

$

2,677,393

 

$

2,558,381

 

Total liabilities

 

$

3,448,397

 

$

3,385,154

 

$

3,279,089

 

$

3,141,236

 

$

3,024,697

 

Common shares outstanding

 

63,161,177

 

62,249,973

 

61,634,645

 

61,560,472

 

61,463,839

 

Total market capitalization

 

$

8,064,386

 

$

7,912,286

 

$

7,673,553

 

$

7,412,402

 

$

6,815,380

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Data

 

 

 

 

 

 

 

 

 

 

 

Total revenues

 

$

145,455

 

$

148,016

 

$

138,432

 

$

139,249

 

$

138,054

 

Rental operations

 

$

44,614

 

$

42,359

 

$

40,911

 

$

41,553

 

$

40,859

 

Operating margins

 

69%

 

71%

 

70%

 

70%

 

70%

 

General and administrative expense as a percentage of total revenues

 

8.6%

 

8.3%

 

7.5%

 

7.6%

 

7.5%

 

Capitalized interest

 

$

16,763

 

$

15,825

 

$

15,266

 

$

16,151

 

$

16,666

 

Weighted average interest rate used for capitalization during period

 

4.35%

 

4.41%

 

4.29%

 

4.35%

 

4.54%

 

Adjusted EBITDA – quarter annualized

 

$

382,616

 

$

403,168

 (2)

$

377,836

 

$

377,964

 

$

377,168

 

Adjusted EBITDA – trailing 12 months

 

$

385,396

 

$

384,034

 (2)

$

378,484

 

$

376,050

 

$

370,998

 

Adjusted EBITDA margins – quarter annualized

 

66%

 

68%

 

68%

 

68%

 

68%

 

 

 

 

 

 

 

 

 

 

 

 

 

Net Income, FFO, and AFFO

 

 

 

 

 

 

 

 

 

 

 

Net income attributable to Alexandria Real Estate Equities, Inc.’s common
stockholders – diluted

 

$

10,646

 (3)

$

17,616

 

$

18,368

 

$

26,960

 

$

24,662

 

FFO attributable to Alexandria Real Estate, Inc.’s common stockholders – diluted

 

$

67,101

 

$

69,964

 

$

59,704

 

$

67,804

 

$

65,268

 

FFO attributable to Alexandria Real Estate, Inc.’s common stockholders – diluted,
as adjusted

 

$

67,101

 

$

65,790

 

$

66,252

 

$

67,804

 

$

67,972

 

AFFO attributable to Alexandria Real Estate Equities, Inc.’s common
stockholders – diluted

 

$

65,016

 

$

63,967

 

$

62,457

 

58,936

 

$

65,058

 

 

 

 

 

 

 

 

 

 

 

 

 

Per Share Data

 

 

 

 

 

 

 

 

 

 

 

Earnings per share – diluted

 

$

0.17

 (3)

$

0.29

 

$

0.30

 

$

0.44

 

$

0.40

 

FFO per share – diluted

 

$

1.08

 

$

1.13

 

$

0.97

 

$

1.10

 

$

1.06

 

FFO per share – diluted, as adjusted

 

$

1.08

 

$

1.07

 

$

1.08

 

$

1.10

 

$

1.11

 

AFFO per share – diluted

 

$

1.04

 

$

1.04

 

$

1.02

 

$

0.96

 

$

1.06

 

 

 

 

 

 

 

 

 

 

 

 

 

Asset Base Statistics

 

 

 

 

 

 

 

 

 

 

 

Number of properties at end of period

 

177

 

182

 

174

 

173

 

171

 

Rentable square feet at end of period

 

16,638,721

 

16,922,327

 

15,548,026

 

15,312,563

 

14,877,807

 

Occupancy of operating properties at end of period

 

93.0%

 

92.9%

 

94.2%

 

94.9%

 

94.6%

 

Occupancy of operating and redevelopment properties at end of period

 

88.3%

 

86.9%

 

87.9%

 

88.5%

 

89.3%

 

 

 

 

 

 

 

 

 

 

 

 

 

Leasing Activity and Same Property Performance

 

 

 

 

 

 

 

 

 

 

 

Leasing activity – Qtr rentable square feet

 

732,094

 

959,295

 

911,926

 

1,142,055

 

985,337

 

Leasing activity – Qtr percentage change in rental rates – cash basis

 

(2.9%

)

(0.8%

)

(2.8%

)

(4.1%

)

(3.0%

)

Leasing activity – Qtr percentage change in rental rates – GAAP basis

 

7.6%

 

5.8%

 

3.3%

 

7.6%

 

2.8%

 

Same property – Qtr percentage change in net operating income – cash basis

 

4.3%

 

1.6%

 

1.7%

 

3.1%

 

4.8%

 

Same property – Qtr percentage change in net operating income – GAAP basis

 

(0.9%

)

(0.2%

)

(0.7%

)

(0.5%

)

(0.2%

)

 

(1)

Quarter annualized.

(2)

Excluding $5.8 million recognized in the second quarter of 2012 related to a realized gain on an equity investment primarily related to one non-tenant life science entity, net debt to Adjusted EBITDA was 7.6x, Adjusted EBITDA – quarter annualized was approximately $379.9 million, and Adjusted EBITDA – trailing 12 months was approximately $378.2 million.

(3)

Net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders – diluted excluding $9.8 million, or $0.16 per share, impairment of real estate, was $20.4 million, or $0.33 per share.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

13

 

 



 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Core Operating Metrics

September 30, 2012

(Unaudited)

 

Quarterly percentage change in same property net operating income

 

 

Percentage change in rental rates on renewed/re-leased space

 

 

Occupancy percentage

 

 

Solid leasing capabilities – rentable square feet leased

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

14

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Summary of Same Property Comparisons

September 30, 2012

(Dollars in thousands)

(Unaudited)

 

 

 

Three Months Ended

 

Nine Months Ended

 

Same property data

 

September 30, 2012

 

September 30, 2012

 

Percentage change in net operating income – cash basis

 

4.3%

 

2.6%

 

Percentage change in net operating income – GAAP basis

 

(0.9%

)

(0.8%

)

 

 

 

 

 

 

Number of properties

 

136

 

133

 

Rentable square feet

 

9,988,751

 

9,809,636

 

Occupancy – current period

 

93.7%

 

93.7%

 

Occupancy – same period prior year

 

93.2%

 

93.5%

 

 

The following table presents a comparison of the components of same property and non-same property net operating income for the three months and nine months ended September 30, 2012, compared to the three months and nine months ended September 30, 2011, and a reconciliation of net operating income to income from continuing operations, the most directly comparable GAAP financial measure:

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

Revenues:

 

2012

 

2011

 

% Change

 

2012

 

2011

 

% Change

 

Total revenues – same properties

 

$

109,310

 

$

109,767

 

(0.4

%)

 (1)

$

321,613

 

$

321,155

 

0.1

%

 (1)

Total revenues – non-same properties

 

36,145

 

28,287

 

27.8

 

 

110,290

 

87,825

 

25.6

 

 

Total revenues – GAAP basis

 

145,455

 

138,054

 

5.4

 

 

431,903

 

408,980

 

5.6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Rental operations – same properties

 

32,739

 

32,473

 

0.8

 

 

94,360

 

92,108

 

2.4

 

 

Rental operations – non-same properties

 

11,875

 

8,386

 

41.6

 

 

33,524

 

25,906

 

29.4

 

 

Total rental operations

 

44,614

 

40,859

 

9.2

 

 

127,884

 

118,014

 

8.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net operating income:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net operating income – same properties

 

76,571

 

77,294

 

(0.9

)

 

227,253

 

229,047

 

(0.8

)

 

Net operating income – non-same properties

 

24,270

 

19,901

 

22.0

 

 

76,766

 

61,919

 

24.0

 

 

Total net operating income – GAAP basis

 

100,841

 

97,195

 

3.8

 

 

304,019

 

290,966

 

4.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

General and administrative

 

12,485

 

10,289

 

21.3

 

 

35,152

 

30,528

 

15.1

 

 

Interest

 

17,094

 

14,273

 

19.8

 

 

51,243

 

48,621

 

5.4

 

 

Depreciation and amortization

 

47,176

 

38,747

 

21.8

 

 

140,778

 

113,326

 

24.2

 

 

Loss on early extinguishment of debt

 

 

2,742

 

(100.0

)

 

2,225

 

6,485

 

(65.7

)

 

Total other expenses

 

76,755

 

66,051

 

16.2

 

 

229,398

 

198,960

 

15.3

 

 

Income from continuing operations

 

$

24,086

 

$

31,144

 

(22.7

%)

 

$

74,621

 

$

92,006

 

(18.9

%)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net operating income – same properties – GAAP basis

 

$

76,571

 

$

77,294

 

(0.9

%)

 

$

227,253

 

$

229,047

 

(0.8

%)

 

Less: straight-line rent adjustments

 

(990

)

(4,824

)

(79.5

)

 (2)

(4,120

)

(11,521

)

(64.2

)

 (2)

Net operating income – same properties – cash basis

 

$

75,581

 

$

72,470

 

4.3

%

 

$

223,133

 

$

217,526

 

2.6

%

 

 

(1)       Same property revenues were significantly impacted by a temporary decline in occupancy at 300 Technology Square in the Greater Boston market.

(2)       The decrease in straight-line rent was primarily related to the commencement of approximately $6.5 million of annual cash rent at 450 East 29th Street in the Greater NYC market in early February 2012.

 

The following table reconciles same properties to total properties for the nine months ended September 30, 2012:

 

 

Number of
Properties

 

 

Number of
Properties

 

 

Number of
Properties

 

Development – active

 

 

Development – deliveries since January 1, 2011

 

 

Development/Redevelopment – Asia

9

(3)

225 Binney Street

1

 

455 Mission Bay Boulevard South

1

 

 

 

 

259 East Grand Avenue

1

 

4755 Nexus Center Drive

1

 

Properties acquired since January 1, 2011

 

 

400/450 East Jamie Court

2

 

7 Triangle Drive

1

 

3013/3033 Science Park Road

1

 

409/499 Illinois Street

2

(1)

Canada

(2)

6 Davis Drive

1

 

5200 Illumina Way

1

 

 

3

 

 

2

 

 

7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redevelopment – active

 

 

Redevelopment – deliveries since January 1, 2011

 

 

Properties held for sale

4

 

11119 North Torrey Pines Road

1

 

10300 Campus Point Drive

1

 

Total properties excluded from same properties

44

 

1551 Eastlake Avenue

1

 

15010 Broschart Road

1

 

Same properties

133

 

20 Walkup Drive

1

 

215 First Street

1

 

Total properties as of September 30, 2012

177

 

285 Bear Hill Road

1

(1)

3530/3550 John Hopkins Court

2

 

 

 

 

343 Oyster Point Blvd

1

 

3565 General Atomics Court

1

 

 

 

 

400 Technology Square

1

 

500 Arsenal Street

1

 

 

 

 

620 Professional Drive

1

 

6101 Quadrangle Drive

1

 

 

 

 

6275 Nancy Ridge Drive

1

 

 

8

 

 

 

 

9800 Medical Center Drive

3

 

 

 

 

 

 

 

 

11

 

 

 

 

 

 

 

 

(1)       Properties acquired since January 1, 2011.

(2)       Property count is included in operating portfolio as of September 30, 2012.

(3)       Property count includes two development deliveries, one redevelopment delivery, one property acquired since January 1, 2011, and five active development and redevelopment properties.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

15

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Summary of Leasing Activity

September 30, 2012

(Unaudited)

 

 

 

Three Months Ended

 

Nine Months Ended

 

Year Ended

 

 

 

September 30, 2012

 

September 30, 2012

 

December 31, 2011

 

December 31, 2010

 

December 31, 2009

 

Leasing activity:

 

Cash

 

GAAP

 

Cash

 

GAAP

 

Cash

 

GAAP

 

Cash

 

GAAP

 

Cash

 

GAAP

 

Lease expirations

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of leases

 

47

 

47

 

131

 

131

 

158

 

158

 

129

 

129

 

131

 

131

 

Rentable square footage

 

441,483

 

441,483

 

1,816,548

 

1,816,548

 

2,689,257

 

2,689,257

 

2,416,291

 

2,416,291

 

1,842,597

 

1,842,597

 

Expiring rates

 

$29.88

 

$28.10

 

$29.42

 

$27.77

 

$29.98

 

$28.42

 

$27.18

 

$28.54

 

$30.61

 

$30.70

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Renewed/re-leased space

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of leases

 

24

 

24

 

79

 

79

 

109

 

109

 

89

 

89

 

95

 

95

 

Leased rentable square footage

 

352,248

 

352,248

 

1,161,049

 

1,161,049

 

1,821,866

 

1,821,866

 

1,777,966

 

1,777,966

 

1,188,184

 

1,188,184

 

Expiring rates

 

$29.89

 

$28.35

 

$29.99

 

$28.36

 

$30.73

 

$28.79

 

$28.84

 

$30.54

 

$28.07

 

$26.78

 

New rates

 

$29.02

 

$30.51

 

$29.43

 

$30.04

 

$30.16

 

$30.00

 

$29.41

 

$32.04

 

$28.11

 

$27.72

 

Rental rate changes

 

(2.9%

)

7.6%

 

(1.9%

) (1)

5.9%

 (1)

(1.9%

)

4.2%

 

2.0%

 

4.9%

 

0.1%

 

3.5%

 

TI’s/lease commissions per square foot

 

$5.23

 

$5.23

 

$5.18

 

$5.18

 

$5.82

 

$5.82

 

$4.40

 

$4.40

 

$3.99

 

$3.99

 

Average lease terms

 

4.8 years

 

4.8 years

 

4.6 years

 

4.6 years

 

4.2 years

 

4.2 years

 

8.1 years

 

8.1 years

 

3.3 years

 

3.3 years

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Developed/redeveloped/previously vacant space leased

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of leases

 

23

 

23

 

67

 

67

 

81

 

81

 

53

 

53

 

47

 

47

 

Rentable square footage

 

379,846

 

379,846

 

1,442,266

 

1,442,266

 

1,585,610

 

1,585,610

 

966,273

 

966,273

 

676,163

 

676,163

 

New rates

 

$29.06

 

$29.75

 

$32.71

 

$34.66

 

$33.45

 

$36.00

 

$36.33

 

$39.89

 

$33.57

 

$36.00

 

TI’s/lease commissions per square foot

 

$13.22

 

$13.22

 

$11.94

 

$11.94

 

$12.78

 

$12.78

 

$8.10

 

$8.10

 

$8.12

 

$8.12

 

Average lease terms

 

8.6 years

 

8.6 years

 

9.1 years

 

9.1 years

 

8.9 years

 

8.9 years

 

9.7 years

 

9.7 years

 

6.6 years

 

6.6 years

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Leasing activity summary:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Totals (2)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Number of leases

 

47

 

47

 

146

 

146

 

190

 

190

 

142

 

142

 

142

 

142

 

Rentable square footage

 

732,094

 

732,094

 

2,603,315

 

2,603,315

 

3,407,476

 

3,407,476

 

2,744,239

 

2,744,239

 

1,864,347

 

1,864,347

 

New rates

 

$29.04

 

$30.12

 

$31.25

 

$32.60

 

$31.69

 

$32.79

 

$31.84

 

$34.80

 

$30.09

 

$30.73

 

TI’s/lease commissions per square foot

 

$9.38

 

$9.38

 

$8.93

 

$8.93

 

$9.06

 

$9.06

 

$5.70

 

$5.70

 

$5.49

 

$5.49

 

Average lease terms

 

6.8 years

 

6.8 years

 

7.1 years

 

7.1 years

 

6.4 years

 

6.4 years

 

8.7 years

 

8.7 years

 

4.5 years

 

4.5 years

 

Retention rate

 

88%

 

88%

 

78%

 

78%

 

87%

 

87%

 

92%

 

92%

 

81%

 

81%

 

 

(1)

Excluding one lease for 48,000 rentable square feet related to one client tenant in the Research Triangle Park market, and one lease for 71,000 rentable square feet related to one client tenant in the Suburban Washington, D.C. market, rental rates for renewed/re-leased space were, on average, 0.1% higher and 7.3% higher than rental rates for expiring leases on a cash and GAAP basis, respectively.

(2)

Excludes 10 month-to-month leases for approximately 25,000 rentable square feet.

 

During the three months ended September 30, 2012, we granted tenant concessions/free rent averaging approximately 1.8 months with respect to the 732,094 rentable square feet leased.  During the nine months ended September 30, 2012, we granted tenant concessions/free rent averaging approximately 1.7 months with respect to the 2,603,315 rentable square feet leased.

 

 

Lease Structure

 

September 30, 2012

Percentage of triple net leases

 

94%

Percentage of leases containing annual rent escalations

 

96%

Percentage of leases providing for the recapture of capital expenditures

 

91%

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

16

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Summary of Lease Expirations

September 30, 2012

(Unaudited)

 

 

 

Year of Lease Expiration

 

 

Number of Leases Expiring

 

 

RSF of Expiring Leases

 

Percentage of
Aggregate Total RSF

 

Annualized Base Rent of
Expiring Leases (per RSF)

 

2012

 

21

 (1)

 

490,382

 (1)

 

3.5%

 

 

$25.84

 

 

2013

 

88

 

 

953,531

 

 

6.9%

 

 

$28.31

 

 

2014

 

86

 

 

1,237,589

 

 

8.9%

 

 

$30.23

 

 

2015

 

67

 

 

1,259,426

 

 

9.1%

 

 

$31.81

 

 

2016

 

52

 

 

1,432,820

 

 

10.3%

 

 

$30.33

 

 

2017

 

59

 

 

1,506,498

 

 

10.9%

 

 

$30.38

 

 

2018

 

19

 

 

1,143,754

 

 

8.3%

 

 

$39.62

 

 

2019

 

16

 

 

595,324

 

 

4.3%

 

 

$34.18

 

 

2020

 

15

 

 

731,680

 

 

5.3%

 

 

$40.36

 

 

2021

 

19

 

 

697,828

 

 

5.0%

 

 

$38.70

 

 

Thereafter

 

32

 

 

2,151,820

 

 

15.5%

 

 

$39.15

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Annualized

 

 

 

 

 

2012 RSF of Expiring Leases

 

Base Rent of

 

 

 

 

 

 

 

Negotiating/

 

Targeted for

 

Remaining

 

 

 

Expiring Leases

 

Market Rent

 

Market

 

Leased

 

Anticipating

 

Redevelopment

 

Expiring Leases

 

Total

 

(per RSF)

 

per RSF (2)

 

Greater Boston

 

13,091

 

3,169

 

 

40,207

 

56,467

 

$

31.58

 

$25.00 - $59.00

 

San Francisco Bay

 

 

 

32,074

 (3)

21,176

 

53,250

 

63.16

 

$20.00 - $47.00

 

San Diego

 

23,218

 

 

243,550

 (4)

3,000

 

269,768

 

21.94

 

$16.00 - $36.00

 

Greater NYC

 

 

 

 

 

 

 

N/A

 

Suburban Washington, D.C.

 

 

 

 

 

 

 

$14.00 - $32.00

 

Seattle

 

14,198

 

 

66,776

 (5)

5,339

 

86,313

 

13.38

 

$17.00 - $44.00

 

Research Triangle Park

 

4,575

 

 

 

10,052

 

14,627

 

24.34

 

$10.00 - $32.00

 

Canada

 

 

 

 

 

 

 

N/A

 

Non-cluster markets

 

 

 

 

 

 

 

N/A

 

Asia

 

 

 

 

9,957

 

9,957

 

9.77

 

$8.00 - $26.00

 

Total

 

55,082

 

3,169

 

342,400

 

89,731

 

490,382

 (1)

$

25.84

 

 

 

Percentage of expiring leases

 

11

 %

1

 %

70

 %

18

 %

100

 %

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Annualized

 

 

 

 

 

2013 RSF of Expiring Leases

 

Base Rent of

 

 

 

 

 

 

 

Negotiating/

 

Targeted for

 

Remaining

 

 

 

Expiring Leases

 

Market Rent

 

Market

 

Leased

 

Anticipating

 

Redevelopment

 

Expiring Leases

 

Total

 

(per RSF)

 

per RSF (2)

 

Greater Boston

 

 

102,215

 

 

80,290

 

182,505

 

$

39.33

 

$25.00 - $59.00

 

San Francisco Bay

 

 

51,281

 

 

234,764

 

286,045

 

26.18

 

$20.00 - $47.00

 

San Diego

 

2,835

 

 

 

128,876

 

131,711

 

21.73

 

$16.00 - $36.00

 

Greater NYC

 

 

 

 

 

 

 

N/A

 

Suburban Washington, D.C.

 

 

66,162

 

54,906

 (6)

127,190

 

248,258

 

30.55

 

$14.00 - $32.00

 

Seattle

 

 

 

 

 

 

 

N/A

 

Research Triangle Park

 

 

16,560

 

 

52,928

 

69,488

 

18.62

 

$10.00 - $32.00

 

Canada

 

 

 

 

 

 

 

N/A

 

Non-cluster markets

 

 

4,006

 

 

21,224

 

25,230

 

16.85

 

$14.00 - $22.00

 

Asia

 

 

2,314

 

 

7,980

 

10,294

 

15.54

 

$8.00 - $26.00

 

Total

 

2,835

 

242,538

 

54,906

 

653,252

 

953,531

 

$

28.31

 

 

 

Percentage of expiring leases

 

 %

25

 %

6

 %

69

 %

100

 %

 

 

 

 

 

(1)

Excludes 10 month-to-month leases for approximately 25,000 rentable square feet.

(2)

Based upon rental rates achieved in recently executed leases over the trailing 12 months.

(3)

Represents a future redevelopment project containing 32,074 rentable square feet at 2625/2627/2631 Hanover Street in the Palo Alto submarket. The current lease expiration date is December 31, 2012. The client tenant may extend the lease on a short-term basis. Upon rollover, we expect to commence redevelopment of this property.

(4)

Represents a project containing 176,500 rentable square feet of non-laboratory space at 3013/3033 Science Park Road, which consists of two buildings acquired in April 2012. The property was 100% leased on a short-term basis and, upon rollover in the fourth quarter of 2012, we expect to redevelop approximately 98,000 rentable square feet. The remaining 78,500 rentable square feet will be classified as future developable square feet. Also, represents a future redevelopment project containing 67,000 rentable square feet at 4757 Nexus Center Drive. The current lease expiration date at 4757 Nexus Center Drive is November 14, 2012.

(5)

Represents a future redevelopment project containing 66,776 rentable square feet of office space at 1616 Eastlake Boulevard in the Seattle market. Of the 66,776 rentable square feet targeted for redevelopment into laboratory space, approximately 41,000 rentable square feet, or 61% has been pre-leased. Redevelopment of this space began in October 2012.

(6)

Represents a project containing 54,906 rentable square feet at 5 Research Court in the Rockville submarket. We expect to redevelop the asset into single or multi-tenant laboratory space beginning in the fourth quarter of 2013.

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

17

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Summary of Properties and Occupancy

September 30, 2012

(Dollars in thousands)

(Unaudited)

 

Summary of properties

 

 

Rentable Square Feet

 

Number of

 

 

 

 

 

Market

 

Operating

 

Development

 

Redevelopment

 

Total

 

% Total

 

Properties

 

Annualized Base Rent

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater Boston

 

2,789,481

 

303,143

 

329,438

 

3,422,062

 

21

%

 

35

 

 

$

107,743

 

26

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Francisco Bay

 

2,252,790

 

456,740

 

53,980

 

2,763,510

 

16

 

 

25

 

 

88,535

 

21

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Diego

 

2,628,695

 

127,373

 

53,784

 

2,809,852

 

17

 

 

36

 

 

82,974

 

20

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater NYC

 

534,827

 

 

 

534,827

 

3

 

 

6

 

 

31,278

 

7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Suburban Washington, D.C.

 

2,334,863

 

 

101,183

 

2,436,046

 

15

 

 

31

 

 

48,768

 

12

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Seattle

 

694,042

 

 

52,141

 

746,183

 

4

 

 

10

 

 

27,052

 

6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research Triangle Park

 

941,807

 

 

 

941,807

 

6

 

 

14

 

 

19,213

 

5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Canada

 

1,096,077

 

 

 

1,096,077

 

7

 

 

5

 

 

9,172

 

2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-cluster markets

 

61,002

 

 

 

61,002

 

 

 

2

 

 

599

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

North America

 

13,333,584

 

887,256

 

590,526

 

14,811,366

 

89

 

 

164

 

 

415,334

 

99

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asia

 

592,188

 

618,976

 

112,061

 

1,323,225

 

8

 

 

9

 

 

4,588

 

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

13,925,772

 

1,506,232

 

702,587

 

16,134,591

 

97

 

 

173

 

 

$

419,922

 

100

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Discontinued operations

 

504,130

 

 

 

504,130

 

3

 

 

4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

14,429,902

 

1,506,232

 

702,587

 

16,638,721

 

100

%

 

177

 

 

 

 

 

 

 

Summary of occupancy percentages

 

 

Operating Properties

 

Operating and Redevelopment Properties

 

Market

 

September 30, 2012

 

June 30, 2012

 

March 31, 2012

 

September 30, 2012

 

June 30, 2012

 

March 31, 2012

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater Boston

 

94.3

%

 

93.1

%

 

91.7

%

 

84.3

%

 

84.1

%

 

83.0

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Francisco Bay

 

98.0

 

 

97.0

 

 

96.2

 

 

95.7

 

 

94.7

 

 

93.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Diego

 

95.2

 

 

95.5

 

 

96.1

 

 

93.3

 

 

85.5

 

 

81.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater NYC

 

95.0

 

 

94.2

 

 

93.0

 

 

95.0

 

 

94.2

 

 

93.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Suburban Washington, D.C.

 

89.4

 

 

90.1

 

 

94.2

 

 

85.7

 

 

86.3

 

 

90.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Seattle

 

96.3

 

 

96.1

 

 

96.7

 

 

89.6

 

 

90.8

 

 

91.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research Triangle Park

 

95.5

 

 

95.5

 

 

95.8

 

 

95.5

 

 

95.5

 

 

95.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Canada

 

92.7

 

 

92.7

 

 

91.8

 

 

92.7

 

 

92.7

 

 

91.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Non-cluster markets

 

51.4

 

 

51.4

 

 

51.4

 

 

51.4

 

 

51.4

 

 

51.4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

North America

 

94.2

 

 

93.9

 

 

94.2

 

 

90.0

 

 

88.4

 

 

87.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asia

 

68.1

 

 

67.4

 

 

N/A

 

 

57.2

 

 

55.0

 

 

N/A

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

93.0

%

 

92.9

%

 

94.2

%

 

88.3

%

 

86.9

%

 

87.9

%

 

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

18

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Property Listing
September 30, 2012
(Dollars in thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Occupancy Percentage

 

 

 

 

 

Rentable Square Feet

 

Number of

 

Annualized

 

 

 

Operating and

 

Address

 

Submarket

 

Operating

 

Development

 

Redevelopment

 

Total

 

Properties

 

Base Rent

 

Operating

 

Redevelopment

 

Greater Boston

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

100 Technology Square

 

Cambridge/Inner Suburbs

 

255,441

 

 

 

255,441

 

1

 

$

17,397

 

100.0

%

 

100.0

%

 

200 Technology Square

 

Cambridge/Inner Suburbs

 

177,101

 

 

 

177,101

 

1

 

10,191

 

100.0

 

 

100.0

 

 

300 Technology Square

 

Cambridge/Inner Suburbs

 

175,609

 

 

 

175,609

 

1

 

7,535

 

87.5

 

 

87.5

 

 

400 Technology Square

 

Cambridge/Inner Suburbs

 

 

 

212,123

 

212,123

 

1

 

 

N/A

 

 

 

 

500 Technology Square

 

Cambridge/Inner Suburbs

 

184,207

 

 

 

184,207

 

1

 

10,009

 

98.4

 

 

98.4

 

 

600 Technology Square

 

Cambridge/Inner Suburbs

 

128,224

 

 

 

128,224

 

1

 

4,383

 

99.6

 

 

99.6

 

 

700 Technology Square

 

Cambridge/Inner Suburbs

 

48,930

 

 

 

48,930

 

1

 

1,891

 

100.0

 

 

100.0

 

 

161 First Street

 

Cambridge/Inner Suburbs

 

46,356

 

 

 

46,356

 

1

 

1,960

 

99.5

 

 

99.5

 

 

167 Sidney Street

 

Cambridge/Inner Suburbs

 

26,589

 

 

 

26,589

 

1

 

1,392

 

100.0

 

 

100.0

 

 

215 First Street

 

Cambridge/Inner Suburbs

 

366,719

 

 

 

366,719

 

1

 

10,651

 

86.2

 

 

86.2

 

 

225 Binney Street

 

Cambridge/Inner Suburbs

 

 

303,143

 

 

303,143

 

1

 

 

N/A

 

 

N/A

 

 

300 Third Street

 

Cambridge/Inner Suburbs

 

131,963

 

 

 

131,963

 

1

 

6,520

 

100.0

 

 

100.0

 

 

480 Arsenal

 

Cambridge/Inner Suburbs

 

140,744

 

 

 

140,744

 

1

 

4,673

 

100.0

 

 

100.0

 

 

500 Arsenal Street

 

Cambridge/Inner Suburbs

 

93,516

 

 

 

93,516

 

1

 

3,385

 

100.0

 

 

100.0

 

 

780/790 Memorial Drive

 

Cambridge/Inner Suburbs

 

99,350

 

 

 

99,350

 

2

 

6,580

 

100.0

 

 

100.0

 

 

79/96 Charlestown Navy Yard

 

Cambridge/Inner Suburbs

 

24,940

 

 

 

24,940

 

1

 

 

 

 

 

 

99 Erie Street

 

Cambridge/Inner Suburbs

 

27,960

 

 

 

27,960

 

1

 

1,143

 

100.0

 

 

100.0

 

 

100 Beaver Street

 

Route 128

 

82,330

 

 

 

82,330

 

1

 

2,336

 

100.0

 

 

100.0

 

 

285 Bear Hill Road

 

Route 128

 

 

 

26,270

 

26,270

 

1

 

 

N/A

 

 

 

 

19 Presidential Way

 

Route 128

 

128,325

 

 

 

128,325

 

1

 

3,398

 

100.0

 

 

100.0

 

 

29 Hartwell Avenue

 

Route 128

 

59,000

 

 

 

59,000

 

1

 

2,049

 

100.0

 

 

100.0

 

 

3 Preston Court

 

Route 128

 

30,123

 

 

 

30,123

 

1

 

393

 

44.4

 

 

44.4

 

 

35 Hartwell Avenue

 

Route 128

 

46,700

 

 

 

46,700

 

1

 

1,650

 

100.0

 

 

100.0

 

 

35 Wiggins Avenue

 

Route 128

 

48,640

 

 

 

48,640

 

1

 

879

 

100.0

 

 

100.0

 

 

44 Hartwell Avenue

 

Route 128

 

26,828

 

 

 

26,828

 

1

 

1,105

 

100.0

 

 

100.0

 

 

45/47 Wiggins Avenue

 

Route 128

 

38,000

 

 

 

38,000

 

1

 

1,114

 

100.0

 

 

100.0

 

 

60 Westview Street

 

Route 128

 

40,200

 

 

 

40,200

 

1

 

1,147

 

100.0

 

 

100.0

 

 

6/8 Preston Court

 

Route 128

 

54,391

 

 

 

54,391

 

1

 

753

 

100.0

 

 

100.0

 

 

111 Forbes Boulevard

 

Route 495/Worcester

 

58,280

 

 

 

58,280

 

1

 

261

 

28.6

 

 

28.6

 

 

130 Forbes Boulevard

 

Route 495/Worcester

 

97,566

 

 

 

97,566

 

1

 

871

 

100.0

 

 

100.0

 

 

20 Walkup Drive

 

Route 495/Worcester

 

 

 

91,045

 

91,045

 

1

 

 

N/A

 

 

 

 

30 Bearfoot Road

 

Route 495/Worcester

 

60,759

 

 

 

60,759

 

1

 

2,765

 

100.0

 

 

100.0

 

 

306 Belmont Street

 

Route 495/Worcester

 

78,916

 

 

 

78,916

 

1

 

1,139

 

100.0

 

 

100.0

 

 

350 Plantation Street

 

Route 495/Worcester

 

11,774

 

 

 

11,774

 

1

 

173

 

100.0

 

 

100.0

 

 

Greater Boston

 

 

 

2,789,481

 

303,143

 

329,438

 

3,422,062

 

35

 

$

107,743

 

94.3

%

 

84.3

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Francisco Bay

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1500 Owens Street

 

Mission Bay

 

158,267

 

 

 

158,267

 

1

 

$

6,700

 

93.8

%

 

93.8

%

 

1700 Owens Street

 

Mission Bay

 

157,340

 

 

 

157,340

 

1

 

10,147

 

99.6

 

 

99.6

 

 

455 Mission Bay Boulevard South

 

Mission Bay

 

210,398

 

 

 

210,398

 

1

 

8,835

 

97.8

 

 

97.8

 

 

409/499 Illinois Street

 

Mission Bay

 

234,249

 

222,780

 

 

457,029

 

2

 

14,197

 

100.0

 

 

100.0

 

 

249 East Grand Avenue

 

South San Francisco

 

129,501

 

 

 

129,501

 

1

 

5,086

 

100.0

 

 

100.0

 

 

259 East Grand Avenue

 

South San Francisco

 

 

170,618

 

 

170,618

 

1

 

 

N/A

 

 

N/A

 

 

341/343 Oyster Point Blvd

 

South San Francisco

 

53,980

 

 

53,980

 

107,960

 

2

 

1,189

 

100.0

 

 

50.0

 

 

400/450 East Jamie Court

 

South San Francisco

 

99,694

 

63,342

 

 

163,036

 

2

 

2,971

 

100.0

 

 

100.0

 

 

500 Forbes Boulevard

 

South San Francisco

 

155,685

 

 

 

155,685

 

1

 

5,540

 

100.0

 

 

100.0

 

 

600/630/650 Gateway Boulevard

 

South San Francisco

 

150,960

 

 

 

150,960

 

3

 

3,823

 

85.1

 

 

85.1

 

 

681 Gateway Boulevard

 

South San Francisco

 

126,971

 

 

 

126,971

 

1

 

6,161

 

100.0

 

 

100.0

 

 

7000 Shoreline Court

 

South San Francisco

 

136,393

 

 

 

136,393

 

1

 

4,167

 

100.0

 

 

100.0

 

 

901/951 Gateway Boulevard

 

South San Francisco

 

170,244

 

 

 

170,244

 

2

 

5,573

 

100.0

 

 

100.0

 

 

2425 Garcia Ave & 2400/2450 Bayshore Parkway

 

Peninsula

 

98,964

 

 

 

98,964

 

1

 

3,232

 

96.6

 

 

96.6

 

 

2625/2627/2631 Hanover Street (1)

 

Peninsula

 

32,074

 

 

 

32,074

 

1

 

1,335

 

100.0

 

 

100.0

 

 

3165 Porter Drive

 

Peninsula

 

91,644

 

 

 

91,644

 

1

 

3,929

 

100.0

 

 

100.0

 

 

3350 West Bayshore Road

 

Peninsula

 

60,000

 

 

 

60,000

 

1

 

1,531

 

100.0

 

 

100.0

 

 

75/125 Shoreway Road

 

Peninsula

 

82,815

 

 

 

82,815

 

1

 

2,044

 

100.0

 

 

100.0

 

 

849/863 Mitten Road & 866 Malcolm Road

 

Peninsula

 

103,611

 

 

 

103,611

 

1

 

2,075

 

95.3

 

 

95.3

 

 

San Francisco Bay

 

 

 

2,252,790

 

456,740

 

53,980

 

2,763,510

 

25

 

$

88,535

 

98.0

%

 

95.7

%

 

 

(1)

Represents a future redevelopment project containing 32,074 rentable square feet at 2625/2627/2631 Hanover Street in the Palo Alto submarket.  The current lease expiration date is December 31, 2012.  The client tenant may extend the lease on a short-term basis.  Upon rollover, we expect to commence redevelopment of this property.

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

19

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Property Listing
September 30, 2012
(Dollars in thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Occupancy Percentage

 

 

 

 

 

Rentable Square Feet

 

Number of

 

Annualized

 

 

 

Operating and

 

Address

 

Submarket

 

Operating

 

Development

 

Redevelopment

 

Total

 

Properties

 

Base Rent

 

Operating

 

Redevelopment

 

San Diego

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

10931/10933 North Torrey Pines Road

 

Torrey Pines

 

96,641

 

 

 

96,641

 

1

 

$

2,977

 

98.8%

 

98.8%

 

10975 North Torrey Pines Road

 

Torrey Pines

 

44,733

 

 

 

44,733

 

1

 

1,595

 

100.0

 

100.0

 

11119 North Torrey Pines Road

 

Torrey Pines

 

18,461

 

 

53,784

 

72,245

 

1

 

590

 

100.0

 

25.6

 

3010 Science Park Road

 

Torrey Pines

 

74,557

 

 

 

74,557

 

1

 

3,215

 

100.0

 

100.0

 

3013/3033 Science Park Road (1)

 

Torrey Pines

 

176,500

 

 

 

176,500

 

1

 

3,055

 

100.0

 

100.0

 

3115/3215 Merryfield Row

 

Torrey Pines

 

158,645

 

 

 

158,645

 

2

 

7,098

 

100.0

 

100.0

 

3530/3550 John Hopkins Court & 3535/3565 General Atomics Court

 

Torrey Pines

 

220,569

 

 

 

220,569

 

4

 

7,807

 

93.4

 

93.4

 

10300 Campus Point Drive

 

University Town Center

 

449,759

 

 

 

449,759

 

1

 

15,761

 

96.1

 

96.1

 

4755/4757/4767 Nexus Center Drive (2)

 

University Town Center

 

177,585

 

 

 

177,585

 

3

 

6,655

 

100.0

 

100.0

 

5200 Illumina Way

 

University Town Center

 

346,581

 

127,373

 

 

473,954

 

1

 

13,474

 

100.0

 

100.0

 

9363/9373/9393 Towne Center Drive

 

University Town Center

 

122,232

 

 

 

122,232

 

3

 

3,523

 

100.0

 

100.0

 

9880 Campus Point Drive

 

University Town Center

 

71,510

 

 

 

71,510

 

1

 

2,774

 

100.0

 

100.0

 

5810/5820 Nancy Ridge Drive

 

Sorrento Mesa

 

87,298

 

 

 

87,298

 

1

 

1,740

 

100.0

 

100.0

 

5871 Oberlin Drive

 

Sorrento Mesa

 

33,817

 

 

 

33,817

 

1

 

478

 

48.0

 

48.0

 

6138/6150 Nancy Ridge Drive

 

Sorrento Mesa

 

56,698

 

 

 

56,698

 

1

 

1,586

 

100.0

 

100.0

 

6146/6166 Nancy Ridge Drive

 

Sorrento Mesa

 

51,273

 

 

 

51,273

 

2

 

639

 

57.2

 

57.2

 

6175/6225/6275 Nancy Ridge Drive

 

Sorrento Mesa

 

105,812

 

 

 

105,812

 

3

 

1,215

 

55.5

 

55.5

 

7330 Carroll Road

 

Sorrento Mesa

 

66,244

 

 

 

66,244

 

1

 

2,141

 

89.4

 

89.4

 

10505 Roselle Street & 3770 Tansy Street

 

Sorrento Valley

 

33,013

 

 

 

33,013

 

2

 

1,001

 

100.0

 

100.0

 

11025/11035/11045 Roselle Street

 

Sorrento Valley

 

66,442

 

 

 

66,442

 

3

 

1,621

 

100.0

 

100.0

 

3985 Sorrento Valley Boulevard

 

Sorrento Valley

 

60,545

 

 

 

60,545

 

1

 

1,534

 

100.0

 

100.0

 

13112 Evening Creek Drive

 

I-15 Corridor

 

109,780

 

 

 

109,780

 

1

 

2,495

 

100.0

 

100.0

 

San Diego

 

 

 

2,628,695

 

127,373

 

53,784

 

2,809,852

 

36

 

$

82,974

 

95.2%

 

93.3%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater NYC

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

450 East 29th Street

 

Manhattan

 

309,141

 

 

 

309,141

 

1

 

$

24,377

 

98.7%

 

98.7%

 

100 Phillips Parkway

 

Bergen County

 

78,501

 

 

 

78,501

 

1

 

2,309

 

100.0

 

100.0

 

102 Witmer Road

 

Pennsylvania

 

50,000

 

 

 

50,000

 

1

 

3,345

 

100.0

 

100.0

 

5100 Campus Drive

 

Pennsylvania

 

21,859

 

 

 

21,859

 

1

 

159

 

64.9

 

64.9

 

701 Veterans Circle

 

Pennsylvania

 

35,155

 

 

 

35,155

 

1

 

735

 

100.0

 

100.0

 

702 Electronic Drive

 

Pennsylvania

 

40,171

 

 

 

40,171

 

1

 

353

 

62.3

 

62.3

 

Greater NYC

 

 

 

534,827

 

 

 

534,827

 

6

 

$

31,278

 

95.0%

 

95.0%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Suburban Washington, D.C.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

12301 Parklawn Drive

 

Rockville

 

49,185

 

 

 

49,185

 

1

 

$

1,196

 

100.0%

 

100.0%

 

1330 Piccard Drive

 

Rockville

 

131,511

 

 

 

131,511

 

1

 

2,716

 

88.8

 

88.8

 

1405 Research Boulevard

 

Rockville

 

71,669

 

 

 

71,669

 

1

 

2,315

 

100.0

 

100.0

 

1500/1550 East Gude Drive

 

Rockville

 

90,489

 

 

 

90,489

 

2

 

1,386

 

77.3

 

77.3

 

14920 Broschart Road

 

Rockville

 

48,500

 

 

 

48,500

 

1

 

1,073

 

100.0

 

100.0

 

15010 Broschart Road

 

Rockville

 

38,203

 

 

 

38,203

 

1

 

687

 

78.1

 

78.1

 

5 Research Court (3)

 

Rockville

 

54,906

 

 

 

54,906

 

1

 

1,425

 

100.0

 

100.0

 

5 Research Place

 

Rockville

 

63,852

 

 

 

63,852

 

1

 

2,357

 

100.0

 

100.0

 

9800 Medical Center Drive

 

Rockville

 

206,530

 

 

75,056

 

281,586

 

4

 

6,787

 

86.1

 

63.2

 

9920 Medical Center Drive

 

Rockville

 

58,733

 

 

 

58,733

 

1

 

455

 

100.0

 

100.0

 

1201 Clopper Road

 

Gaithersburg

 

143,585

 

 

 

143,585

 

1

 

3,984

 

100.0

 

100.0

 

1300 Quince Orchard Road

 

Gaithersburg

 

54,874

 

 

 

54,874

 

1

 

812

 

100.0

 

100.0

 

16020 Industrial Drive

 

Gaithersburg

 

71,000

 

 

 

71,000

 

1

 

1,052

 

100.0

 

100.0

 

19/20/22 Firstfield Road

 

Gaithersburg

 

132,639

 

 

 

132,639

 

3

 

2,975

 

95.9

 

95.9

 

25/35/45 West Watkins Mill Road

 

Gaithersburg

 

138,938

 

 

 

138,938

 

1

 

3,640

 

100.0

 

100.0

 

401 Professional Drive

 

Gaithersburg

 

63,154

 

 

 

63,154

 

1

 

959

 

78.9

 

78.9

 

620 Professional Drive

 

Gaithersburg

 

 

 

26,127

 

26,127

 

1

 

 

N/A

 

 

708 Quince Orchard Road

 

Gaithersburg

 

49,624

 

 

 

49,624

 

1

 

1,145

 

99.3

 

99.3

 

9 West Watkins Mill Road

 

Gaithersburg

 

92,449

 

 

 

92,449

 

1

 

2,766

 

100.0

 

100.0

 

910 Clopper Road

 

Gaithersburg

 

180,650

 

 

 

180,650

 

1

 

2,922

 

79.3

 

79.3

 

930/940 Clopper Road

 

Gaithersburg

 

104,302

 

 

 

104,302

 

2

 

1,654

 

93.4

 

93.4

 

950 Wind River Lane

 

Gaithersburg

 

50,000

 

 

 

50,000

 

1

 

1,082

 

100.0

 

100.0

 

8000/9000/10000 Virginia Manor Road

 

Beltsville

 

191,884

 

 

 

191,884

 

1

 

1,039

 

41.8

 

41.8

 

14225 Newbrook Drive

 

Northern Virginia

 

248,186

 

 

 

248,186

 

1

 

4,341

 

100.0

 

100.0

 

Suburban Washington, D.C.

 

 

 

2,334,863

 

 

101,183

 

2,436,046

 

31

 

$

48,768

 

89.4%

 

85.7%

 

 

(1)

Represents a project containing 176,500 rentable square feet of non-laboratory space at 3013/3033 Science Park Road, which consists of two buildings acquired in April 2012. The property was 100% leased on a short-term basis and, upon rollover in the fourth quarter of 2012, we expect to redevelop approximately 98,000 rentable square feet. The remaining 78,500 rentable square feet will be classified as future developable square feet.

(2)

Represents a future redevelopment project containing 67,000 rentable square feet at 4757 Nexus Center Drive. The current lease expiration date at 4757 Nexus Center Drive is November 14, 2012.

(3)

Represents a project containing 54,906 rentable square feet at 5 Research Court in the Rockville submarket. We expect to redevelop the asset into single or multi-tenant laboratory space beginning in the fourth quarter of 2013.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

20

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Property Listing
September 30, 2012
(Dollars in thousands)

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Occupancy Percentage

 

 

 

 

 

Rentable Square Feet

 

Number of

 

Annualized

 

 

 

Operating and

 

Address

 

Submarket

 

Operating

 

Development

 

Redevelopment

 

Total

 

Properties

 

Base Rent

 

Operating

 

Redevelopment

 

Seattle

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1201/1208 Eastlake Avenue

 

Lake Union

 

203,369

 

 

 

203,369

 

2

 

$

8,748

 

100.0%

 

100.0%

 

1551 Eastlake Avenue

 

Lake Union

 

65,342

 

 

52,141

 

117,483

 

1

 

2,151

 

100.0

 

55.6

 

1600 Fairview Avenue

 

Lake Union

 

27,991

 

 

 

27,991

 

1

 

1,520

 

100.0

 

100.0

 

1616 Eastlake Avenue (1)

 

Lake Union

 

168,490

 

 

 

168,490

 

1

 

4,433

 

92.9

 

92.9

 

199 East Blaine Street

 

Lake Union

 

115,084

 

 

 

115,084

 

1

 

6,165

 

100.0

 

100.0

 

219 Terry Avenue

 

Lake Union

 

30,845

 

 

 

30,845

 

1

 

1,422

 

93.4

 

93.4

 

3000/3018 Western Avenue

 

Elliott Bay

 

47,746

 

 

 

47,746

 

1

 

1,795

 

100.0

 

100.0

 

410 West Harrison & 410 Elliott Avenue West

 

Elliott Bay

 

35,175

 

 

 

35,175

 

2

 

818

 

67.4

 

67.4

 

Seattle

 

 

 

694,042

 

 

52,141

 

746,183

 

10

 

$

27,052

 

96.3%

 

89.6%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research Triangle Park

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

100 Capitola Drive

 

Research Triangle Park

 

65,965

 

 

 

65,965

 

1

 

$

1,046

 

100.0%

 

100.0%

 

108/110/112/114 Alexander Road

 

Research Triangle Park

 

158,417

 

 

 

158,417

 

1

 

4,896

 

100.0

 

100.0

 

2525 East NC Highway 54

 

Research Triangle Park

 

81,580

 

 

 

81,580

 

1

 

1,673

 

100.0

 

100.0

 

5 Triangle Drive

 

Research Triangle Park

 

32,120

 

 

 

32,120

 

1

 

824

 

100.0

 

100.0

 

601 Keystone Park Drive

 

Research Triangle Park

 

77,395

 

 

 

77,395

 

1

 

1,306

 

100.0

 

100.0

 

6101 Quadrangle Drive

 

Research Triangle Park

 

30,122

 

 

 

30,122

 

1

 

440

 

77.0

 

77.0

 

7 Triangle Drive

 

Research Triangle Park

 

96,626

 

 

 

96,626

 

1

 

3,165

 

100.0

 

100.0

 

7010/7020/7030 Kit Creek

 

Research Triangle Park

 

133,654

 

 

 

133,654

 

3

 

1,921

 

77.0

 

77.0

 

800/801 Capitola Drive

 

Research Triangle Park

 

120,905

 

 

 

120,905

 

2

 

2,128

 

95.9

 

95.9

 

6 Davis Drive

 

Research Triangle Park

 

100,000

 

 

 

100,000

 

1

 

1,062

 

100.0

 

100.0

 

555 Heritage Drive

 

Palm Beach

 

45,023

 

 

 

45,023

 

1

 

752

 

100.0

 

100.0

 

Research Triangle Park

 

 

 

941,807

 

 

 

941,807

 

14

 

$

19,213

 

95.5%

 

95.5%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Canada

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Canada

 

 

 

46,032

 

 

 

46,032

 

1

 

$

1,891

 

100.0%

 

100.0%

 

Canada

 

 

 

66,000

 

 

 

66,000

 

1

 

1,212

 

100.0

 

100.0

 

Canada

 

 

 

132,790

 

 

 

132,790

 

1

 

2,897

 

82.8

 

82.8

 

Canada

 

 

 

68,000

 

 

 

68,000

 

1

 

3,172

 

100.0

 

100.0

 

Canada (2)

 

 

 

783,255

 

 

 

783,255

 

1

 

N/A

 

N/A

 

N/A

 

Total Canada

 

 

 

1,096,077

 

 

 

1,096,077

 

5

 

$

9,172

 

92.7%

 

92.7%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Other market properties

 

 

 

61,002

 

 

 

61,002

 

2

 

599

 

51.4%

 

51.4%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

North America

 

 

 

13,333,584

 

887,256

 

590,526

 

14,811,366

 

164

 

$

415,334

 

94.2%

 

90.0%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asia

 

 

 

592,188

 

618,976

 

112,061

 

1,323,225

 

9

 

$

4,588

 

68.1%

 

57.2%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Continuing operations

 

 

 

13,925,772

 

1,506,232

 

702,587

 

16,134,591

 

173

 

$

419,922

 

93.0%

 

88.3%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Properties “held for sale”

 

 

 

504,130

 

 

 

504,130

 

4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total

 

 

 

14,429,902

 

1,506,232

 

702,587

 

16,638,721

 

177

 

 

 

 

 

 

 

 

(1)

Represents a future redevelopment project containing 66,776 rentable square feet of office space at 1616 Eastlake Boulevard in the Seattle market. Of the 66,776 rentable square feet targeted for redevelopment into laboratory space, approximately 41,000 rentable square feet, or 61% has been pre-leased. Redevelopment of this space began in October 2012.

(2)

Represents land and improvements subject to a ground lease with a client tenant.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

21

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Top 20 Client Tenants and Client Tenant Mix

September 30, 2012

(Tabular dollar amounts in thousands)

(Unaudited)

 

Top 20 client tenants

 

 

 

 

 

 

 

Remaining Lease

 

Approximate
Aggregate

 

Percentage
of
Aggregate

 

 

 

Percentage
of
Aggregate

 

Investment-Grade Entities (3)

 

 

 

 

 

 

 

Number

 

Term in Years

 

Rentable

 

Total

 

Annualized

 

Annualized

 

Fitch

 

Moody’s

 

S&P

 

Education/

 

 

 

Client Tenant

 

of Leases

 

(1)

 

(2)

 

Square Feet

 

Square Feet

 

Base Rent

 

Base Rent

 

Rating

 

Rating

 

Rating

 

Research

 

1

 

Novartis AG

 

11

 

4.1

 

4.3

 

608,876

 

3.7%

 

$

30,544

 

7.3%

 

AA

 

Aa2

 

AA-

 

 

2

 

Bristol-Myers Squibb Company

 

6

 

5.1

 

5.4

 

419,624

 

2.5

 

15,840

 

3.8

 

A+

 

A2

 

A+

 

 

3

 

Eli Lilly and Company

 

5

 

8.8

 

10.4

 

262,182

 

1.6

 

15,048

 

3.6

 

A

 

A2

 

AA-

 

 

4

 

FibroGen, Inc.

 

1

 

11.1

 

11.1

 

234,249

 

1.4

 

14,197

 

3.4

 

 

 

 

 

5

 

Roche

 

3

 

5.5

 

5.6

 

348,918

 

2.1

 

13,867

 

3.3

 

AA-

 

A1

 

AA-

 

 

6

 

Illumina, Inc.

 

1

 

19.1

 

19.1

 

346,581

 

2.1

 

13,474

 

3.2

 

 

 

 

 

7

 

United States Government

 

8

 

4.3

 

5.3

 

324,577

 

1.9

 

12,727

 

3.0

 

AAA

 

Aaa

 

AA+

 

 

8

 

GlaxoSmithKline plc

 

4

 

7.2

 

6.9

 

207,812

 

1.2

 

10,238

 

2.4

 

A+

 

A1

 

A+

 

 

9

 

Celgene Corporation

 

4

 

9.0

 

8.9

 

255,780

 

1.5

 

9,565

 

2.3

 

 

Baa2

 

BBB+

 

 

10

 

Massachusetts Institute of Technology

 

3

 

4.7

 

4.9

 

178,952

 

1.1

 

8,230

 

2.0

 

 

Aaa

 

AAA

 

ü

 

11

 

The Regents of the University of California

 

3

 

8.9

 

8.9

 

182,242

 

1.1

 

7,435

 

1.8

 

AA+

 

Aa1

 

AA

 

ü

 

12

 

NYU-Neuroscience Translational Research Institute

 

2

 

13.2

 

12.4

 

78,597

 

0.5

 

6,993

 

1.7

 

 

Aa3

 

AA-

 

ü

 

13

 

Alnylam Pharmaceuticals, Inc. (4)

 

1

 

4.0

 

4.0

 

129,424

 

0.8

 

6,066

 

1.4

 

 

 

 

 

14

 

Gilead Sciences, Inc.

 

1

 

7.8

 

7.8

 

109,969

 

0.7

 

5,824

 

1.4

 

 

Baa1

 

A-

 

 

15

 

Pfizer Inc.

 

2

 

6.7

 

6.5

 

116,518

 

0.7

 

5,502

 

1.3

 

A+

 

A1

 

AA

 

 

16

 

The Scripps Research Institute

 

2

 

4.2

 

4.1

 

99,377

 

0.6

 

5,197

 

1.2

 

AA-

 

Aa3

 

 

ü

 

17

 

Theravance, Inc. (5)

 

2

 

7.7

 

7.7

 

130,342

 

0.8

 

4,895

 

1.2

 

 

 

 

 

18

 

Infinity Pharmaceuticals, Inc.

 

2

 

2.3

 

2.3

 

68,020

 

0.4

 

4,423

 

1.1

 

 

 

 

 

19

 

Qiagen N.V.

 

2

 

3.8

 

3.8

 

158,879

 

0.9

 

4,380

 

1.0

 

 

 

 

 

20

 

Quest Diagnostics Incorporated

 

1

 

4.3

 

4.3

 

248,186

 

1.5

 

4,341

 

1.0

 

BBB+

 

Baa2

 

BBB+

 

 

 

 

Total/Weighted Average:

 

64

 

7.1

 

7.5

 

4,509,105

 

27.1%

 

$

198,786

 

47.4%

 

 

 

 

 

 

 

 

 

 

(1)

Represents remaining lease term in years based on percentage of leased square feet.

(2)

Represents remaining lease term in years based on percentage of annualized base rent in effect as of September 30, 2012.

(3)

Ratings obtained from Fitch Ratings, Moody’s Investors Service, and Standard & Poor’s.

(4)

As of June 30, 2012, Novartis AG owned approximately 11% of the outstanding stock of Alnylam Pharmaceuticals, Inc.

(5)

As of July 25, 2012, GlaxoSmithKline plc owned approximately 27% of the outstanding stock of Theravance, Inc.

 

Client tenant mix by annualized base rent

 

GRAPHIC

 

Multinational Pharmaceutical

 

Institutional: University,
Non-Profit, and Government

 

Life Science Product and Service,
Medical Device, and Industrial Biotech

 

Biotechnology: Public & Private

·  Abbott Laboratories

·  Astellas Pharma Inc.

·  AstraZeneca PLC

·  Bayer AG

·  Bristol-Myers Squibb Company

·  Eisai Co., Ltd.

·  Eli Lilly and Company

·  Genomics Institute of the Novartis  Research Foundation

·  GlaxoSmithKline plc

·  Johnson & Johnson

·  Merck & Co., Inc.

·  Novartis AG

·  Pfizer Inc.

·  Roche

·  Sanofi

·  Shire plc

·  UCB S.A.

 

·  California Institute of Technology

·  Dana-Farber Cancer Institute, Inc.

·  Duke University

·  Environmental Protection Agency

·  Fred Hutchinson Cancer Research  Center

·  Massachusetts Institute of Technology

·  National Institutes of Health

·  NYU-Neuroscience Translational  Research Institute

·  Sanford-Burnham Medical Research  Institute

·  Stanford University

·  The Regents of the University of  California

·  The Scripps Research Institute

·  UMass Memorial Health Care, Inc.

·  UNC Health Care System

·  United States Government

·  University of Washington

 

·  Canon U.S. Life Sciences, Inc.

·  Covance Inc.

·  DSM N.V.

·  Fluidigm Corporation

·  Illumina, Inc.

·  Laboratory Corporation of America  Holdings

·  Life Technologies Corporation

·  Monsanto Company

·  Qiagen N.V.

·  Quest Diagnostics Incorporated

·  Sapphire Energy, Inc.

·  Thermo Fisher Scientific, Inc.

 

 

·  Alnylam Pharmaceuticals, Inc.

·  Amgen Inc.

·  Biogen Idec Inc.

·  Celgene Corporation

·  Constellation Pharmaceuticals, Inc.

·  Epizyme, Inc.

·  Fate Therapeutics, Inc.

·  FibroGen, Inc.

·  FORMA Therapeutics, Inc.

·  Gilead Sciences, Inc.

·  Infinity Pharmaceuticals, Inc.

·  Kadmon Corporation, LLC

·  Medicago Inc.

·  Onyx Pharmaceuticals, Inc.

·  Proteostasis Therapeutics, Inc.

·  Quanticel Pharmaceuticals, Inc.

·  Theravance, Inc.

·  Warp Drive Bio, LLC

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

22

 

 



 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Significant Future Growth Opportunities

September 30, 2012

(Unaudited)

 

ALEXANDRIA CENTERTM FOR LIFE SCIENCE – NEW YORK CITY

 

 

 

 

 

 

 

The Alexandria Center™ for Life Science – New York City may consist of three buildings aggregating approximately 1.1 million rentable square feet.  The East Tower consists of approximately 309,000 rentable square feet and is 98.7% occupied as of September 30, 2012.  This flagship destination for life science innovation also includes 419,806 developable square feet in the future West Tower project, as well as an option parcel supporting the future ground-up development of approximately 385,000 rentable square feet on the north end of the campus.  We expect to commence vertical construction for the 419,806 rentable square feet West Tower project in the fourth quarter of 2012.

 

 

 

 

 

 

 

 

 

ALEXANDRIA CENTERTM FOR SCIENCE AND TECHNOLOGY – MISSION BAY

 

 

 

ALEXANDRIA CENTERTM AT KENDALL SQUARE

 

 

The Alexandria Center for Science and Technology – Mission Bay will consist of up to seven high-quality facilities aggregating approximately 1.3 million rentable square feet.  We currently have five buildings aggregating approximately 760,000 rentable square feet leased to FibroGen, Inc., Celgene Corporation, Pfizer Inc., Bayer AG, Nektar Therapeutics, Inc., and UCSF as well as other top-tier life science entities, 223,000 rentable square feet undergoing development, and future potential buildings aggregating approximately 290,000 rentable square feet.

 

 

 

Alexandria owns and operates approximately 2.4 million rentable square feet in Cambridge, including 1.2 million rentable square feet at Cambridge’s flagship destination for life science, Alexandria’s Technology Square.  The Alexandria Center at Kendall Square represents five future ground-up, build-to-suit life science laboratory developments aggregating 1.9 million rentable square feet, including a 303,000 rentable square feet build-to-suit project for Biogen Idec Inc. currently undergoing ground-up development.

 

Legend

  

Completed

  

Under development/redevelopment

  

Future development

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

ALL RIGHTS RESERVED © 2012

23

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Summary of Investments in Real Estate

September 30, 2012

(Tabular dollar amounts in thousands, except per square foot amounts)

(Unaudited)

 

Summary of investments in real estate

 

 

September 30, 2012

 

June 30, 2012

 

 

 

Book Value

 

Square Feet

 

Cost per
Square Foot

 

Book Value

 

Square Feet

 

Cost per
Square Foot

 

Land (related to rental properties)

 

$

506,823

 

 

 

 

 

$

520,593

 

 

 

 

 

Buildings and building improvements

 

4,682,998

 

 

 

 

 

4,600,499

 

 

 

 

 

Other improvements

 

184,301

 

 

 

 

 

184,209

 

 

 

 

 

Rental properties

 

5,374,122

 

14,429,902

 

$

372

 

5,305,301

 

14,354,168

 

$

370

 

Less: accumulated depreciation

 

(854,332

)

 

 

 

 

(822,369

)

 

 

 

 

Rental properties, net

 

4,519,790

 

 

 

 

 

4,482,932

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Construction in progress (“CIP”)/current value-added projects:

 

 

 

 

 

 

 

 

 

 

 

 

 

Active development in North America

 

304,619

 

887,256

 

343

 

290,289

 

954,702

 

304

 

Active redevelopment in North America

 

277,506

 

590,526

 

470

 

275,086

 

812,505

 

339

 

Generic infrastructure/building improvement projects in North America

 

72,739

 

 

 

80,877

 

 

 

Active development and redevelopment in Asia

 

95,301

 

731,037

 

130

 

97,744

 

800,851

 

122

 

 

 

750,165

 

2,208,819

 

340

 

743,996

 

2,568,058

 

290

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Subtotal

 

5,269,955

 

16,638,721

 

317

 

5,226,928

 

16,922,226

 

309

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Land/future value-added projects:

 

 

 

 

 

 

 

 

 

 

 

 

 

Land held for future development in North America

 

326,932

 

5,451,000

 

60

 

324,586

 

5,620,000

 

58

 

Land undergoing preconstruction activities (additional CIP) in North America

 

597,631

 

2,370,000

 

252

 

569,805

 

2,350,000

 

242

 

Land held for future development/land undergoing preconstruction activities (additional CIP) in Asia

 

78,511

 

6,789,000

 

12

 

60,161

 

6,700,000

 

9

 

 

 

1,003,074

 

14,610,000

 

69

 

954,552

 

14,670,000

 

65

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Investment in unconsolidated real estate entity

 

26,998

 

414,000

 

65

 

26,874

 

414,000

 

65

 

Investments in real estate, net

 

6,300,027

 

31,662,721

 

$

199

 

6,208,354

 

32,006,226

 

$

194

 

Add: accumulated depreciation

 

854,332

 

 

 

 

 

822,369

 

 

 

 

 

Gross investments in real estate (1)

 

$

7,154,359

 

31,662,721

 

 

 

$

7,030,723

 

32,006,226

 

 

 

 

(1)       In addition to assets included in our gross investments in real estate, we hold options/rights for parcels supporting the future ground-up development of approximately 385,000 rentable square feet in Alexandria Center™ for Life Science – New York City related to an option under our ground lease.

 

 

Non-income-producing real estate assets as a percentage of gross investments in real estate

 

GRAPHIC

 

As of September 30, 2012, our active development and redevelopment projects represent 11% of gross investments in real estate, a significant amount of which is pre-leased and expected to be delivered over the next one to five quarters.  Land undergoing preconstruction activities represents 9% of gross investment in real estate.  The two largest projects included in land undergoing preconstruction consist of our 1.6 million developable square feet at Alexandria Center™ at Kendall Square in East Cambridge, Massachusetts, and our 419,806 developable square feet site for the West Tower at Alexandria Center™ for Life Science – New York City.  Land held for future development represent 5% of our non-income producing assets.  Over the next few years, we may also identify certain land parcels for potential sale.  Over time, our goal is to reduce non-income-producing assets to 15% or less of our gross investments in real estate.

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

ALL RIGHTS RESERVED © 2012

24

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Development and Redevelopment Projects in North America
September 30, 2012

(Tabular dollar amounts in thousands)

 (Unaudited)

 

 

 

Project RSF

 

Leased Status RSF

 

Investment

 

Initial Stabilized

 

Project

 

 

 

 

 

Market – Submarket/

 

In

 

 

 

 

 

 

 

 

 

 

 

 

 

% Leased/

 

September 30, 2012

 

To Complete

 

Total at

 

Yield (1)

 

Start

 

Occupancy

 

Stabilization

 

Property

 

Service

 

CIP

 

Total

 

Leased

 

Negotiating

 

Marketing

 

Total

 

Negotiating

 

In Service

 

CIP

 

2012

 

Thereafter

 

Completion

 

Cash

 

GAAP

 

Date

 

Date

 

Date

 

Development projects in North America

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater Boston – Cambridge

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

225 Binney Street

 

 

303,143

 

303,143

 

303,143

 

 

 

303,143

 

100%

 

$

 

$

84,163

 

$

8,788

 

$

87,322

 

$

180,273

 

7.5%

 

8.1%

 

4Q11

 

4Q13

 

4Q13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Francisco Bay – Mission Bay

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

499 Illinois Street (2)

 

 

222,780

 

222,780

 

 

 

222,780

 

222,780

 

 

$

 

$

111,219

 

$

2,867

 

$

39,123

 

$

153,209

 

6.4%

 

7.2%

 

2Q11

 

2Q14

 

1Q15

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Francisco Bay – South SF

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

259 East Grand Avenue (3)

 

 

170,618

 

170,618

 

170,618

 

 

 

170,618

 

100%

 

$

 

$

45,226

 

$

13,498

(3)

$

22,137

 (3)

$

80,861

 

7.8–8.2%

 

7.8–8.2%

 

1Q12

 

4Q12

 

4Q12

 

400/450 East Jamie Court

 

99,694

 

63,342

 

163,036

 

127,732

 

 

35,304

 

163,036

 

78%

 

$

58,481

 

$

39,340

 

$

5,962

 

$

9,230

 

$

113,013

 

4.2%

 

4.3%

 

4Q06

 

3Q11

 

2Q13

 

Other - 400/450 East Jamie Court (4)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

20,659

 

$

(20,659

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Diego – University Town Center

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5200 Illumina Way

 

 

127,373

 

127,373

 

127,373

 

 

 

127,373

 

100%

 

$

 

$

45,330

 

$

2,229

 

$

1,741

 

$

49,300

 

7.0%

 

10.8%

 

4Q10

 

4Q12

 

4Q12

 

Development projects in North America

 

99,694

 

887,256

 

986,950

 

728,866

 

 

258,084

 

986,950

 

74%

 

$

79,140

 

$

304,619

 

$

33,344

 

$

159,553

 

$

576,656

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redevelopment projects in North America

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Greater Boston – Cambridge

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

400 Technology Square

 

 

212,123

 

212,123

 

169,939

 

 

42,184

 

212,123

 

80%

 

$

 

$

111,297

 

$

15,891

 

$

17,500

 

$

144,688

 

8.1%

 

8.9%

 

4Q11

 

4Q12

 

4Q13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Seattle – Lake Union

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

1551 Eastlake Avenue

 

65,342

 

52,141

 

117,483

 

74,914

 

8,000

 

34,569

 

117,483

 

71%

 

$

36,148

 

$

20,366

 

$

2,730

 

$

4,766

 

$

64,010

 

6.7%

 

6.7%

 

4Q11

 

4Q11

 

4Q13

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Suburban and other redevelopment projects

 

18,461

 

326,262

 

344,723

 

211,388

 

55,270

 

78,065

 

344,723

 

77%

 

$

11,840

 

$

151,650

 

$

7,504

 

$

37,590

 

$

208,584

 

 

 

 

 

 

 

 

 

 

 

Other – suburban and other redevelopment projects (4)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

5,807

 

$

(5,807

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Redevelopment projects in North America

 

83,803

 

590,526

 

674,329

 

456,241

 

63,270

 

154,818

 

674,329

 

77%

 

$

53,795

 

$

277,506

 

$

26,125

 

$

59,856

 

$

417,282

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total development and redevelopment projects in North America

 

183,497

 

1,477,782

 

1,661,279

 

1,185,107

 

63,270

 

412,902

 

1,661,279

 

75%

 

$

132,935

 

$

582,125

 

$

59,469

 

$

219,409

 

$

993,938

 

 

 

 

 

 

 

 

 

 

 

 

(1)

As of September 30, 2012, 96% of our overall leases contained annual rent escalations that were either fixed or based on a consumer price index or another index. Our Initial Stabilized Yield on a cash basis reflects cash rents upon stabilization and does not reflect contractual rent escalations beyond the stabilization date. We expect, on average, our contractual cash rents related to our value-added projects to increase over time.

(2)

The cash and GAAP Initial Stabilized Yields related to the development of 499 Illinois Street declined by approximately 0.3% and 0.2%, respectively, to allow for a slightly longer absorption period. Despite this change, we still expect to achieve overall yields for the entire project (including the occupied portion of 409 Illinois) within our original expectations of 6.5%-7.0% and 7.2%-7.6% for cash and GAAP, respectively.

(3)

Funding for this project will be provided primarily by the $55 million secured construction loan we closed in June 2012.

(4)

As of the period end, some portion of the real estate basis associated with the rentable square feet under development or redevelopment was classified as in service because activities necessary to prepare the asset for its intended use were no longer in process. In the near future, we anticipate recommencing activities necessary to prepare the asset for its intended use upon execution of leasing and final decisions related to design of each space.

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

ALL RIGHTS RESERVED © 2012

25

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Investment in Unconsolidated Real Estate Entity and Future Value-Added Projects in North America
September 30, 2012

(Tabular dollar amounts in thousands)

(Unaudited)

 

Investment in unconsolidated real estate entity

 

In March 2012, we contributed our 55% ownership interest in a land parcel supporting a future building with 414,000 rentable square feet in the Longwood Medical Area of the Greater Boston market to a newly formed joint venture (the “Restated JV”) with National Development and Charles River Realty Investors, and admitted as a 50% member, Clarion Partners, LLC, resulting in a reduction of our ownership interest from 55% to 27.5%.  The transfer of one-half of our 55% ownership interest in this real estate venture to Clarion Partners, LLC, was accounted for as an in-substance partial sale of an interest in the underlying real estate.  Upon formation of the Restated JV, the existing $38.4 million secured loan was refinanced with a seven-year (including two one-year extension options) non-recourse $213 million secured construction loan with initial loan proceeds of $50 million.  As of September 30, 2012, the outstanding balance on the construction loan was $56.4 million.  We do not expect our share of capital contributions through the completion of the project to exceed the approximate $22.3 million in net proceeds received in this transaction.  Construction of this $350 million project commenced in April 2012.  The initial occupancy date for this project is expected in the fourth quarter of 2014, the project is 37% pre-leased to Dana-Farber Cancer Institute, Inc.  In addition, Dana-Farber Cancer Institute, Inc. has an option to lease an additional two floors approximating 99,000 rentable square feet, or 24% of the total rentable square feet of the project.  We expect to earn development and other fees of approximately $3.5 million through 2015, and recurring annual property management fees thereafter, from this project.  As of September 30, 2012, key information regarding the unconsolidated real estate entity in the Greater Boston market was as follows:

 

360 Longwood Avenue, Greater Boston

 

Our

 

Total Venture

 

Current

 

 

 

 

 

 

 

Unlevered Initial

 

Total Venture

 

Venture Debt

 

Debt

 

Our Equity

 

Ownership

 

Costs at

 

Venture

 

Project

 

Percentage

 

Stabilization

 

Stabilized Yield

 

Debt

 

Outstanding

 

Available

 

Investment

 

Percentage

 

Completion

 

CIP

 

RSF

 

Leased

 

Date

 

Cash

 

GAAP

 

Commitment (1)

 

as of 9/30/12

 

as of 9/30/12

 

as of 9/30/12 (2)

 

27.5%

 

$

350,000

 

$

126,833

 

414,000

 

37% (3)

 

2016

 

8.1-8.5%

 

8.7-9.1%

 

$

213,200

 

$

56,411

 

$

156,789

 

$

26,998

 

 

(1)             Total joint venture loan commitment is comprised of borrowings up to $175.2 million which bears interest at fixed interest rate of 5.25%, and additional borrowings up to $38 million that bears interest at LIBOR plus 3.75% with a floor of 5.25%, which will be used to fund tenant improvements, leasing commissions, and other related expenses.  The joint venture has entered into an interest rate hedge agreement to cap LIBOR at a maximum of 3.50%.  The notes carry a maturity date of April 1, 2019, assuming the joint venture exercises its option to extend the stated maturity date of April 1, 2017, by one year, twice.

(2)             We expect to reinvest $18.3 million of the $22.3 million received in March 2012 from sale of a portion of our interest in the land parcel.

(3)             Dana-Farber Cancer Institute, Inc. has an option to lease an additional two floors approximating 99,000 rentable square feet, or 24% of the total rentable square feet of the project.

 

 

Future value-added projects in North America

 

The following table summarizes the components of our future value-added developable square footage in North America as of September 30, 2012:

 

Market

 

Land Undergoing
Preconstruction Activities
(additional CIP)

 

Land Held for
Future Development

 

Total Land (1)

 

Future
Redevelopment (2)

 

 

 

 

 

 

 

 

 

 

 

Greater Boston

 

1,589,000

 (3)

155,000

 

1,744,000

 

119,000

 

 

 

 

 

 

 

 

 

 

 

San Francisco Bay - Mission Bay

 

-

 

290,000

 

290,000

 

-

 

 

 

 

 

 

 

 

 

 

 

San Francisco Bay - South San Francisco

 

-

 

1,024,000

 

1,024,000

 

40,000

 

 

 

 

 

 

 

 

 

 

 

San Diego

 

255,000

 (4)

522,000

 

777,000

 

264,000

 

 

 

 

 

 

 

 

 

 

 

Greater NYC

 

420,000

 (1) (5)

-

 

420,000

 

-

 

 

 

 

 

 

 

 

 

 

 

Suburban Washington, D.C.

 

-

 

1,274,000

 

1,274,000

 

416,000

 

 

 

 

 

 

 

 

 

 

 

Seattle

 

106,000

 (6)

959,000

 

1,065,000

 

82,000

 

 

 

 

 

 

 

 

 

 

 

Other markets

 

-

 

1,085,000

 

1,085,000

 

105,000

 

 

 

 

 

 

 

 

 

 

 

Canada

 

-

 

142,000

 

142,000

 

-

 

 

 

 

 

 

 

 

 

 

 

Total future value-added projects in North America

 

2,370,000

 

5,451,000

 

7,821,000

 

1,026,000

 

 

(1)             In addition to assets included in our gross investment in real estate, we hold options/rights for parcels supporting the future ground-up development of approximately 385,000 rentable square feet in Alexandria Center™ for Life Science – New York City related to an option under our ground lease.

(2)             Our asset base also includes non-laboratory space (office, warehouse, and industrial space) identified for future conversion into life science laboratory space through redevelopment.  These spaces are classified in investments in real estate, net, in the condensed consolidated balance sheets.

(3)             Represents preconstruction related to four future ground-up development projects aggregating 1.6 million rentable square feet related to The Alexandria Center™ at Kendall Square.

(4)             Represents preconstruction related to a future development site for 205,000 rentable square feet in Torrey Pines.  This site also contains a parking structure and other improvements.  Additionally, this also includes a future development site for 50,000 rentable square feet in University Town Center.

(5)             Represents preconstruction related to a future ground-up development project for 419,806 rentable square feet for the West Tower of the Alexandria Center™ for Life Science – New York City.  Our investment to date includes costs related to steel, curtain wall, foundation, and underground parking garage.

(6)             Represents preconstruction related to a future ground-up development project for 106,000 rentable square feet in Lake Union.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

26

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Summary of Capital Expenditures
September 30, 2012

(Unaudited)

 

Construction spending - actuals

 

 

Nine Months Ended
September 30, 2012
(in thousands)

 

Development projects in North America

 

 

$

 135,914

 

Redevelopment projects in North America

 

 

145,042

 

Preconstruction

 

 

57,418

 

Generic infrastructure/building improvement projects in North America (1)

 

 

73,387

 

Development and redevelopment projects in Asia

 

 

17,067

 

Total construction spending (2)

 

 

$

428,828

 

 

 

Construction spending - projection

 

Three Months Ended
December 31, 2012
(in thousands)

 

Year Ended
December 31, 2013
(in thousands)

 

Thereafter
(in thousands)

 

Active development projects in North America

 

$

33,344

 

$

122,582

 

$

36,971

 

Active redevelopment projects in North America

 

26,125

 

59,720

 

136

 

Preconstruction

 

26,609

 

84,475

 

TBD

 (3)

Generic infrastructure/building improvement projects in North America

 

43,484

 

67,872

 

TBD

 (3)

Future projected construction projects (4)

 

27,612

 

250,000 - 300,000

 

TBD

 (3)

Development and redevelopment projects in Asia

 

10,173

 

30,258

 

17,060

 

Total construction spending (2)

 

$

167,347

 

$

614,907 - 664,907

 

$

54,167

 

 

(1)             Includes revenue-enhancing projects and amounts shown in the table below related to non-incremental revenue-enhancing capital expenditures.

(2)             Amounts include indirect project costs, including interest, property taxes, insurance, and payroll costs.

(3)             Estimated spending beyond 2013 related to preconstruction, generic infrastructure improvements, major capital spending, and projected construction projects will be determined at a future date and is contingent upon many factors.

(4)             Includes future ground-up development related to the West Tower of the Alexandria Center™ for Life Science – New York City.  Also, includes future redevelopment projects in North America at 1616 Eastlake Avenue, 2625/2627/2631 Hanover Street, 3033 Science Park Road, 4757 Nexus Center Drive, 5 Research Court, and 6175 Nancy Ridge Drive.

 

The table below shows the average per square foot property-related non-incremental revenue-enhancing capital expenditures, tenant improvements, and leasing costs (excluding capital expenditures and tenant improvements that are recoverable from client tenants, revenue-enhancing, or related to properties that have undergone redevelopment).

 

 

 

Nine Months Ended

 

Non-incremental revenue-enhancing capital expenditures (1):

 

September 30, 2012

 

Major capital expenditures

 

$

182,247

 

Other building improvements

 

$

1,556,346

 

Square feet in asset base

 

13,962,954

 

Per square foot:

 

 

 

Major capital expenditures

 

$

0.01

 

Other building improvements

 

$

0.11

 

Tenant improvements and leasing costs:

 

 

 

Re-tenanted space (2)

 

 

 

Tenant improvements and leasing costs

 

$

2,576,059

 

Re-tenanted square feet

 

268,083

 

Per square foot

 

$

9.61

 

Renewal space

 

 

 

Tenant improvements and leasing costs

 

$

3,434,682

 

Renewal square feet

 

892,966

 

Per square foot

 

$

3.85

 

 

(1)             Major capital expenditures typically consist of significant improvements such as roof and HVAC systems replacements.  Other building improvements exclude major capital expenditures.

(2)             Excludes space that has undergone redevelopment before re-tenanting.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

27

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Summary of Real Estate Investment in Asia
September 30, 2012

(Tabular dollar amounts in thousands, except per square foot amounts)

(Unaudited)

 

Property listing

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Occupancy Percentage

 

 

 

Rentable Square Feet

 

Number of

 

Annualized

 

 

 

Operating and

 

Country

 

Operating

 

Development

 

Redevelopment

 

Total

 

Properties

 

Base Rent

 

Operating

 

Redevelopment

 

China

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

China

 

299,484

 

-

 

-

 

299,484

 

1

 

$

442

 (1)

46.7

%

 

46.7

%

 

China

 

-

 

309,476

 

-

 

309,476

 

1

 

-

 

N/A

 

 

N/A

 

 

Total China

 

299,484

 

309,476

 

-

 

608,960

 

2

 

$

442

 

46.7

%

 

46.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

India

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

India

 

33,698

 

-

 

-

 

33,698

 

1

 

$

328

 

69.4

%

 

69.4

%

 

India

 

143,260

 

-

 

-

 

143,260

 

1

 

2,554

 

86.5

 

 

86.5

 

 

India

 

-

 

134,500

 

-

 

134,500

 

1

 

-

 

N/A

 

 

N/A

 

 

India

 

-

 

175,000

 

-

 

175,000

 

1

 

-

 

N/A

 

 

N/A

 

 

India

 

29,546

 

-

 

67,401

 

96,947

 

1

 

332

 

100.0

 

 

30.5

 

 

India

 

-

 

-

 

44,660

 

44,660

 

1

 

-

 

N/A

 

 

-

 

 

India

 

86,200

 

-

 

-

 

86,200

 

1

 

932

 

100.0

 

 

100.0

 

 

Total India

 

292,704

 

309,500

 

112,061

 

714,265

 

7

 

$

4,146

 

89.9

%

 

65.0

%

 

Total Asia

 

592,188

 

618,976

 

112,061

 

1,323,225

 

9

 

$

4,588

 

68.1

%

 

57.2

%

 

 

(1)             Represents annualized base rent for non-laboratory use.

 

Summary of investments in real estate

 

 

 

September 30, 2012

 

 

 

Book Value

 

Square Feet

 

Cost per
Square Foot

 

Rental properties, net, in China

 

$

21,435

 

299,484

 

$

72

 

Rental properties, net, in India

 

31,191

 

292,704

 

107

 

 

 

 

 

 

 

 

 

CIP/current value-added projects:

 

 

 

 

 

 

 

Active development in China

 

56,098

 

309,476

 

181

 

Active development in India

 

26,337

 

309,500

 

85

 

Active redevelopment projects in India

 

12,866

 

112,061

 

115

 

 

 

95,301

 

731,037

 

130

 

 

 

 

 

 

 

 

 

Land held for future development/land undergoing preconstruction activities (additional CIP) - India

 

78,511

 

6,789,000

 

12

 

Total investments in real estate, net, in Asia

 

$

226,438

 

8,112,225

 

$

28

 

 

Active development and redevelopment

 

 

 

Project RSF

 

Leased Status RSF

 

Investment

 

 

 

In

 

 

 

 

 

 

 

 

 

 

 

 

 

Leased/

 

September 30, 2012

 

To Complete

 

Total at

 

Description

 

Service

 

CIP

 

Total

 

Leased

 

Negotiating

 

Marketing

 

Total

 

Negotiating %

 

In Service

 

CIP

 

2012

 

Thereafter

 

Completion

 

China development project

 

-

 

309,476

 

309,476

 

-

 

-

 

309,476

 

309,476

 

-%

 

$

-

 

$

56,098

 

$

1,767

 

$

24,435

 

$

82,300

 

India development projects

 

-

 

309,500

 

309,500

 

-

 

-

 

309,500

 

309,500

 

-%

 

-

 

26,337

 

7,939

 

17,509

 

51,785

 

India redevelopment projects

 

29,546

 

112,061

 

141,607

 

29,546

 

44,660

 

67,401

 

141,607

 

52%

 

3,729

 

12,866

 

4,774

 

1,340

 

22,709

 

Total active development and redevelopment in Asia

 

29,546

 

731,037

 

760,583

 

 

 

 

 

 

 

 

 

 

 

$

3,729

 

$

95,301

 

$

14,480

 

$

43,284

 

$

156,794

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

28

 

 



 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Credit Metrics

September 30, 2012

(Unaudited)

 

Net Debt/Adjusted EBITDA

 

Fixed Charge Coverage Ratio

 

 

 

 

 

 

 

 

 

 

Net Debt to Gross Assets (Excluding Cash and Restricted Cash)

 

Interest Coverage Ratio

 

 

 

 

 

 

 

 

 

 

Unencumbered NOI as a % of Total NOI

 

Unencumbered Assets Gross Book Value as a % of Gross Assets

 

 

 

 

 

 

 

 

 

 

Liquidity

 

Unhedged Variable Rate Debt as a % of Total Debt

 

 

 

 

 

(1)    Periods represent quarter annualized metrics.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

29

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Summary of Debt
September 30, 2012
(Tabular dollar amounts in thousands)

(Unaudited)

 

Fixed rate/hedged and unhedged variable rate debt

 

 

 

Fixed Rate/Hedged
Variable Rate

 

Unhedged
Variable Rate

 

Total
Consolidated

 

Percentage of
Total

 

Weighted Average
Interest Rate at
End of Period (1)

 

Weighted Average
Remaining Term
(Years)

 

Secured notes payable (2)

 

$

640,815

 

$

78,535

 

$

719,350

 

23.7

%

 

5.76

%

 

3.2

 

Unsecured senior notes payable (2)

 

549,794

 

-

 

549,794

 

18.1

 

 

4.61

 

 

9.5

 

Unsecured senior line of credit (3)

 

50,000

 

363,000

 

413,000

 

13.6

 

 

1.46

 

 

4.6

 

2016 Unsecured Senior Bank Term Loan (4)

 

750,000

 

-

 

750,000

 

24.8

 

 

3.12

 

 

3.8

 

2017 Unsecured Senior Bank Term Loan (5)

 

600,000

 

-

 

600,000

 

19.8

 

 

3.84

 

 

4.3

 

Total debt

 

$

2,590,609

 

$

441,535

 

$

3,032,144

 

100.0

%

 

3.93

%

 

4.9

 

Percentage of total debt

 

85%

 

15%

 

100%

 

 

 

 

 

 

 

 

 

 

(1)             Represents the contractual interest rate as of the end of the period plus the impact of debt premiums/discounts and our interest rate hedge agreements.  The weighted average interest rate excludes bank fees and amortization of loan fees.

(2)             Represents amounts net of unamortized premiums/discounts.

(3)             Total commitments available for borrowing aggregate $1.5 billion under our unsecured senior line of credit.  As of September 30, 2012, we had approximately $1.1 billion available for borrowings under our unsecured senior line of credit.  Weighted average remaining term assumes we exercise our sole option to extend the stated maturity date of April 30, 2016, by six months, twice, to April 30, 2017.

(4)             Assumes we exercise our sole option to extend the stated maturity date of June 30, 2015, by one year, to June 30, 2016.

(5)             Assumes we exercise our sole option to extend the stated maturity date of January 31, 2016, by one year, to January 31, 2017.

 

Debt maturities

 

Debt

 

Stated Rate

 

Effective
Interest
Rate (1)

 

Maturity
Date

 

 

2012

 

2013

 

2014

 

2015

 

2016

 

Thereafter

 

Total

 

Secured notes payable

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

San Diego

 

6.21

%

 

6.21

%

 

3/1/13

 

 

$

78

 

$

7,934

 

$

-

 

$

-

 

$

-

 

$

-

 

$

8,012

 

Suburban Washington, D.C.

 

6.36

 

 

6.36

 

 

9/1/13

 

 

135

 

26,093

 

-

 

-

 

-

 

-

 

26,228

 

San Francisco Bay

 

6.14

 

 

6.14

 

 

11/16/13

 

 

-

 

7,527

 

-

 

-

 

-

 

-

 

7,527

 

Greater Boston

 

5.26

 

 

5.59

 

 

4/1/14

 

 

929

 

3,839

 

208,683

 

-

 

-

 

-

 

213,451

 

Suburban Washington, D.C.

 

2.33

 

 

2.33

 

 

4/20/14

 

 

-

 

-

 

76,000

 

-

 

-

 

-

 

76,000

 

San Diego

 

6.05

 

 

4.88

 

 

7/1/14

 

 

22

 

142

 

6,458

 

-

 

-

 

-

 

6,622

 

San Diego

 

5.39

 

 

4.00

 

 

11/1/14

 

 

29

 

177

 

7,495

 

-

 

-

 

-

 

7,701

 

Seattle

 

6.00

 (2)

 

6.00

 

 

11/18/14

 

 

60

 

240

 

240

 

-

 

-

 

-

 

540

 

Suburban Washington, D.C.

 

5.64

 

 

4.50

 

 

6/1/15

 

 

21

 

130

 

138

 

5,788

 

-

 

-

 

6,077

 

San Francisco Bay

 

LIBOR+1.50

 

1.74

 

 

7/1/15

 (3)

 

-

 

-

 

-

 

1,995

 

-

 

-

 

1,995

 

Greater Boston, San Francisco Bay, and San Diego

 

5.73

 

 

5.73

 

 

1/1/16

 

 

393

 

1,616

 

1,713

 

1,816

 

75,501

 

-

 

81,039

 

Greater Boston, San Diego, and Greater NYC

 

5.82

 

 

5.82

 

 

4/1/16

 

 

208

 

878

 

931

 

988

 

29,389

 

-

 

32,394

 

San Francisco Bay

 

6.35

 

 

6.35

 

 

8/1/16

 

 

542

 

2,332

 

2,487

 

2,652

 

126,715

 

-

 

134,728

 

San Diego, Suburban Washington, D.C., and Seattle

 

7.75

 

 

7.75

 

 

4/1/20

 

 

320

 

1,345

 

1,453

 

1,570

 

1,696

 

110,301

 

116,685

 

San Francisco Bay

 

6.50

 

 

6.50

 

 

6/1/37

 

 

4

 

16

 

17

 

17

 

19

 

801

 

874

 

Average/Total

 

5.70

%

 

5.76

 

 

 

 

 

2,741

 

52,269

 

305,615

 

14,826

 

233,320

 

111,102

 

719,873

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$1.5 Billion unsecured senior line of credit

 

LIBOR+1.20% (4)

 

1.46

 

 

4/30/17

 (5)

 

-

 

-

 

-

 

-

 

-

 

413,000

 

413,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2016 Unsecured Senior Bank Term Loan

 

LIBOR+1.75%

 

3.12

 

 

6/30/16

 (6)

 

-

 

-

 

-

 

-

 

750,000

 

-

 

750,000

 

2017 Unsecured Senior Bank Term Loan

 

LIBOR+1.50%

 

3.84

 

 

1/31/17

 (7)

 

-

 

-

 

-

 

-

 

-

 

600,000

 

600,000

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unsecured senior notes payable (8)

 

4.60

%

 

4.61

 

 

4/1/22

 

 

-

 

-

 

250

 

-

 

-

 

550,000

 

550,250

 

Average/Subtotal

 

 

 

 

3.93

 

 

 

 

 

2,741

 

52,269

 

305,865

 

14,826

 

983,320

 

1,674,102

 

3,033,123

 

Unamortized discounts

 

 

 

 

-

 

 

 

 

 

(112

)

(464

)

(78

)

(12

)

(44

)

(269

)

(979

)

Average/Total

 

 

 

 

3.93

%

 

 

 

 

$

2,629

 

$

51,805

 

$

305,787

 

$

14,814

 

$

983,276

 

$

1,673,833

 

$

3,032,144

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balloon payments

 

 

 

 

 

 

 

 

 

 

$

-

 

$

41,165

 

$

297,330

 

$

7,723

 

$

980,029

 

$

1,666,791

 

$

2,993,038

 

Principal amortization

 

 

 

 

 

 

 

 

 

 

2,629

 

10,640

 

8,457

 

7,091

 

3,247

 

7,042

 

39,106

 

Total consolidated debt

 

 

 

 

 

 

 

 

 

 

$

2,629

 

$

51,805

 

$

305,787

 

$

14,814

 

$

983,276

 

$

1,673,833

 

$

3,032,144

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed rate/hedged variable rate debt

 

 

 

 

 

 

 

 

 

 

$

2,569

 

$

51,565

 

$

229,547

 

$

12,819

 

$

983,276

 

$

1,310,833

 

$

2,590,609

 

Unhedged variable rate debt

 

 

 

 

 

 

 

 

 

 

60

 

240

 

76,240

 

1,995

 

-

 

363,000

 

441,535

 

Total consolidated debt

 

 

 

 

 

 

 

 

 

 

$

2,629

 

$

51,805

 

$

305,787

 

$

14,814

 

$

983,276

 

$

1,673,833

 

$

3,032,144

 

 

(1)             Represents the contractual interest rate as of the end of the period plus the impact of debt premiums/discounts and our interest rate hedge agreements.  The weighted average interest rate excludes bank fees and amortization of loan fees.

(2)             Represents a loan assumed with the acquisition of a property.  The interest rate is based upon 10 year U.S. treasury bills plus 3%, with a floor of 6% and a ceiling of 8.5%.

(3)             We have an option to extend the stated maturity date of July 1, 2015, by one year, twice, to July 1, 2017.

(4)             In addition to the stated rate, we are subject to an annual facility fee of 0.25%.

(5)             Assumes we exercise our sole option to extend the stated maturity date of April 30, 2016, by six months, twice, to April 30, 2017.

(6)             Assumes we exercise our sole option to extend the stated maturity date of June 30, 2015, by one year, to June 30, 2016.

(7)             Assumes we exercise our sole option to extend the stated maturity date of January 31, 2016, by one year, to January 31, 2017.

(8)             Includes $550 million of our 4.60% unsecured senior notes payable due in April 2022, and $250,000 of our 8.00% unsecured senior convertible notes payable with a maturity date of April 15, 2014.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

30

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Summary of Debt
September 30, 2012

(Tabular dollar amounts in thousands)
(Unaudited)

 

Debt covenants

 

 

 

Unsecured Senior Notes Payable

 

Unsecured Senior Line of Credit and
Unsecured Senior Bank Term Loans

 

Debt Covenant Ratios

 

Requirement

 

Actual (1)

 

Requirement

 

Actual (1)

 

Total Debt to Total Assets (2)

 

< 60%

 

39%

 

< 60.0% (3)

 

36%

 

 

 

 

 

 

 

 

 

 

 

Consolidated EBITDA to Interest Expense (4)

 

> 1.5x

 

5.9x

 

> 1.50x

 

2.5x

 

 

 

 

 

 

 

 

 

 

 

Unencumbered Total Asset Value to Unsecured Debt

 

> 150%

 

259%

 

N/A

 

N/A

 

 

 

 

 

 

 

 

 

 

 

Secured Debt to Total Assets (5)

 

< 40%

 

9%

 

< 40.0% (3)

 

8%

 

 

 

 

 

 

 

 

 

 

 

Unsecured Leverage Ratio

 

N/A

 

N/A

 

< 60.0% (3)

 

40%

 

 

 

 

 

 

 

 

 

 

 

Unsecured Interest Coverage Ratio

 

N/A

 

N/A

 

> 1.75x

 

7.8x

 

 

(1)             Actual covenants are calculated pursuant to the specific terms of each agreement.

(2)             Under the unsecured senior line of credit and unsecured senior bank term loans, this ratio is referred to as the Leverage Ratio.

(3)             These ratios may increase by an additional 5% in connection with a Material Acquisition, as defined, for up to four quarters.

(4)             Under the unsecured senior line of credit and unsecured senior bank term loans, this ratio is referred to as the Fixed Charge Coverage Ratio.

(5)             Under the unsecured senior line of credit and unsecured senior bank term loans, this ratio is referred to as the Secured Debt Ratio.

 

Summary of interest rate hedge agreements

 

 

 

 

 

 

 

 

 

 

 

Notional Amount in Effect as of

 

Transaction Date

 

Effective Date

 

Termination Date

 

Interest Pay
Rate (1)

 

Fair Value as of
September 30, 2012

 

September 30,
2012

 

December 31,
2012

 

December 31,
2013

 

December 31,
2014

 

December 2006

 

December 29, 2006

 

March 31, 2014

 

4.990 %

 

$

(3,614

)

$

50,000

 

$

50,000

 

$

50,000

 

$

-

 

October 2007

 

October 31, 2007

 

September 30, 2013

 

4.642 %

 

(2,251

)

50,000

 

50,000

 

-

 

-

 

October 2007

 

July 1, 2008

 

March 31, 2013

 

4.622 %

 

(555

)

25,000

 

25,000

 

-

 

-

 

October 2007

 

July 1, 2008

 

March 31, 2013

 

4.625 %

 

(555

)

25,000

 

25,000

 

-

 

-

 

December 2006

 

November 30, 2009

 

March 31, 2014

 

5.015 %

 

(5,449

)

75,000

 

75,000

 

75,000

 

-

 

December 2006

 

November 30, 2009

 

March 31, 2014

 

5.023 %

 

(5,458

)

75,000

 

75,000

 

75,000

 

-

 

December 2006

 

December 31, 2010

 

October 31, 2012

 

5.015 %

 

(440

)

100,000

 

-

 

-

 

-

 

December 2011

 

December 30, 2011

 

December 31, 2012

 

0.480 %

 

(180

)

250,000

 

250,000

 

-

 

-

 

December 2011

 

December 30, 2011

 

December 31, 2012

 

0.480 %

 

(180

)

250,000

 

250,000

 

-

 

-

 

December 2011

 

December 30, 2011

 

December 31, 2012

 

0.480 %

 

(90

)

125,000

 

125,000

 

-

 

-

 

December 2011

 

December 30, 2011

 

December 31, 2012

 

0.480 %

 

(90

)

125,000

 

125,000

 

-

 

-

 

December 2011

 

December 30, 2011

 

December 31, 2012

 

0.495 %

 

(95

)

125,000

 

125,000

 

-

 

-

 

December 2011

 

December 30, 2011

 

December 31, 2012

 

0.508 %

 

(99

)

125,000

 

125,000

 

-

 

-

 

December 2011

 

December 31, 2012

 

December 31, 2013

 

0.640 %

 

(1,041

)

 

-

 

250,000

 

-

 

December 2011

 

December 31, 2012

 

December 31, 2013

 

0.640 %

 

(1,041

)

-

 

-

 

250,000

 

-

 

December 2011

 

December 31, 2012

 

December 31, 2013

 

0.644 %

 

(526

)

-

 

-

 

125,000

 

-

 

December 2011

 

December 31, 2012

 

December 31, 2013

 

0.644 %

 

(526

)

-

 

-

 

125,000

 

-

 

December 2011

 

December 31, 2013

 

December 31, 2014

 

0.977 %

 

(1,574

)

-

 

-

 

-

 

250,000

 

December 2011

 

December 31, 2013

 

December 31, 2014

 

0.976 %

 

(1,572

)

-

 

-

 

-

 

250,000

 

Total

 

 

 

 

 

 

 

$

(25,336

)

$

1,400,000

 

$

1,300,000

 

$

950,000

 

$

500,000

 

 

(1)             In addition to the interest pay rate, borrowings outstanding under our unsecured senior line of credit and unsecured senior bank term loans include an applicable margin currently ranging from 1.20% to 1.75%.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

 

31

 

 



 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Definitions and Other Information

September 30, 2012

(Tabular dollar amounts in thousands)

(Unaudited)

 

This section contains additional information for sections throughout this supplemental information package as well as explanations of certain non-GAAP financial measures and the reasons why we use these supplemental measures of performance.  Additional detail can be found in our most recent annual report on Form 10-K and subsequent quarterly reports on Form 10-Q, as well as other documents filed with or furnished to the SEC from time to time.

 

Adjusted EBITDA and Adjusted EBITDA margins

 

EBITDA represents earnings before interest, taxes, depreciation, and amortization (“EBITDA”), a non-GAAP financial measure, and is used by us and others as a supplemental measure of performance.  We use adjusted EBITDA (“Adjusted EBITDA”) to assess the performance of our core operations, for financial and operational decision making, and as a supplemental or additional means of evaluating period-to-period comparisons on a consistent basis.  Adjusted EBITDA also serves as a proxy for a component of a financial covenant under certain of our debt obligations.  Adjusted EBITDA is calculated as EBITDA excluding net stock compensation expense, gains or losses on early extinguishment of debt, gains or losses on sales of land parcels, gains or losses on sales of real estate, and impairments of real estate.  We believe Adjusted EBITDA provides investors relevant and useful information because it permits investors to view income from our operations on an unleveraged basis before the effects of taxes, non-cash depreciation and amortization, net stock compensation expense, gains or losses on early extinguishment of debt, gains or losses on sales of land parcels, gains or losses on sales of real estate, and impairments of real estate.  By excluding interest expense, EBITDA and Adjusted EBITDA allow investors to measure our performance independent of our capital structure and indebtedness and, therefore, allow for a more meaningful comparison of our performance to that of other companies, both in the real estate industry and in other industries.  We believe that excluding non-cash charges related to stock-based compensation facilitates a comparison of our operations across periods and among other equity REITs without the variances caused by different valuation methodologies, the volatility of the expense (which depends on market forces outside our control), and the assumptions and the variety of award types that a company can use.  We believe that adjusting for the effects of gains or losses on early extinguishment of debt, gains or losses on sales of land parcels, gains or losses on sales of real estate, and impairments of real estate provides useful information by excluding certain items that are not representative of our core operating results.  These items are not related to core operations, not dependent upon historical costs, and not subject to judgmental valuation inputs and the timing of our decisions.  EBITDA and Adjusted EBITDA have limitations as measures of our performance. EBITDA and Adjusted EBITDA do not reflect our historical cash expenditures or future cash requirements for capital expenditures or contractual commitments.  While EBITDA and Adjusted EBITDA are relevant and widely used measures of performance, they do not represent net income or cash flow from operations as defined by GAAP, and they should not be considered as alternatives to those indicators in evaluating performance or liquidity.  Further, our computation of EBITDA and Adjusted EBITDA may not be comparable to similar measures reported by other companies.

 

The following table reconciles net income, the most directly comparable financial measure calculated and presented in accordance with GAAP, to EBITDA and Adjusted EBITDA:

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

9/30/12

 

6/30/12

 

3/31/12

 

12/31/11

 

9/30/11

 

9/30/12

 

9/30/11

 

Net income

 

$

18,305

 

$

25,641

 

$

32,775

 

$

35,462

 

$

32,995

 

$

76,721

 

$

99,931

 

Interest expense – continuing operations

 

17,094

 

17,922

 

16,227

 

14,757

 

14,273

 

51,243

 

48,621

 

Interest expense – discontinued operations

 

 

 

 

 

 

 

65

 

Depreciation and amortization – continuing operations

 

47,176

 

51,276

 

42,326

 

39,762

 

38,747

 

140,778

 

113,326

 

Depreciation and amortization – discontinued operations

 

997

 

1,079

 

1,079

 

1,204

 

1,243

 

3,155

 

3,734

 

EBITDA

 

83,572

 

95,918

 

92,407

 

91,185

 

87,258

 

271,897

 

265,677

 

Stock compensation expense

 

3,845

 

3,274

 

3,293

 

3,306

 

3,344

 

10,412

 

8,449

 

Loss on early extinguishment of debt

 

 

1,602

 

623

 

 

2,742

 

2,225

 

6,485

 

Gain on sale of land parcel

 

 

 

(1,864

)

 

(46

)

(1,864

)

(46

)

Gain on sale of real estate

 

(1,562

)

(2

)

 

 

 

(1,564

)

 

Impairment of real estate

 

9,799

 

 

 

 

994

 

9,799

 

994

 

Adjusted EBITDA

 

$

95,654

 

$

100,792

 

$

94,459

 

$

94,491

 

$

94,292

 

$

290,905

 

$

281,559

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total revenues

 

$

145,455

 

$

148,016

 

$

138,432

 

$

139,249

 

$

138,054

 

$

431,903

 

$

408,980

 

Adjusted EBITDA margins

 

66%

 

68%

 

68%

 

68%

 

68%

 

67%

 

69%

 

 

Adjusted funds from operations

 

AFFO is a non-GAAP financial measure that we use as a supplemental measure of our performance.  We compute AFFO by adding to or deducting from FFO, as adjusted: (1) non-incremental revenue-enhancing capital expenditures, tenant improvements, and leasing commissions (excludes redevelopment expenditures); (2) effects of straight-line rent and straight-line rent on ground leases; (3) capitalized income from development projects; (4) amortization of acquired above and below market leases, loan fees, and debt premiums/discounts; (5) non-cash compensation expense; and (6) allocation of AFFO attributable to unvested restricted stock awards.

 

We believe that AFFO is a useful supplemental performance measure because it further adjusts to: (1) deduct certain expenditures that, although capitalized and included in depreciation expense, do not enhance the revenue or cash flows of our properties; (2) eliminate the effect of straight-lining our rental income and capitalizing income from development projects in order to reflect the actual amount of contractual rents due in the period presented; and (3) eliminate the effect of non-cash items that are not indicative of our core operations and do not actually reduce the amount of cash generated by our operations.  We believe that eliminating the effect of non-cash charges related to stock-based compensation facilitates a comparison of our operations across periods and among other equity REITs without the variances caused by different valuation methodologies, the volatility of the expense (which depends on market forces outside our control), and the assumptions and the variety of award types that a company can use.  We believe that AFFO provides useful information by excluding certain items that are not representative of our core operating results because such items are dependent upon historical costs or subject to judgmental valuation inputs and the timing of our decisions.

 

AFFO is not intended to represent cash flow for the period, and is only intended to provide an additional measure of performance.  We believe that net income attributable to Alexandria Real Estate Equities, Inc.’s common stockholders is the most directly comparable GAAP financial measure to AFFO.  We believe that AFFO is a widely recognized measure of the operations of equity REITs, and presenting AFFO will enable investors to assess our performance in comparison to other equity REITs.  However, other equity REITs may use different methodologies for calculating AFFO and, accordingly, our AFFO may not be comparable to AFFO calculated by other equity REITs.  AFFO should not be considered as an alternative to net income (determined in accordance with GAAP) as an indication of financial performance, or to cash flows from operating activities (determined in accordance with GAAP) as a measure of our liquidity, nor is it indicative of funds available to fund our cash needs, including our ability to make distributions.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

32

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Definitions and Other Information

September 30, 2012

(Unaudited)

 

Annualized base rent

 

Annualized base rent means the annualized fixed base rental amount in effect as of the end of the period, related to our operating rentable square feet (using rental revenue computed on a straight-line basis in accordance with GAAP).

 

Capitalized interest

 

A key component of our business model is our value-added development and redevelopment programs.  These programs are focused on providing high-quality generic life science laboratory space to meet the real estate requirements of and are reusable by various life science industry client tenants.  Upon completion, each value-added project is expected to generate significant revenues and cash flows.  Our development and redevelopment projects are generally in locations that are highly desirable to life science entities which we believe results in higher occupancy levels, longer lease terms, and higher rental income and returns.  Development projects consist of the ground-up development of generic life science laboratory facilities.  Redevelopment projects consist of the permanent change in use of office, warehouse, and shell space into generic life science laboratory space, including the conversion of single-tenancy space to multi-tenancy space or vice versa.  We also have certain significant value-added projects undergoing important and substantial preconstruction activities to bring these assets to their intended use.  These critical activities add significant value and are required for the construction of buildings. The projects will provide high-quality facilities for the life science industry and are expected to generate significant revenue and cash flows for the Company.  In accordance with GAAP, we capitalize project costs clearly related to the construction, development, and redevelopment as a cost of the project. Indirect project costs such as construction administration, legal fees, and office costs that clearly relate to projects under construction, development, and redevelopment are also capitalized as a cost of the project.  We capitalize project costs only during periods in which activities necessary to prepare an asset for its intended use are in progress.  We also capitalize interest cost as a cost of the project only during the period for which activities necessary to prepare an asset for its intended use are ongoing, provided that expenditures for the asset have been made and interest cost is incurred.  Additionally, should activities necessary to prepare an asset for its intended use cease, interest, taxes, insurance, and certain other direct project costs related to these assets would be expensed as incurred.

 

Cash interest

 

Cash interest is equal to interest expense calculated in accordance with GAAP, plus capitalized interest, less amortization of loan fees, and amortization of debt premiums/discounts.

 

Construction in progress/current value-added projects

 

Active development/active redevelopment projects

 

A key component of our business model is our value-added development and redevelopment programs.  These programs are focused on providing high-quality, generic, and reusable life science laboratory space to meet the real estate requirements of a wide range of clients in the life science industry.  Upon completion, each value-added project is expected to generate significant revenues and cash flows.  Our development and redevelopment projects are generally in locations that are highly desirable to life science entities, which we believe results in higher occupancy levels, longer lease terms, and higher rental income and returns.  Development projects consist of the ground-up development of generic and reusable life science laboratory facilities.  We generally will not commence new development projects for aboveground vertical construction of new life science laboratory space without first securing pre-leasing for such space except when there is significant market demand for high-quality laboratory facilities.  Redevelopment projects consist of the permanent change in use of office, warehouse, and shell space into generic life science laboratory space, including the conversion of single-tenancy space to multi-tenancy space or vice versa.

 

Generic infrastructure/building improvement projects

 

Generic infrastructure/building improvement projects include revenue-enhancing capital spending, non-incremental revenue-enhancing capital expenditures, and tenant improvements.

 

Dividend payout ratio

 

Dividend payout ratio (common stock) is the ratio of the absolute dollar amount of dividends on our common stock (shares of common stock outstanding on the respective record date multiplied by the related dividend per share) to FFO attributable to Alexandria Real Estate Equities, Inc.’s common stockholders on a diluted basis, as adjusted.

 

Dividend yield

 

Dividend yield for the quarter represents the annualized quarter dividend divided by the closing common stock price at the end of the quarter.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

33

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Definitions and Other Information

September 30, 2012

(Tabular dollar amounts in thousands)

(Unaudited)

 

EBITDA

 

See Adjusted EBITDA and Adjusted EBITDA margins

 

Fixed charge coverage ratio

 

The fixed charge coverage ratio is useful to investors as a supplemental measure of our ability to satisfy fixed financing obligations and dividends on preferred stock.  The following table presents a reconciliation of interest expense, the most directly comparable GAAP financial measure to cash interest and fixed charges:

 

 

 

Three Months Ended

 

 

 

9/30/12

 

6/30/12

 

3/31/12

 

12/31/11

 

9/30/11

 

Adjusted EBITDA

 

$

95,654

 

$

100,792

 

$

94,459

 

$

94,491

 

$

94,292

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest expense – continuing operations

 

$

17,094

 

$

17,922

 

$

16,227

 

$

14,757

 

$

14,273

 

Interest expense – discontinued operations

 

 

 

 

 

 

Add: capitalized interest

 

16,763

 

15,825

 

15,266

 

16,151

 

16,666

 

Less: amortized loan fees

 

(2,470

)

(2,214

)

(2,643

)

(2,551

)

(2,144

)

Less: amortization of debt premium/discounts

 

(112

)

(110

)

(179

)

(565

)

(750

)

Cash interest

 

31,275

 

31,423

 

28,671

 

27,792

 

28,045

 

Dividends on preferred stock

 

6,471

 

6,903

 

7,483

 

7,090

 

7,089

 

Fixed charges

 

$

37,746

 

$

38,326

 

$

36,154

 

$

34,882

 

$

35,134

 

 

 

 

 

 

 

 

 

 

 

 

 

Fixed charge coverage ratio – quarter annualized

 

2.5x

 

2.6x

 

2.6x

 

2.7x

 

2.7x

 

Fixed charge coverage ratio – trailing 12 months

 

2.6x

 

2.7x

 

2.7x

 

2.7x

 

2.7x

 

 

Funds from operations and funds from operations, as adjusted

 

GAAP basis accounting for real estate assets utilizes historical cost accounting and assumes real estate values diminish over time.  In an effort to overcome the difference between real estate values and historical cost accounting for real estate assets, the Board of Governors of the National Association of Real Estate Investment Trusts (“NAREIT”) established the measurement tool of FFO.  Since its introduction, FFO has become a widely used non-GAAP financial measure among equity REITs.  We believe that FFO is helpful to investors as an additional measure of the performance of an equity REIT.  Moreover, we believe that FFO, as adjusted, is also helpful because it allows investors to compare our performance to the performance of other real estate companies between periods, and on a consistent basis, without having to account for differences caused by investment decisions, financing decisions, terms of securities, capital structures, and capital market transactions. We compute FFO in accordance with standards established by the Board of Governors of NAREIT in its April 2002 white paper and related implementation guidance (“NAREIT White Paper”). The NAREIT White Paper defines FFO as net income (computed in accordance with GAAP), excluding gains (losses) from sales and impairments of real estate, plus real estate related depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures.  Impairments of real estate relate to decreases in the estimated fair value of real estate due to changes in general market conditions and do not necessarily reflect the operating performance of the properties during the corresponding period.  Impairments of real estate represent the non-cash write-down of assets when fair value over the recoverability period is less than the carrying value.  We compute FFO, as adjusted, as FFO calculated in accordance with the NAREIT White Paper, plus losses from early extinguishment of debt and preferred stock redemption charges, less realized gain on equity investment primarily related to one non-tenant life science entity, and the amount of such items which are allocable to our unvested restricted stock awards. Our calculations of both FFO and FFO, as adjusted, may differ from those methodologies utilized by other equity REITs for similar performance measurements, and, accordingly, may not be comparable to other equity REITs.  Neither FFO nor FFO, as adjusted, should be considered as an alternative to net income (determined in accordance with GAAP) as an indication of financial performance, or to cash flows from operating activities (determined in accordance with GAAP) as a measure of liquidity, nor are they indicative of the availability of funds for our cash needs, including funds available to make distributions.

 

Future value-added projects

 

Land held for future development

 

All preconstruction efforts have been advanced to appropriate stages and no further preconstruction activities are ongoing and therefore, interest, property taxes, and other costs related to these assets are expensed as incurred.  We generally will not commence new development projects for aboveground vertical construction of new life science laboratory space without first securing pre-leasing for such space.

 

Land undergoing preconstruction activities (additional CIP)

 

Preconstruction activities include Building Information Modeling (3-D virtual modeling), design development and construction drawings, sustainability and energy optimization review, budgeting, planning for future site and infrastructure work, and other activities prior to commencement of vertical construction of aboveground shell and core improvements.  Our objective with preconstruction is to reduce the time it takes to deliver projects to prospective client tenants.  Project costs are capitalized as a cost of the project during periods when activities necessary to prepare an asset for its intended use are in progress.  We generally will not commence ground-up development of any parcels undergoing preconstruction activities without first securing pre-leasing for such space.  If vertical aboveground construction is not initiated at completion of preconstruction activities, the land parcel will be classified as land held for future development.  The two largest projects included in land undergoing preconstruction consist of our 1.6 million developable square feet at Alexandria Center™ at Kendall Square in East Cambridge, Massachusetts, and our 419,806 developable square feet site for the West Tower at Alexandria Center™ for Life Science – New York City.

 

Future redevelopment

 

Our asset base also includes non-laboratory space (office, warehouse, and industrial space), classified as rental properties, representing square feet for future conversion into life science laboratory space through redevelopment.  These spaces are currently classified in investments in real estate, net, in the condensed consolidated balance sheets.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

34

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Definitions and Other Information

September 30, 2012

(Tabular dollar amounts in thousands)

(Unaudited)

 

Gross assets (excluding cash and restricted cash)

 

Gross assets (excluding cash and restricted cash) are equal to total assets plus accumulated depreciation, less cash, cash equivalents, and restricted cash.

 

Initial stabilized yield - cash

 

Initial Stabilized Yield is calculated as the quotient of net operating income and our investment in the property at stabilization.  Our Initial Stabilized Yield on a cash basis reflects cash rents upon stabilization and does not reflect contractual rent escalations beyond the stabilization date.  We expect, on average, our contractual cash rents related to our value-added projects to increase over time.  Our Initial Stabilized Yield excludes the impact of leverage.

 

Interest coverage ratio

 

Interest coverage ratio is the ratio of Adjusted EBITDA to cash interest. This ratio is useful to investors as an indicator of our ability to service our cash interest obligations.  See fixed charge coverage ratio for calculation of cash interest.  The following table summarizes the calculation of the interest coverage ratio:

 

 

 

Three Months Ended

 

 

 

9/30/12

 

6/30/12

 

3/31/12

 

12/31/11

 

9/30/11

 

Adjusted EBITDA

 

$

95,654

 

$

100,792

 

$

94,459

 

$

94,491

 

$

94,292

 

Cash interest

 

$

31,275

 

$

31,423

 

$

28,671

 

$

27,792

 

$

28,045

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest coverage ratio – quarter annualized

 

3.1x

 

3.2x

 

3.3x

 

3.4x

 

3.4x

 

Interest coverage ratio – trailing 12 months

 

3.2x

 

3.3x

 

3.4x

 

3.4x

 

3.3x

 

 

Net debt

 

Net debt is equal to the sum of total debt less cash, cash equivalents, and restricted cash.

 

Net operating income

 

Net operating income is a non-GAAP financial measure equal to income from continuing operations, the most directly comparable GAAP financial measure, plus loss on early extinguishment of debt, depreciation and amortization, interest expense, and general and administrative expense.  We believe net operating income provides useful information to investors regarding our financial condition and results of operations because it reflects primarily those income and expense items that are incurred at the property level.  Therefore, we believe net operating income is a useful measure for evaluating the operating performance of our real estate assets.  Net operating income on a cash basis is net operating income on a GAAP basis, adjusted to exclude the effect of straight-line rent adjustments required by GAAP.  We believe that net operating income on a cash basis is helpful to investors as an additional measure of operating performance because it eliminates straight-line rent adjustments to rental revenue.

 

Further, we believe net operating income is useful to investors as a performance measure, because when compared across periods, net operating income reflects the impact on operations from trends in occupancy rates, rental rates, and operating costs, providing perspective not immediately apparent from income from continuing operations.  Net operating income excludes certain components from income from continuing operations in order to provide results that are more closely related to the results of operations of our properties.  For example, interest expense is not necessarily linked to the operating performance of a real estate asset and is often incurred at the corporate level rather than at the property level.  In addition, depreciation and amortization, because of historical cost accounting and useful life estimates, may distort operating performance at the property level.  Property operating expenses that are included in determining net operating income consist of costs that are related to our operating properties, such as utilities, repairs and maintenance, rental expense related to ground leases, contracted services, such as janitorial, engineering, and landscaping, property taxes and insurance, and property level salaries.  General and administrative expenses consist primarily of accounting and corporate compensation, corporate insurance, professional fees, office rent, and office supplies, that are incurred as part of corporate office management. Net operating income presented by us may not be comparable to net operating income reported by other equity REITs that define net operating income differently.  We believe that in order to facilitate a clear understanding of our operating results, net operating income should be examined in conjunction with income from continuing operations as presented in our condensed consolidated statements of income.  Net operating income should not be considered as an alternative to income from continuing operations as an indication of our performance, or as an alternative to cash flows as a measure of liquidity, or our ability to make distributions.

 

Same property comparisons

 

As a result of changes within our total property portfolio, the financial data presented in the Summary of Same Property Comparisons shows significant changes in revenue and expenses from period to period.  In order to supplement an evaluation of our results of operations over a given period, we analyze the operating performance for all properties that were fully operating for the entire periods presented for the quarter periods (herein referred to as “Same Properties”) separate from properties acquired subsequent to the first day in the first period presented, properties undergoing active development and active redevelopment, and corporate entities (legal entities performing general and administrative functions), which are excluded from same property results (herein referred to as “Non-Same Properties”).  Additionally, rental revenues from lease termination fees, if any, are excluded from the results of the Same Properties.

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

35

 

 



 

ALEXANDRIA REAL ESTATE EQUITIES, INC.

Definitions and Other Information

September 30, 2012

(Tabular dollar amounts in thousands)

(Unaudited)

 

Total market capitalization

 

Total market capitalization is equal to the sum of outstanding shares of Series E Preferred Stock and common stock multiplied by the related closing price of each class at the end of each period presented, the liquidation value of the series D cumulative convertible preferred stock (“Series D Convertible Preferred Stock”), and total debt.

 

Unencumbered net operating income as a percentage of total net operating income

 

Unencumbered net operating income as a percentage of total net operating income is a non-GAAP financial measure that we believe is useful to investors as a performance measure of our results of operations of our unencumbered real estate assets, as it reflects primarily those income and expense items that are incurred at the unencumbered property level.  We use unencumbered net operating income as a percentage of total net operating income in order to assess our compliance with our financial covenants under our debt obligations because the measure serves as a proxy for a financial measure under certain of our debt obligations.  Unencumbered net operating income is derived from assets classified in continuing operations which are not subject to any mortgage, deed of trust, lien, or other security interest.  Unencumbered net operating income for periods through June 30, 2012 has been reclassified to conform to current period presentation related to discontinued operations.

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

9/30/12

 

6/30/12

 

3/31/12

 

12/31/11

 

9/30/11

 

9/30/12

 

9/30/11

 

Unencumbered net operating income

 

$

73,543

 

$

76,989

 

$

68,462

 

$

66,968

 

$

64,264

 

$

218,994

 

$

185,413

 

Encumbered net operating income

 

27,298

 

28,668

 

29,059

 

30,728

 

32,931

 

85,025

 

105,553

 

Total net operating income

 

$

100,841

 

$

105,657

 

$

97,521

 

$

97,696

 

$

97,195

 

$

304,019

 

$

290,966

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Unencumbered net operating income as a percentage of total net operating income

 

73%

 

73%

 

70%

 

69%

 

66%

 

72%

 

64%

 

 

Weighted average interest rate for capitalization

 

The weighted average interest rate for calculating capitalization of interest required pursuant to GAAP represents a weighted average rate based on the rates applicable to borrowings outstanding during the period and includes the impact of our interest rate hedge agreements, amortization of debt discounts/premiums, amortization of loan fees, and other bank fees.  A separate calculation is performed each month to determine our weighted average interest rate for capitalization for the month.  The rate will vary each month due to changes in variable interest rates, outstanding debt balances, the proportion of variable rate debt to fixed rate debt, the amount and terms of effective interest rate hedge agreements, and the amount of loan fee amortization.

 

Weighted average shares for calculating FFO, FFO, as adjusted, and AFFO per share

 

Weighted average shares represent the weighted average of common shares outstanding during the period.  The following calculation of weighted average shares was applied to arrive at FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders, FFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders, as adjusted, and AFFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders:

 

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

9/30/12

 

6/30/12

 

3/31/12

 

12/31/11

 

9/30/11

 

9/30/12

 

9/30/11

 

Weighted average shares of common stock outstanding for calculating FFO, FFO, as adjusted, and AFFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders –basic

 

62,364,210

 

61,663,367

 

61,507,807

 

61,427,495

 

61,295,659

 

61,847,023

 

58,271,270

 

Effect of assumed conversion and dilutive securities:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assumed conversion of 8.00% Unsecured Senior Convertible Notes

 

6,087

 

6,087

 

6,087

 

6,087

 

6,047

 

6,087

 

6,047

 

Dilutive effect of stock options

 

 

173

 

1,160

 

3,939

 

8,310

 

448

 

13,475

 

Weighted average shares of common stock outstanding for calculating FFO, FFO, as adjusted, and AFFO per share attributable to Alexandria Real Estate Equities, Inc.’s common stockholders –diluted

 

62,370,297

 

61,669,627

 

61,515,054

 

61,437,521

 

61,310,016

 

61,853,558

 

58,290,792

 

 

ALEXANDRIA REAL ESTATE EQUITIES, INC.
ALL RIGHTS RESERVED © 2012

36